[S02DA03, antipyrine, The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Antipyrine.]
[B01AD01, streptokinase, Acetylsalicylic acid may increase the anticoagulant activities of Streptokinase.]
[J01GA01, streptomycin, Acetylsalicylic acid may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[L01AD04, streptozocin, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Streptozocin.]
[M03AB01, succinylcholine, The risk or severity of hyperkalemia can be increased when Succinylcholine is combined with Acetylsalicylic acid.]
[J01CG01, sulbactam, Acetylsalicylic acid may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Sulfadiazine.]
[S01AB01, sulfamethizole, The metabolism of Acetylsalicylic acid can be decreased when combined with Sulfamethizole.]
[J01EC01, sulfamethoxazole, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Sulfamethoxazole.]
[J01EC03, sulfamoxole, The metabolism of Acetylsalicylic acid can be decreased when combined with Sulfamoxole.]
[J01EB04, sulfapyridine, The metabolism of Acetylsalicylic acid can be decreased when combined with Sulfapyridine.]
[M04AB02, sulfinpyrazone, Acetylsalicylic acid may increase the antiplatelet activities of Sulfinpyrazone.]
[S01AB02, sulfisoxazole, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Sulfisoxazole.]
[M01AB02, sulindac, The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Sulindac.]
[M01AE07, suprofen, The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Suprofen.]
[A10BB04, glibornuride, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Glibornuride.]
[A10BC01, glymidine, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Glymidine.]
[M01AX04, apazone, The therapeutic efficacy of Azapropazone can be decreased when used in combination with Acetylsalicylic acid.]
[L01BB02, mercaptopurine, The excretion of Mercaptopurine can be decreased when combined with Acetylsalicylic acid.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be increased when combined with Acetylsalicylic acid.]
[N05CD07, temazepam, Acetylsalicylic acid may decrease the excretion rate of Temazepam which could result in a higher serum level.]
[L01CB02, teniposide, The metabolism of Teniposide can be increased when combined with Acetylsalicylic acid.]
[R03CC03, terbutaline, The risk or severity of hypertension can be increased when Terbutaline is combined with Acetylsalicylic acid.]
[B01AE07, dabigatran etexilate, Acetylsalicylic acid may increase the anticoagulant activities of Dabigatran etexilate.]
[G03BA03, testosterone, Acetylsalicylic acid may decrease the excretion rate of Testosterone which could result in a higher serum level.]
[S03AA02, tetracycline, The excretion of Tetracycline can be decreased when combined with Acetylsalicylic acid.]
[J01DI02, ceftaroline fosamil, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Ceftaroline fosamil.]
[N05AE05, lurasidone, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Lurasidone.]
[A04AD10, dronabinol, The metabolism of Acetylsalicylic acid can be decreased when combined with Dronabinol.]
[L04AX02, thalidomide, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Thalidomide.]
[R03DA07, theobromine, Acetylsalicylic acid may decrease the excretion rate of Theobromine which could result in a higher serum level.]
[P02CA02, thiabendazole, Acetylsalicylic acid may decrease the excretion rate of Thiabendazole which could result in a higher serum level.]
[L01XX41, eribulin, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Eribulin.]
[R06AD03, thiethylperazine, Acetylsalicylic acid may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.]
[L01AC01, thiotepa, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Thiotepa.]
[L01BB03, thioguanine, The metabolism of Tioguanine can be decreased when combined with Acetylsalicylic acid.]
[N05CA19, thiopental, The metabolism of Thiopental can be increased when combined with Acetylsalicylic acid.]
[N05AB08, thioproperazine, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Thioproperazine.]
[N05AC02, thioridazine, The risk or severity of hypertension can be increased when Thioridazine is combined with Acetylsalicylic acid.]
[G04BE06, moxisylyte, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Moxisylyte.]
[N05AL03, tiapride, Acetylsalicylic acid may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, Acetylsalicylic acid may increase the antiplatelet activities of Ticlopidine.]
[S01ED01, timolol, Acetylsalicylic acid may decrease the antihypertensive activities of Timolol.]
[P01AB02, tinidazole, Acetylsalicylic acid may decrease the excretion rate of Tinidazole which could result in a higher serum level.]
[S01AA12, tobramycin, Acetylsalicylic acid may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Tolazamide.]
[M02AX02, tolazoline, Acetylsalicylic acid may decrease the antihypertensive activities of Tolazoline.]
[V04CA01, tolbutamide, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Tolbutamide.]
[M02AA21, tolmetin, The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Tolmetin.]
[N02AX02, tramadol, Acetylsalicylic acid may decrease the excretion rate of Tramadol which could result in a higher serum level.]
[N06AF04, tranylcypromine, The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Acetylsalicylic acid.]
[C01DX11, trapidil, Acetylsalicylic acid may increase the antiplatelet activities of Trapidil.]
[N06AX05, trazodone, The risk or severity of gastrointestinal bleeding can be increased when Trazodone is combined with Acetylsalicylic acid.]
[L01XF01, tretinoin, The metabolism of Acetylsalicylic acid can be decreased when combined with Tretinoin.]
[S01BA05, triamcinolone, The risk or severity of adverse effects can be increased when Triamcinolone is combined with Acetylsalicylic acid.]
[C03DB02, triamterene, Acetylsalicylic acid may decrease the excretion rate of Triamterene which could result in a higher serum level.]
[N05CD05, triazolam, Acetylsalicylic acid may decrease the excretion rate of Triazolam which could result in a higher serum level.]
[C03AA06, trichlormethiazide, Acetylsalicylic acid may decrease the excretion rate of Trichlormethiazide which could result in a higher serum level.]
[A16AX12, trientine, Acetylsalicylic acid may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[N05AB06, trifluoperazine, The risk or severity of hypertension can be increased when Trifluoperazine is combined with Acetylsalicylic acid.]
[S01AD02, trifluridine, The excretion of Trifluridine can be decreased when combined with Acetylsalicylic acid.]
[D07AC02, fluclorolone, The risk or severity of gastrointestinal irritation can be increased when Fluclorolone is combined with Acetylsalicylic acid.]
[R03BA07, mometasone, The risk or severity of adverse effects can be increased when Mometasone is combined with Acetylsalicylic acid.]
[A03AA05, trimebutine, The risk or severity of hyperkalemia can be increased when Acetylsalicylic acid is combined with Trimebutine.]
[N03AC02, trimethadione, The risk or severity of hyperkalemia can be increased when Trimethadione is combined with Acetylsalicylic acid.]
[C02BA01, trimethaphan, Acetylsalicylic acid may decrease the antihypertensive activities of Trimethaphan.]
[J01EA01, trimethoprim, The risk or severity of hyperkalemia can be increased when Trimethoprim is combined with Acetylsalicylic acid.]
[N06AA06, trimipramine, The risk or severity of gastrointestinal bleeding can be increased when Trimipramine is combined with Acetylsalicylic acid.]
[N06AX24, vilazodone, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Vilazodone.]
[C09CA09, azilsartan medoxomil, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Azilsartan medoxomil is combined with Acetylsalicylic acid.]
[R03DX07, roflumilast, Acetylsalicylic acid may decrease the excretion rate of Roflumilast which could result in a higher serum level.]
[L01FX04, ipilimumab, Acetylsalicylic acid may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[R02AA14, oxyquinoline, Acetylsalicylic acid may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[A10BH05, linagliptin, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Linagliptin.]
[J05AG05, rilpivirine, The metabolism of Acetylsalicylic acid can be decreased when combined with Rilpivirine.]
[B01AD04, urokinase, Acetylsalicylic acid may increase the anticoagulant activities of Urokinase.]
[S01AA28, vancomycin, Acetylsalicylic acid may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, Acetylsalicylic acid may decrease the excretion rate of Ezogabine which could result in a higher serum level.]
[B01AF01, rivaroxaban, Acetylsalicylic acid may increase the anticoagulant activities of Rivaroxaban.]
[R03AC18, indacaterol, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Indacaterol.]
[B01AC24, ticagrelor, The therapeutic efficacy of Ticagrelor can be decreased when used in combination with Acetylsalicylic acid.]
[C08DA01, verapamil, The risk or severity of bleeding can be increased when Verapamil is combined with Acetylsalicylic acid.]
[N06AX09, viloxazine, Acetylsalicylic acid may decrease the excretion rate of Viloxazine which could result in a higher serum level.]
[L01CA01, vinblastine, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Vinblastine.]
[C04AX07, vincamine, Acetylsalicylic acid may decrease the antihypertensive activities of Vincamine.]
[L01CA03, vindesine, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Vindesine.]
[B03BA01, vitamin B12, Acetylsalicylic acid may decrease the excretion rate of Cyanocobalamin which could result in a higher serum level.]
[A11HA03, vitamin E, Vitamin E may increase the antiplatelet activities of Acetylsalicylic acid.]
[B01AA03, warfarin, Acetylsalicylic acid may increase the anticoagulant activities of Warfarin.]
[N01AX15, xenon, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Xenon.]
[C03BA10, xipamide, Acetylsalicylic acid may decrease the excretion rate of Xipamide which could result in a higher serum level.]
[J05AF01, zidovudine, The risk or severity of bleeding can be increased when Zidovudine is combined with Acetylsalicylic acid.]
[N05AF05, zuclopenthixol, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Zuclopenthixol.]
[L01EC01, vemurafenib, The metabolism of Acetylsalicylic acid can be decreased when combined with Vemurafenib.]
[M05BA05, tiludronic acid, The serum concentration of Tiludronic acid can be decreased when it is combined with Acetylsalicylic acid.]
[B06AC02, icatibant, The risk or severity of angioedema can be increased when Acetylsalicylic acid is combined with Icatibant.]
[B01AE01, desirudin, Acetylsalicylic acid may increase the anticoagulant activities of Lepirudin.]
[R03DC01, zafirlukast, The metabolism of Acetylsalicylic acid can be decreased when combined with Zafirlukast.]
[A02BC04, rabeprazole, Acetylsalicylic acid may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[M05BA06, ibandronic acid, The risk or severity of gastrointestinal bleeding can be increased when Acetylsalicylic acid is combined with Ibandronate.]
[J01MA13, trovafloxacin, Acetylsalicylic acid may increase the neuroexcitatory activities of Trovafloxacin.]
[N05AE04, ziprasidone, The risk or severity of hypertension can be increased when Ziprasidone is combined with Acetylsalicylic acid.]
[G03AC10, drospirenone, The risk or severity of hyperkalemia can be increased when Acetylsalicylic acid is combined with Drospirenone.]
[V03AC02, deferiprone, Acetylsalicylic acid may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[L04AA34, alemtuzumab, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Alemtuzumab.]
[J01MB04, pipemidic acid, Acetylsalicylic acid may increase the neuroexcitatory activities of Pipemidic acid.]
[M05BA03, pamidronic acid, The risk or severity of gastrointestinal bleeding can be increased when Acetylsalicylic acid is combined with Pamidronic acid.]
[L01EJ01, ruxolitinib, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Ruxolitinib.]
[G04BD07, tolterodine, Acetylsalicylic acid may decrease the excretion rate of Tolterodine which could result in a higher serum level.]
[J01DH04, doripenem, The excretion of Doripenem can be decreased when combined with Acetylsalicylic acid.]
[C07AB03, atenolol, Acetylsalicylic acid may decrease the antihypertensive activities of Atenolol.]
[L03AB11, peginterferon alfa-2a, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Peginterferon alfa-2a.]
[L01FA01, rituximab, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Rituximab.]
[J02AC03, voriconazole, The serum concentration of Acetylsalicylic acid can be increased when it is combined with Voriconazole.]
[S01FA01, atropine, The risk or severity of hypertension can be increased when Atropine is combined with Acetylsalicylic acid.]
[M01CB03, auranofin, Acetylsalicylic acid may decrease the excretion rate of Auranofin which could result in a higher serum level.]
[L01XJ01, vismodegib, The metabolism of Vismodegib can be decreased when combined with Acetylsalicylic acid.]
[L01EK01, axitinib, The metabolism of Axitinib can be increased when combined with Acetylsalicylic acid.]
[S01EE05, tafluprost, The therapeutic efficacy of Tafluprost can be decreased when used in combination with Acetylsalicylic acid.]
[H02AB11, prednylidene, The risk or severity of adverse effects can be increased when Prednylidene is combined with Acetylsalicylic acid.]
[B03XA04, peginesatide, Acetylsalicylic acid may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Azacitidine.]
[L04AX01, azathioprine, The metabolism of Azathioprine can be decreased when combined with Acetylsalicylic acid.]
[L01BC05, gemcitabine, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Gemcitabine.]
[J01DF01, aztreonam, Acetylsalicylic acid may decrease the excretion rate of Aztreonam which could result in a higher serum level.]
[R02AB04, bacitracin, The risk or severity of nephrotoxicity can be increased when Bacitracin is combined with Acetylsalicylic acid.]
[G04BE10, avanafil, The metabolism of Avanafil can be decreased when combined with Acetylsalicylic acid.]
[M03BX01, baclofen, Acetylsalicylic acid may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[J07BK01, varicella-zoster virus vaccine live (Oka-Merck) strain, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Varicella zoster vaccine (live/attenuated).]
[L01FX02, gemtuzumab ozogamicin, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Gemtuzumab ozogamicin.]
[A08AA11, lorcaserin, Acetylsalicylic acid may decrease the excretion rate of Lorcaserin which could result in a higher serum level.]
[G04BD12, mirabegron, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Mirabegron.]
[L01XG02, carfilzomib, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Carfilzomib.]
[L02BB04, enzalutamide, The serum concentration of Acetylsalicylic acid can be decreased when it is combined with Enzalutamide.]
[L01EA04, bosutinib, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Bosutinib.]
[B01AX01, defibrotide, Acetylsalicylic acid may increase the antiplatelet activities of Defibrotide.]
[C01CA18, octopamine, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Octopamine.]
[H02AA01, aldosterone, The risk or severity of gastrointestinal irritation can be increased when Aldosterone is combined with Acetylsalicylic acid.]
[L01EX05, regorafenib, The metabolism of Acetylsalicylic acid can be decreased when combined with Regorafenib.]
[C01AA01, acetyldigitoxin, The serum concentration of Acetyldigitoxin can be decreased when it is combined with Acetylsalicylic acid.]
[D02BA02, octinoxate, Acetylsalicylic acid may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[L01AA09, bendamustine, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Bendamustine.]
[N04BD02, rasagiline, The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Acetylsalicylic acid.]
[C08CA13, lercanidipine, Acetylsalicylic acid may decrease the antihypertensive activities of Lercanidipine.]
[N06DA02, donepezil, The metabolism of Acetylsalicylic acid can be decreased when combined with Donepezil.]
[L04AA29, tofacitinib, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Tofacitinib.]
[N02CC03, zolmitriptan, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Acetylsalicylic acid.]
[V09IX04, fluorodeoxyglucose F18, Acetylsalicylic acid may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[N01AA01, ethyl ether, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Diethyl ether.]
[L01EX07, cabozantinib, The metabolism of Cabozantinib can be decreased when combined with Acetylsalicylic acid.]
[G04BE03, sildenafil, The metabolism of Acetylsalicylic acid can be decreased when combined with Sildenafil.]
[V08CA11, gadofosveset, Acetylsalicylic acid may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[L01EA05, ponatinib, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Ponatinib.]
[B01AF02, apixaban, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Apixaban.]
[A16AX08, teduglutide, Acetylsalicylic acid may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[C04AX11, bencyclane, The risk or severity of hyperkalemia can be increased when Acetylsalicylic acid is combined with Bencyclane.]
[A10BH04, alogliptin, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Alogliptin.]
[A16AX09, glycerol phenylbutyrate, Acetylsalicylic acid may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.]
[C03AA01, bendroflumethiazide, Acetylsalicylic acid may decrease the excretion rate of Bendroflumethiazide which could result in a higher serum level.]
[L04AX06, pomalidomide, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Pomalidomide.]
[G03XC05, ospemifene, The metabolism of Ospemifene can be decreased when combined with Acetylsalicylic acid.]
[N02BA10, benorilate, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Benorilate.]
[A10BK02, canagliflozin, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Canagliflozin.]
[J01MA15, gemifloxacin, Acetylsalicylic acid may increase the neuroexcitatory activities of Gemifloxacin.]
[M04AB03, benzbromarone, The therapeutic efficacy of Benzbromarone can be decreased when used in combination with Acetylsalicylic acid.]
[S01AE07, moxifloxacin, Acetylsalicylic acid may increase the neuroexcitatory activities of Moxifloxacin.]
[H03AA04, tiratricol, The therapeutic efficacy of Tiratricol can be increased when used in combination with Acetylsalicylic acid.]
[A10AE05, insulin detemir, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Insulin detemir.]
[A10BX05, pramlintide, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Pramlintide.]
[L03AA12, ancestim, Acetylsalicylic acid may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, The risk or severity of gastrointestinal irritation can be increased when Celecoxib is combined with Acetylsalicylic acid.]
[N02CC02, naratriptan, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Naratriptan.]
[C10AC04, colesevelam, Colesevelam can cause a decrease in the absorption of Acetylsalicylic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L04AA18, everolimus, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Everolimus.]
[N04AC01, benztropine, Acetylsalicylic acid may decrease the excretion rate of Benzatropine which could result in a higher serum level.]
[L01EC02, dabrafenib, The serum concentration of Acetylsalicylic acid can be decreased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Benzydamine.]
[L01EE01, trametinib, Acetylsalicylic acid may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[V09AX05, florbetapir F-18, Acetylsalicylic acid may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[N06AX28, levomilnacipran, Levomilnacipran may increase the antiplatelet activities of Acetylsalicylic acid.]
[C08EA02, bepridil, Acetylsalicylic acid may decrease the antihypertensive activities of Bepridil.]
[C02KX05, riociguat, Acetylsalicylic acid may decrease the antihypertensive activities of Riociguat.]
[A10BJ03, lixisenatide, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Lixisenatide.]
[A05AA03, cholic acid, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Cholic Acid.]
[C02KX04, macitentan, Acetylsalicylic acid may decrease the antihypertensive activities of Macitentan.]
[L01EL01, ibrutinib, The risk or severity of adverse effects can be increased when Ibrutinib is combined with Acetylsalicylic acid.]
[N06AX26, vortioxetine, The risk or severity of bleeding can be increased when Vortioxetine is combined with Acetylsalicylic acid.]
[G03AC08, etonogestrel, Acetylsalicylic acid may decrease the excretion rate of Etonogestrel which could result in a higher serum level.]
[V03AE05, sucroferric oxyhydroxide, The serum concentration of Acetylsalicylic acid can be decreased when it is combined with Iron sucrose.]
[J05AP08, sofosbuvir, Acetylsalicylic acid may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Dapagliflozin.]
[C01CA27, droxidopa, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Droxidopa.]
[C07AB04, acebutolol, Acetylsalicylic acid may decrease the antihypertensive activities of Acebutolol.]
[N05CH03, tasimelteon, Acetylsalicylic acid may decrease the excretion rate of Tasimelteon which could result in a higher serum level.]
[L04AA32, apremilast, The metabolism of Acetylsalicylic acid can be increased when combined with Apremilast.]
[L02BG02, formestane, Acetylsalicylic acid may decrease the excretion rate of Formestane which could result in a higher serum level.]
[S03BA03, betamethasone, The risk or severity of adverse effects can be increased when Betamethasone is combined with Acetylsalicylic acid.]
[S01ED02, betaxolol, Acetylsalicylic acid may decrease the antihypertensive activities of Betaxolol.]
[B01AE03, argatroban, Acetylsalicylic acid may increase the anticoagulant activities of Argatroban.]
[V03AB34, fomepizole, Acetylsalicylic acid may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[C02CC01, bethanidine, Acetylsalicylic acid may decrease the antihypertensive activities of Bethanidine.]
[A10BJ04, albiglutide, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Albiglutide.]
[L04AC11, siltuximab, The metabolism of Acetylsalicylic acid can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The metabolism of Acetylsalicylic acid can be decreased when combined with Ceritinib.]
[B01AC26, vorapaxar, Acetylsalicylic acid may increase the antiplatelet activities of Vorapaxar.]
[B01AA07, acenocoumarol, Acetylsalicylic acid may increase the anticoagulant activities of Acenocoumarol.]
[L01XH04, belinostat, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Belinostat.]
[A10BK03, empagliflozin, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Empagliflozin.]
[R03AC19, olodaterol, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Olodaterol.]
[L03AB13, peginterferon beta-1a, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Peginterferon beta-1a.]
[V08AA01, diatrizoic acid, Acetylsalicylic acid may decrease the excretion rate of Diatrizoate which could result in a higher serum level.]
[S01EE02, unoprostone, The therapeutic efficacy of Unoprostone can be decreased when used in combination with Acetylsalicylic acid.]
[V08AA04, iothalamic acid, Acetylsalicylic acid may decrease the excretion rate of Diatrizoate which could result in a higher serum level.]
[J01XA05, oritavancin, The metabolism of Acetylsalicylic acid can be decreased when combined with Oritavancin.]
[S01AA15, dihydrostreptomycin, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Dihydrostreptomycin.]
[N05AA04, acepromazine, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Acepromazine.]
[A10BJ05, dulaglutide, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Dulaglutide.]
[L01BC08, decitabine, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Decitabine.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Acetylsalicylic acid.]
[S03AA06, gentamicin, Acetylsalicylic acid may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[L01FX07, blinatumomab, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Blinatumomab.]
[L01XK01, olaparib, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Olaparib.]
[B01AA01, dicumarol, Acetylsalicylic acid may increase the anticoagulant activities of Dicoumarol.]
[B01AF03, edoxaban, Acetylsalicylic acid may increase the anticoagulant activities of Edoxaban.]
[N06AX11, mirtazapine, The risk or severity of hypertension can be increased when Mirtazapine is combined with Acetylsalicylic acid.]
[L04AC10, secukinumab, The metabolism of Acetylsalicylic acid can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Palbociclib.]
[L01DC01, bleomycin, Acetylsalicylic acid may decrease the excretion rate of Bleomycin which could result in a higher serum level.]
[B01AA11, tioclomarol, Acetylsalicylic acid may increase the anticoagulant activities of Tioclomarol.]
[J05AF08, adefovir dipivoxil, The risk or severity of nephrotoxicity can be increased when Adefovir dipivoxil is combined with Acetylsalicylic acid.]
[J05AP06, asunaprevir, The metabolism of Asunaprevir can be decreased when combined with Acetylsalicylic acid.]
[A07DA06, eluxadoline, The excretion of Eluxadoline can be decreased when combined with Acetylsalicylic acid.]
[B01AC25, cangrelor, Acetylsalicylic acid may increase the antiplatelet activities of Cangrelor.]
[N05AX16, brexpiprazole, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Brexpiprazole.]
[G02CX02, flibanserin, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Flibanserin.]
[N05AX15, cariprazine, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Cariprazine.]
[A10BF01, acarbose, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Acarbose.]
[M02AA25, aceclofenac, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Aceclofenac.]
[M01AB11, acemetacin, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Acemetacin.]
[S01EC01, acetazolamide, Acetylsalicylic acid may decrease the excretion rate of Acetazolamide which could result in a higher serum level.]
[A10AE06, insulin degludec, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Insulin degludec.]
[A02BC03, lansoprazole, The metabolism of Acetylsalicylic acid can be decreased when combined with Lansoprazole.]
[V03AB37, idarucizumab, Acetylsalicylic acid may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be increased when combined with Acetylsalicylic acid.]
[J02AC05, isavuconazole, The metabolism of Acetylsalicylic acid can be decreased when combined with Isavuconazole.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Acetylsalicylic acid.]
[L01XG03, ixazomib, Acetylsalicylic acid may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[B01AC27, selexipag, Acetylsalicylic acid may decrease the antihypertensive activities of Selexipag.]
[A10BB31, acetohexamide, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Acetohexamide.]
[M04AB05, lesinurad, The therapeutic efficacy of Lesinurad can be decreased when used in combination with Acetylsalicylic acid.]
[M01AE16, alminoprofen, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Alminoprofen.]
[N02BA02, aloxiprin, The therapeutic efficacy of Aloxiprin can be decreased when used in combination with Acetylsalicylic acid.]
[N03AX23, brivaracetam, Acetylsalicylic acid may decrease the excretion rate of Brivaracetam which could result in a higher serum level.]
[N05BA08, bromazepam, Acetylsalicylic acid may decrease the excretion rate of Bromazepam which could result in a higher serum level.]
[N04BC01, bromocriptine, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Bromocriptine.]
[A02AD05, aluminum magnesium silicate, Acetylsalicylic acid may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[N06AA19, amineptin, The risk or severity of gastrointestinal bleeding can be increased when Amineptine is combined with Acetylsalicylic acid.]
[C08CA01, amlodipine, Acetylsalicylic acid may decrease the antihypertensive activities of Amlodipine.]
[M02AA09, bufexamac, The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Bufexamac.]
[A05AA04, obeticholic acid, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Obeticholic acid.]
[C03CA02, bumetanide, Acetylsalicylic acid may decrease the excretion rate of Bumetanide which could result in a higher serum level.]
[N01BB01, bupivacaine, Acetylsalicylic acid may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.]
[C07AA19, bupranolol, Acetylsalicylic acid may decrease the antihypertensive activities of Bupranolol.]
[N07BC01, buprenorphine, The metabolism of Acetylsalicylic acid can be decreased when combined with Buprenorphine.]
[N05BE01, buspirone, The risk or severity of hypertension can be increased when Buspirone is combined with Acetylsalicylic acid.]
[L01AB01, busulfan, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Busulfan.]
[L01XX27, arsenic trioxide, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Arsenic trioxide.]
[P01BE02, artemether, The metabolism of Artemether can be decreased when combined with Acetylsalicylic acid.]
[M02AA03, clofezone, Acetylsalicylic acid may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[J01MA09, sparfloxacin, Acetylsalicylic acid may increase the neuroexcitatory activities of Sparfloxacin.]
[S01GX07, azelastine, The metabolism of Azelastine can be decreased when combined with Acetylsalicylic acid.]
[L01XK03, rucaparib, The metabolism of Acetylsalicylic acid can be decreased when combined with Rucaparib.]
[A07EC04, balsalazide, The therapeutic efficacy of Balsalazide can be decreased when used in combination with Acetylsalicylic acid.]
[R03CC12, bambuterol, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Bambuterol.]
[A06AH05, naldemedine, Acetylsalicylic acid may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Acetylsalicylic acid may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, The risk or severity of angioedema can be increased when Pregabalin is combined with Acetylsalicylic acid.]
[C09AA07, benazepril, The therapeutic efficacy of Benazepril can be decreased when used in combination with Acetylsalicylic acid.]
[A10BX06, benfluorex, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Benfluorex.]
[P01CA02, benznidazole, Acetylsalicylic acid may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J01XX08, linezolid, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Acetylsalicylic acid.]
[J05AF06, abacavir, Acetylsalicylic acid may decrease the excretion rate of Abacavir which could result in a higher serum level.]
[J05AE09, tipranavir, Tipranavir may increase the antiplatelet activities of Acetylsalicylic acid.]
[N07XX13, valbenazine, Acetylsalicylic acid may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[L04AB02, infliximab, The metabolism of Acetylsalicylic acid can be increased when combined with Infliximab.]
[N04BD03, safinamide, The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Acetylsalicylic acid.]
[J01MA23, delafloxacin, Acetylsalicylic acid may increase the neuroexcitatory activities of Delafloxacin.]
[B01AF04, betrixaban, The risk or severity of bleeding can be increased when Betrixaban is combined with Acetylsalicylic acid.]
[L01BC06, capecitabine, The metabolism of Acetylsalicylic acid can be decreased when combined with Capecitabine.]
[L01XX59, enasidenib, The metabolism of Acetylsalicylic acid can be decreased when combined with Enasidenib.]
[L01XH01, vorinostat, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Vorinostat.]
[C07AB07, bisoprolol, Acetylsalicylic acid may decrease the antihypertensive activities of Bisoprolol.]
[R03AC17, bitolterol, The risk or severity of hypertension can be increased when Bitolterol is combined with Acetylsalicylic acid.]
[J05AG03, efavirenz, The metabolism of Acetylsalicylic acid can be decreased when combined with Efavirenz.]
[J01DC10, cefprozil, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Cefprozil.]
[C07AA17, bopindolol, Acetylsalicylic acid may decrease the antihypertensive activities of Bopindolol.]
[L01BA03, raltitrexed, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Raltitrexed.]
[S01BC11, bromfenac, The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Bromfenac.]
[C03DA03, canrenone, Acetylsalicylic acid may decrease the excretion rate of Canrenone which could result in a higher serum level.]
[R03BA02, budesonide, The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Acetylsalicylic acid.]
[C04AX20, buflomedil, Acetylsalicylic acid may increase the antiplatelet activities of Buflomedil.]
[M01AB07, bumadizone, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Bumadizone.]
[S01EE06, latanoprostene bunod, The therapeutic efficacy of Latanoprostene bunod can be decreased when used in combination with Acetylsalicylic acid.]
[N06AA15, butriptyline, The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Acetylsalicylic acid.]
[C01AA02, acetyldigoxins, Acetylsalicylic acid may decrease the excretion rate of Acetyldigoxin which could result in a higher serum level.]
[A10BJ06, semaglutide, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Semaglutide.]
[A10BK04, ertugliflozin, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Ertugliflozin.]
[R06AX18, acrivastine, Acetylsalicylic acid may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[C09AA01, captopril, The therapeutic efficacy of Captopril can be decreased when used in combination with Acetylsalicylic acid.]
[V04CD06, macimorelin, The therapeutic efficacy of Macimorelin can be decreased when used in combination with Acetylsalicylic acid.]
[L02BB05, apalutamide, Acetylsalicylic acid may decrease the excretion rate of Apalutamide which could result in a higher serum level.]
[N03AF01, carbamazepine, Acetylsalicylic acid may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L03AB06, interferon alfa-n1, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Interferon alfa-n1.]
[C07AG02, carvedilol, Acetylsalicylic acid may decrease the antihypertensive activities of Carvedilol.]
[N03AX24, cannabidiol, The metabolism of Acetylsalicylic acid can be decreased when combined with Cannabidiol.]
[B02BX08, avatrombopag, The metabolism of Acetylsalicylic acid can be increased when combined with Avatrombopag.]
[L04AA37, baricitinib, The serum concentration of Baricitinib can be increased when it is combined with Acetylsalicylic acid.]
[J01DE01, cefepime, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Cefepime.]
[J01DD10, cefetamet, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Cefetamet.]
[J01DD09, cefodizime, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Cefodizime.]
[J01DC11, ceforanide, The risk or severity of nephrotoxicity can be increased when Ceforanide is combined with Acetylsalicylic acid.]
[J01DD13, cefpodoxime, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Cefpodoxime.]
[J01DD14, ceftibuten, The excretion of Ceftibuten can be decreased when combined with Acetylsalicylic acid.]
[J01GB14, plazomicin, Acetylsalicylic acid may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[C07AB08, celiprolol, Acetylsalicylic acid may decrease the antihypertensive activities of Celiprolol.]
[L01XX62, ivosidenib, The metabolism of Acetylsalicylic acid can be increased when combined with Ivosidenib.]
[A16AX14, migalastat, Acetylsalicylic acid may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, The metabolism of Acetylsalicylic acid can be decreased when combined with Stiripentol.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Acetylsalicylic acid.]
[S01GX12, cetirizine, Acetylsalicylic acid may decrease the excretion rate of Cetirizine which could result in a higher serum level.]
[A10BB06, carbutamide, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Carbutamide.]
[D08AE05, chloroxylenol, Acetylsalicylic acid may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Lornoxicam.]
[N07XX15, inotersen, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Inotersen.]
[M03BA02, carisoprodol, The metabolism of Carisoprodol can be increased when combined with Acetylsalicylic acid.]
[L04AA39, emapalumab, The metabolism of Acetylsalicylic acid can be increased when combined with Emapalumab.]
[L01AD01, carmustine, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Carmustine.]
[A06AX05, prucalopride, Acetylsalicylic acid may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C09AA08, cilazapril, The therapeutic efficacy of Cilazapril can be decreased when used in combination with Acetylsalicylic acid.]
[B01AX07, caplacizumab, Acetylsalicylic acid may increase the antiplatelet activities of Caplacizumab.]
[B01AC23, cilostazol, Acetylsalicylic acid may increase the antiplatelet activities of Cilostazol.]
[A03FA08, cinitapride, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Cinitapride.]
[P02BX04, triclabendazole, The metabolism of Acetylsalicylic acid can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The risk or severity of hypertension can be increased when Esketamine is combined with Acetylsalicylic acid.]
[L04AA42, siponimod, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Siponimod.]
[N06BA14, solriamfetol, The risk or severity of hypertension can be increased when Solriamfetol is combined with Acetylsalicylic acid.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be decreased when combined with Acetylsalicylic acid.]
[N05BA09, clobazam, Acetylsalicylic acid may decrease the excretion rate of Clobazam which could result in a higher serum level.]
[H02AB14, cloprednol, The risk or severity of adverse effects can be increased when Cloprednol is combined with Acetylsalicylic acid.]
[C09CA06, candesartan, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Acetylsalicylic acid.]
[L04AB01, etanercept, The metabolism of Acetylsalicylic acid can be increased when combined with Etanercept.]
[V03AE02, sevelamer, Sevelamer can cause a decrease in the absorption of Acetylsalicylic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[H02AB17, cortivazol, The risk or severity of adverse effects can be increased when Cortivazol is combined with Acetylsalicylic acid.]
[L01EM03, alpelisib, The serum concentration of Acetylsalicylic acid can be decreased when it is combined with Alpelisib.]
[J01DC04, cefaclor, The excretion of Cefaclor can be decreased when combined with Acetylsalicylic acid.]
[J01DB05, cefadroxil, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Cefadroxil.]
[J01DC03, cefamandole, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Cefamandole.]
[J01DB07, cefatrizine, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Cefatrizine.]
[J01DB04, cefazolin, The excretion of Cefazolin can be decreased when combined with Acetylsalicylic acid.]
[J01DC09, cefmetazole, The risk or severity of nephrotoxicity can be increased when Cefmetazole is combined with Acetylsalicylic acid.]
[J01DC06, cefonicid, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Cefonicid.]
[J01DD12, cefoperazone, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Cefoperazone.]
[J01DD01, cefotaxime, The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Acetylsalicylic acid.]
[J01DC05, cefotetan, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Cefotetan.]
[J01DC07, cefotiam, The excretion of Cefotiam can be decreased when combined with Acetylsalicylic acid.]
[J01DC01, cefoxitin, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Cefoxitin.]
[J01DD03, cefsulodin, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Cefsulodin.]
[J01DD02, ceftazidime, The risk or severity of nephrotoxicity can be increased when Ceftazidime is combined with Acetylsalicylic acid.]
[C03BX03, cicletanine, Acetylsalicylic acid may decrease the excretion rate of Cicletanine which could result in a higher serum level.]
[J01DD07, ceftizoxime, The excretion of Ceftizoxime can be decreased when combined with Acetylsalicylic acid.]
[J01DD04, ceftriaxone, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Ceftriaxone.]
[S01AA27, cefuroxime, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Cefuroxime.]
[N07XX11, pitolisant, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Pitolisant.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Acetylsalicylic acid.]
[C03AA09, cyclothiazide, Acetylsalicylic acid may decrease the excretion rate of Cyclothiazide which could result in a higher serum level.]
[G04BE04, yohimbine, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Yohimbine.]
[A10AE03, insulin, regular, pork, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Insulin pork.]
[J01XX09, daptomycin, Acetylsalicylic acid may decrease the excretion rate of Daptomycin which could result in a higher serum level.]
[J01DB01, cephalexin, The excretion of Cephalexin can be decreased when combined with Acetylsalicylic acid.]
[J01DB02, cephaloridine, The excretion of Cefaloridine can be decreased when combined with Acetylsalicylic acid.]
[J01DB03, cephalothin, The risk or severity of nephrotoxicity can be increased when Cefalotin is combined with Acetylsalicylic acid.]
[J01DB08, cephapirin, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Cefapirin.]
[J01DB09, cephradine, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Cefradine.]
[H02AB13, deflazacort, The risk or severity of adverse effects can be increased when Deflazacort is combined with Acetylsalicylic acid.]
[L01FD03, ado-trastuzumab emtansine, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Trastuzumab emtansine.]
[G03AC09, desogestrel, The metabolism of Acetylsalicylic acid can be decreased when combined with Desogestrel.]
[B06AX03, voxelotor, The metabolism of Voxelotor can be decreased when combined with Acetylsalicylic acid.]
[A16AX16, givosiran, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Givosiran.]
[M09AX08, golodirsen, Acetylsalicylic acid may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[S01XA12, dexpanthenol, Acetylsalicylic acid may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[L01EX18, avapritinib, The metabolism of Acetylsalicylic acid can be decreased when combined with Avapritinib.]
[M01AX21, diacetylrhein, The metabolism of Acetylsalicylic acid can be decreased when combined with Diacerein.]
[S01AE06, gatifloxacin, Acetylsalicylic acid may increase the neuroexcitatory activities of Gatifloxacin.]
[J05AE05, amprenavir, The metabolism of Acetylsalicylic acid can be decreased when combined with Amprenavir.]
[N02CC07, frovatriptan, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Frovatriptan.]
[G04CB02, dutasteride, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Dutasteride.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Acetylsalicylic acid.]
[R02AA03, dichlorobenzyl alcohol, Acetylsalicylic acid may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Acetylsalicylic acid may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[N02CC06, eletriptan, The risk or severity of hypertension can be increased when Eletriptan is combined with Acetylsalicylic acid.]
[M01AH02, rofecoxib, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Rofecoxib.]
[L01XF03, bexarotene, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Bexarotene.]
[C08CA16, clevidipine, The metabolism of Acetylsalicylic acid can be decreased when combined with Clevidipine.]
[C01BD07, dronedarone, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Dronedarone.]
[L01AA02, chlorambucil, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Chlorambucil.]
[S03AA08, chloramphenicol, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Chloramphenicol.]
[C02AA06, methoserpidine, Acetylsalicylic acid may decrease the antihypertensive activities of Methoserpidine.]
[C01CA14, dopexamine, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Dopexamine.]
[D07XB03, fluprednidene, The risk or severity of adverse effects can be increased when Fluprednidene is combined with Acetylsalicylic acid.]
[M01AC04, droxicam, The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Droxicam.]
[V08CA05, mangafodipir, Acetylsalicylic acid may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[L01EX22, selpercatinib, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Selpercatinib.]
[B01AE02, lepirudin, Acetylsalicylic acid may increase the anticoagulant activities of Lepirudin.]
[M02AA27, dexketoprofen, The risk or severity of bleeding and gastrointestinal bleeding can be increased when Acetylsalicylic acid is combined with Dexketoprofen.]
[C08CA17, levamlodipine, Acetylsalicylic acid may decrease the antihypertensive activities of Levamlodipine.]
[P01BB01, proguanil, The metabolism of Proguanil can be decreased when combined with Acetylsalicylic acid.]
[L04AC19, satralizumab, The serum concentration of Acetylsalicylic acid can be decreased when it is combined with Satralizumab.]
[P01BA01, chloroquine, Acetylsalicylic acid may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[L01EX23, pralsetinib, The metabolism of Acetylsalicylic acid can be decreased when combined with Pralsetinib.]
[C03AA04, chlorothiazide, Acetylsalicylic acid may decrease the excretion rate of Chlorothiazide which could result in a higher serum level.]
[N05AA01, chlorpromazine, The risk or severity of hypertension can be increased when Chlorpromazine is combined with Acetylsalicylic acid.]
[A10BB02, chlorpropamide, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Chlorpropamide.]
[C03BA04, chlorthalidone, Acetylsalicylic acid may decrease the excretion rate of Chlorthalidone which could result in a higher serum level.]
[M03BB03, chlorzoxazone, Acetylsalicylic acid may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.]
[N02BA07, ethenzamide, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Ethenzamide.]
[C10AC01, cholestyramine resin, Cholestyramine can cause a decrease in the absorption of Acetylsalicylic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N02BA03, choline salicylate, The therapeutic efficacy of Choline salicylate can be decreased when used in combination with Acetylsalicylic acid.]
[N06BX18, vinpocetine, The risk or severity of hyperkalemia can be increased when Acetylsalicylic acid is combined with Vinpocetine.]
[M01AB08, etodolac, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Etodolac.]
[M02AA06, etofenamate, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Etofenamate.]
[A16AX20, lonafarnib, The metabolism of Lonafarnib can be decreased when combined with Acetylsalicylic acid.]
[L01BB05, fludarabine, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Fludarabine.]
[M01AX25, chondroitin sulfates, Acetylsalicylic acid may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[L01FX21, naxitamab, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Naxitamab.]
[L01EX21, tepotinib, The metabolism of Acetylsalicylic acid can be decreased when combined with Tepotinib.]
[N03AX10, felbamate, The metabolism of Acetylsalicylic acid can be decreased when combined with Felbamate.]
[M01AE05, fenbufen, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Fenbufen.]
[C01CA19, fenoldopam, Acetylsalicylic acid may decrease the antihypertensive activities of Fenoldopam.]
[N06BA08, fenozolone, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Fenozolone.]
[B03AB02, iron sucrose, The serum concentration of Acetylsalicylic acid can be decreased when it is combined with Iron sucrose.]
[G04CB01, finasteride, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Finasteride.]
[J01DD15, cefdinir, The excretion of Cefdinir can be decreased when combined with Acetylsalicylic acid.]
[J01MB07, flumequine, Acetylsalicylic acid may increase the neuroexcitatory activities of Flumequine.]
[R03BA03, flunisolide, The risk or severity of gastrointestinal irritation can be increased when Flunisolide is combined with Acetylsalicylic acid.]
[S02BA08, fluocinolone acetonide, The risk or severity of gastrointestinal irritation can be increased when Fluocinolone acetonide is combined with Acetylsalicylic acid.]
[S01JA01, fluorescein, The excretion of Fluorescein can be decreased when combined with Acetylsalicylic acid.]
[N02BG07, flupirtine, Acetylsalicylic acid may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[R03CC15, formoterol, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Formoterol.]
[A10AF01, insulin, regular, human, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Insulin human.]
[N01AB05, trichloroethylene, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Trichloroethylene.]
[L03AB10, peginterferon alfa-2b, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Peginterferon alfa-2b.]
[H04AA02, dasiglucagon, Acetylsalicylic acid may decrease the antihypertensive activities of Dasiglucagon.]
[A02BA01, cimetidine, The excretion of Cimetidine can be decreased when combined with Acetylsalicylic acid.]
[V08CA04, gadoteridol, Acetylsalicylic acid may decrease the excretion rate of Gadoteridol which could result in a higher serum level.]
[N07CA02, cinnarizine, The risk or severity of hyperkalemia can be increased when Cinnarizine is combined with Acetylsalicylic acid.]
[J01MB06, cinoxacin, Acetylsalicylic acid may increase the neuroexcitatory activities of Cinoxacin.]
[S03AA07, ciprofloxacin, Acetylsalicylic acid may increase the neuroexcitatory activities of Ciprofloxacin.]
[L01XA01, cisplatin, Acetylsalicylic acid may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[N06AB04, citalopram, The risk or severity of gastrointestinal bleeding can be increased when Citalopram is combined with Acetylsalicylic acid.]
[C03DA05, finerenone, Acetylsalicylic acid may decrease the excretion rate of Finerenone which could result in a higher serum level.]
[V09AB03, ioflupane I-123, Acetylsalicylic acid may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Acetylsalicylic acid may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Acetylsalicylic acid may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[M01AG01, mefenamic acid, The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Mefenamic acid.]
[A10BB12, glimepiride, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Glimepiride.]
[A10BB08, gliquidone, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Gliquidone.]
[R03CC13, clenbuterol, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Clenbuterol.]
[L01EA06, asciminib, The metabolism of Acetylsalicylic acid can be decreased when combined with Asciminib.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Ropeginterferon alfa-2b.]
[D11AH08, abrocitinib, The risk or severity of bleeding and thrombocytopenia can be increased when Acetylsalicylic acid is combined with Abrocitinib.]
[B01AD11, tenecteplase, Acetylsalicylic acid may increase the anticoagulant activities of Tenecteplase.]
[N01BB10, levobupivacaine, Acetylsalicylic acid may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.]
[N06AA04, clomipramine, The risk or severity of gastrointestinal bleeding can be increased when Clomipramine is combined with Acetylsalicylic acid.]
[N03AE01, clonazepam, Acetylsalicylic acid may decrease the excretion rate of Clonazepam which could result in a higher serum level.]
[S01EA04, clonidine, Acetylsalicylic acid may decrease the antihypertensive activities of Clonidine.]
[C01EB24, mavacamten, The serum concentration of Acetylsalicylic acid can be decreased when it is combined with Mavacamten.]
[J05AH02, oseltamivir, The excretion of Oseltamivir can be decreased when combined with Acetylsalicylic acid.]
[A10BX16, tirzepatide, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Tirzepatide.]
[C03BA03, clopamide, Acetylsalicylic acid may decrease the excretion rate of Clopamide which could result in a higher serum level.]
[A04AA01, ondansetron, The metabolism of Acetylsalicylic acid can be decreased when combined with Ondansetron.]
[M02AA08, felbinac, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Felbinac.]
[N05AH02, clozapine, The risk or severity of hypertension can be increased when Clozapine is combined with Acetylsalicylic acid.]
[A10BX01, guar gum, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Guar gum.]
[A10BK06, sotagliflozin, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Sotagliflozin.]
[J01GB12, arbekacin, Acetylsalicylic acid may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[C02KB01, metyrosine, Acetylsalicylic acid may decrease the antihypertensive activities of Metyrosine.]
[L04AC21, bimekizumab, The metabolism of Acetylsalicylic acid can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Proquazone.]
[M04AC01, colchicine, Acetylsalicylic acid may decrease the excretion rate of Colchicine which could result in a higher serum level.]
[C10AC02, colestipol, Colestipol can cause a decrease in the absorption of Acetylsalicylic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J01XB01, colistin, Acetylsalicylic acid may decrease the excretion rate of Colistin which could result in a higher serum level.]
[L01XX40, omacetaxine mepesuccinate, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Omacetaxine mepesuccinate.]
[J01DE02, cefpirome, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Cefpirome.]
[L04AA13, leflunomide, The metabolism of Acetylsalicylic acid can be decreased when combined with Leflunomide.]
[N01AB07, desflurane, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Desflurane.]
[A04AA03, tropisetron, Acetylsalicylic acid may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[C04AX28, ifenprodil, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Ifenprodil.]
[A10BX03, nateglinide, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Nateglinide.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Imidazole salicylate.]
[H01AC03, mecasermin, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Mecasermin.]
[L01BB07, nelarabine, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Nelarabine.]
[A10AE04, insulin glargine, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Insulin glargine.]
[R03BA08, ciclesonide, The risk or severity of adverse effects can be increased when Ciclesonide is combined with Acetylsalicylic acid.]
[B01AC10, indobufen, Acetylsalicylic acid may increase the antiplatelet activities of Indobufen.]
[J05AB14, valganciclovir, Acetylsalicylic acid may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[C05BB03, invert sugar, Acetylsalicylic acid may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Acetylsalicylic acid may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Acetylsalicylic acid may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Acetylsalicylic acid may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Acetylsalicylic acid may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Valdecoxib.]
[C01AA06, lanatoside C, The serum concentration of Lanatoside C can be decreased when it is combined with Acetylsalicylic acid.]
[A03AX10, isometheptene, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Isometheptene.]
[N02CC05, almotriptan, The risk or severity of hypertension can be increased when Almotriptan is combined with Acetylsalicylic acid.]
[M01AH04, parecoxib, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Parecoxib.]
[J02AC02, itraconazole, The risk or severity of hyperkalemia can be increased when Acetylsalicylic acid is combined with Itraconazole.]
[B01AB12, bemiparin, Acetylsalicylic acid may increase the anticoagulant activities of Bemiparin.]
[S01AD03, acyclovir, The excretion of Acyclovir can be decreased when combined with Acetylsalicylic acid.]
[N05BA10, ketazolam, Acetylsalicylic acid may decrease the excretion rate of Ketazolam which could result in a higher serum level.]
[M01AA06, kebuzone, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Kebuzone.]
[L01EA01, imatinib, The metabolism of Acetylsalicylic acid can be decreased when combined with Imatinib.]
[S01EE04, travoprost, The therapeutic efficacy of Travoprost can be decreased when used in combination with Acetylsalicylic acid.]
[S01EE03, bimatoprost, The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Acetylsalicylic acid.]
[C08CA09, lacidipine, Acetylsalicylic acid may decrease the antihypertensive activities of Lacidipine.]
[N03AX09, lamotrigine, The risk or severity of hyperkalemia can be increased when Lamotrigine is combined with Acetylsalicylic acid.]
[S01BA03, cortisone, The risk or severity of adverse effects can be increased when Cortisone is combined with Acetylsalicylic acid.]
[N07BC04, lofexidine, Acetylsalicylic acid may decrease the antihypertensive activities of Lofexidine.]
[S01AE04, lomefloxacin, Acetylsalicylic acid may increase the neuroexcitatory activities of Lomefloxacin.]
[M01AB09, lonazolac, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Lonazolac.]
[M02AA31, loxoprofen, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Loxoprofen.]
[J01DC08, loracarbef, The risk or severity of nephrotoxicity can be increased when Loracarbef is combined with Acetylsalicylic acid.]
[C09AA03, lisinopril, The therapeutic efficacy of Lisinopril can be decreased when used in combination with Acetylsalicylic acid.]
[C08CA11, manidipine, The metabolism of Acetylsalicylic acid can be decreased when combined with Manidipine.]
[A08AA09, mefenorex, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Mefenorex.]
[C07AA14, mepindolol, Acetylsalicylic acid may decrease the antihypertensive activities of Mepindolol.]
[H02AB15, meprednisone, The risk or severity of adverse effects can be increased when Meprednisone is combined with Acetylsalicylic acid.]
[J01DH02, meropenem, Acetylsalicylic acid may decrease the excretion rate of Meropenem which could result in a higher serum level.]
[C04AX01, cyclandelate, The risk or severity of hyperkalemia can be increased when Acetylsalicylic acid is combined with Cyclandelate.]
[R03CB02, methoxyphenamine, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Methoxyphenamine.]
[R06AE03, cyclizine, The metabolism of Acetylsalicylic acid can be decreased when combined with Cyclizine.]
[S01BC10, nepafenac, The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Nepafenac.]
[C03DA04, eplerenone, Acetylsalicylic acid may decrease the excretion rate of Eplerenone which could result in a higher serum level.]
[N05AD03, metylperon, Acetylsalicylic acid may decrease the excretion rate of Melperone which could result in a higher serum level.]
[C03AA07, cyclopenthiazide, Acetylsalicylic acid may decrease the excretion rate of Cyclopenthiazide which could result in a higher serum level.]
[A10BF02, miglitol, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Miglitol.]
[J05AF07, tenofovir disoproxil, Acetylsalicylic acid may increase the nephrotoxic activities of Tenofovir disoproxil.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be increased when combined with Acetylsalicylic acid.]
[N06AX07, minaprine, The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Acetylsalicylic acid.]
[S01XA18, cyclosporine, The risk or severity of renal failure and hypertension can be increased when Acetylsalicylic acid is combined with Cyclosporine.]
[N06AG02, moclobemide, The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Acetylsalicylic acid.]
[N06BA07, modafinil, The metabolism of Acetylsalicylic acid can be decreased when combined with Modafinil.]
[C09AA13, moexipril, The therapeutic efficacy of Moexipril can be decreased when used in combination with Acetylsalicylic acid.]
[M02AA02, mofebutazone, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Mofebutazone.]
[M01AX22, morniflumate, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Morniflumate.]
[C03XA02, conivaptan, Acetylsalicylic acid may decrease the excretion rate of Conivaptan which could result in a higher serum level.]
[C02AC05, moxonidine, Acetylsalicylic acid may decrease the antihypertensive activities of Moxonidine.]
[L01BC01, cytarabine, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Cytarabine.]
[M01AH05, etoricoxib, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Etoricoxib.]
[L01AX04, dacarbazine, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Dacarbazine.]
[L01DA01, dactinomycin, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Dactinomycin.]
[M03CA01, dantrolene, The risk or severity of hyperkalemia can be increased when Acetylsalicylic acid is combined with Dantrolene.]
[J04BA02, dapsone, The metabolism of Acetylsalicylic acid can be decreased when combined with Dapsone.]
[L01DB02, daunorubicin, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Daunorubicin.]
[C02CC04, debrisoquin, Acetylsalicylic acid may decrease the antihypertensive activities of Debrisoquine.]
[A04AD11, nabilone, The metabolism of Acetylsalicylic acid can be decreased when combined with Nabilone.]
[M01AX01, nabumetone, The protein binding of Nabumetone can be decreased when combined with Acetylsalicylic acid.]
[N07BB05, nalmefene, Acetylsalicylic acid may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[B05XA15, potassium lactate, Potassium lactate may increase the hyperkalemic activities of Acetylsalicylic acid.]
[C07AB12, nebivolol, Acetylsalicylic acid may decrease the antihypertensive activities of Nebivolol.]
[S01GX04, nedocromil, Acetylsalicylic acid may decrease the excretion rate of Nedocromil which could result in a higher serum level.]
[N06AX06, nefazodone, Nefazodone may increase the antiplatelet activities of Acetylsalicylic acid.]
[C01DX16, nicorandil, The risk or severity of hemorrhage, gastrointestinal bleeding, and gastrointestinal ulceration can be increased when Acetylsalicylic acid is combined with Nicorandil.]
[L02BB02, nilutamide, The metabolism of Acetylsalicylic acid can be decreased when combined with Nilutamide.]
[C01CA23, theodrenaline, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Theodrenaline.]
[C01CA05, norfenefrine, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Norfenefrine.]
[B01AX05, fondaparinux, Acetylsalicylic acid may increase the anticoagulant activities of Fondaparinux.]
[N06AB10, escitalopram, The risk or severity of gastrointestinal bleeding can be increased when Escitalopram is combined with Acetylsalicylic acid.]
[G04BD08, solifenacin, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Solifenacin.]
[A07EC03, olsalazine, The therapeutic efficacy of Olsalazine can be decreased when used in combination with Acetylsalicylic acid.]
[N06AA01, desipramine, The risk or severity of gastrointestinal bleeding can be increased when Desipramine is combined with Acetylsalicylic acid.]
[C01AA07, deslanoside, The serum concentration of Deslanoside can be decreased when it is combined with Acetylsalicylic acid.]
[H01BA02, desmopressin, The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Acetylsalicylic acid is combined with Desmopressin.]
[D07XC02, desoximetasone, The risk or severity of gastrointestinal irritation can be increased when Desoximetasone is combined with Acetylsalicylic acid.]
[V04CH02, indigo carmine, Acetylsalicylic acid may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[H02AA03, desoxycorticosterone, The risk or severity of gastrointestinal irritation can be increased when Desoxycortone is combined with Acetylsalicylic acid.]
[J01DH03, ertapenem, Acetylsalicylic acid may decrease the excretion rate of Ertapenem which could result in a higher serum level.]
[C09XA02, aliskiren, The risk or severity of renal failure and hypertension can be increased when Acetylsalicylic acid is combined with Aliskiren.]
[L01XA03, oxaliplatin, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Oxaliplatin.]
[M01AE12, oxaprozin, The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Oxaprozin.]
[S03BA01, dexamethasone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Acetylsalicylic acid.]
[L04AB04, adalimumab, The metabolism of Acetylsalicylic acid can be increased when combined with Adalimumab.]
[N06BA02, dextroamphetamine, The risk or severity of hypertension can be increased when Amphetamine is combined with Acetylsalicylic acid.]
[N03AC01, paramethadione, The metabolism of Acetylsalicylic acid can be decreased when combined with Paramethadione.]
[N06AB05, paroxetine, The risk or severity of gastrointestinal bleeding can be increased when Paroxetine is combined with Acetylsalicylic acid.]
[C01DA05, pentaerythritol tetranitrate, Acetylsalicylic acid may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.]
[P03AC04, permethrin, Acetylsalicylic acid may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, Acetylsalicylic acid may decrease the excretion rate of Diazepam which could result in a higher serum level.]
[V03AH01, diazoxide, Acetylsalicylic acid may decrease the antihypertensive activities of Diazoxide.]
[N06AA08, dibenzepin, The risk or severity of gastrointestinal bleeding can be increased when Dibenzepin is combined with Acetylsalicylic acid.]
[R05DA08, pholcodine, Acetylsalicylic acid may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[M05BA02, clodronic acid, The risk or severity of gastrointestinal bleeding can be increased when Acetylsalicylic acid is combined with Clodronic acid.]
[S01EC02, dichlorphenamide, Acetylsalicylic acid may decrease the excretion rate of Diclofenamide which could result in a higher serum level.]
[S01BC03, diclofenac, The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Diclofenac.]
[J05AD01, foscarnet, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Foscarnet.]
[A03AA07, dicyclomine, Acetylsalicylic acid may decrease the excretion rate of Dicyclomine which could result in a higher serum level.]
[J05AF03, zalcitabine, The excretion of Zalcitabine can be decreased when combined with Acetylsalicylic acid.]
[J05AF02, didanosine, Acetylsalicylic acid may decrease the excretion rate of Didanosine which could result in a higher serum level.]
[C02DG01, pinacidil, Acetylsalicylic acid may decrease the antihypertensive activities of Pinacidil.]
[A03AX04, pinaverium, The risk or severity of hyperkalemia can be increased when Acetylsalicylic acid is combined with Pinaverium.]
[A10BG03, pioglitazone, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Pioglitazone.]
[L01DC04, ixabepilone, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Ixabepilone.]
[R03CC07, pirbuterol, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Pirbuterol.]
[C03CA03, piretanide, Acetylsalicylic acid may decrease the excretion rate of Piretanide which could result in a higher serum level.]
[A08AA03, diethylpropion, The risk or severity of hypertension can be increased when Diethylpropion is combined with Acetylsalicylic acid.]
[L02AA01, diethylstilbestrol, The metabolism of Acetylsalicylic acid can be decreased when combined with Diethylstilbestrol.]
[C08CA03, isradipine, Acetylsalicylic acid may decrease the antihypertensive activities of Isradipine.]
[D07XC04, diflucortolone, The risk or severity of adverse effects can be increased when Difluocortolone is combined with Acetylsalicylic acid.]
[N02BA11, diflunisal, The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Diflunisal.]
[C01AA04, digitoxin, The serum concentration of Digitoxin can be decreased when it is combined with Acetylsalicylic acid.]
[C01AA05, digoxin, Acetylsalicylic acid may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[C02DB01, dihydralazine, Acetylsalicylic acid may decrease the antihypertensive activities of Dihydralazine.]
[C04AE04, dihydroergocristine, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Dihydroergocristine.]
[N02CA01, dihydroergotamine, The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Acetylsalicylic acid.]
[N02AA03, hydromorphone, Acetylsalicylic acid may decrease the excretion rate of Hydromorphone which could result in a higher serum level.]
[L04AX04, lenalidomide, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Lenalidomide.]
[J05AE08, atazanavir, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Atazanavir.]
[B01AC21, treprostinil, The risk or severity of bleeding can be increased when Treprostinil is combined with Acetylsalicylic acid.]
[H03BC01, potassium perchlorate, Potassium perchlorate may increase the hyperkalemic activities of Acetylsalicylic acid.]
[V03AB04, pralidoxime, Acetylsalicylic acid may decrease the excretion rate of Pralidoxime which could result in a higher serum level.]
[C08DB01, diltiazem, The risk or severity of bleeding can be increased when Diltiazem is combined with Acetylsalicylic acid.]
[V03AB09, dimercaprol, Acetylsalicylic acid may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[R03CC08, procaterol, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Procaterol.]
[M02AX03, dimethyl sulfoxide, Acetylsalicylic acid may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.]
[N02BB04, propyphenazone, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Propyphenazone.]
[M01AB14, proglumetacin, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Proglumetacin.]
[G02AD01, dinoprost, The therapeutic efficacy of Dinoprost can be decreased when used in combination with Acetylsalicylic acid.]
[G02AD02, dinoprostone, The excretion of Dinoprostone can be decreased when combined with Acetylsalicylic acid.]
[C05CA03, diosmin, The metabolism of Acetylsalicylic acid can be decreased when combined with Diosmin.]
[N05CD10, quazepam, The metabolism of Quazepam can be decreased when combined with Acetylsalicylic acid.]
[C09AA06, quinapril, The therapeutic efficacy of Quinapril can be decreased when used in combination with Acetylsalicylic acid.]
[N06BA11, dexmethylphenidate, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Dexmethylphenidate.]
[B01AD10, drotrecogin alfa, Acetylsalicylic acid may increase the anticoagulant activities of Drotrecogin alfa.]
[N06AA23, quinupramine, The risk or severity of gastrointestinal bleeding can be increased when Quinupramine is combined with Acetylsalicylic acid.]
[S01XA23, sirolimus, The risk or severity of angioedema can be increased when Sirolimus is combined with Acetylsalicylic acid.]
[R03CC14, reproterol, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Reproterol.]
[S01AX06, resorcinol, Acetylsalicylic acid may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Disopyramide.]
[S02AA12, rifamycin SV, The metabolism of Acetylsalicylic acid can be decreased when combined with Rifamycin.]
[N05AX08, risperidone, The risk or severity of hypertension can be increased when Risperidone is combined with Acetylsalicylic acid.]
[R06AE09, levocetirizine, Acetylsalicylic acid may decrease the excretion rate of Levocetirizine which could result in a higher serum level.]
[N01BB09, ropivacaine, Acetylsalicylic acid may decrease the excretion rate of Ropivacaine which could result in a higher serum level.]
[J01MB01, rosoxacin, Acetylsalicylic acid may increase the neuroexcitatory activities of Rosoxacin.]
[L01EX01, sunitinib, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Sunitinib.]
[C03XA01, tolvaptan, Acetylsalicylic acid may decrease the excretion rate of Tolvaptan which could result in a higher serum level.]
[L01XG01, bortezomib, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Bortezomib.]
[G04BE08, tadalafil, Acetylsalicylic acid may decrease the antihypertensive activities of Tadalafil.]
[S01BC05, ketorolac, The risk or severity of adverse effects can be increased when Ketorolac is combined with Acetylsalicylic acid.]
[C02KX02, ambrisentan, Acetylsalicylic acid may decrease the antihypertensive activities of Ambrisentan.]
[C01EB18, ranolazine, Acetylsalicylic acid may decrease the excretion rate of Ranolazine which could result in a higher serum level.]
[N02BA06, salsalate, The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Salsalate.]
[R03AC12, salmeterol, The risk or severity of hypertension can be increased when Salmeterol is combined with Acetylsalicylic acid.]
[H05BA01, salmon calcitonin, Acetylsalicylic acid may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.]
[C01CA07, dobutamine, The risk or severity of hypertension can be increased when Dobutamine is combined with Acetylsalicylic acid.]
[C01CA04, dopamine, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Dopamine.]
[N06AA16, dothiepin, The risk or severity of gastrointestinal bleeding can be increased when Dosulepin is combined with Acetylsalicylic acid.]
[R07AB01, doxapram, The risk or severity of hypertension can be increased when Doxapram is combined with Acetylsalicylic acid.]
[N06AA12, doxepin, The risk or severity of gastrointestinal bleeding can be increased when Doxepin is combined with Acetylsalicylic acid.]
[L01DB01, doxorubicin, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Doxorubicin.]
[J01AA02, doxycycline, Acetylsalicylic acid may decrease the excretion rate of Doxycycline which could result in a higher serum level.]
[N06AB06, sertraline, The risk or severity of bleeding can be increased when Sertraline is combined with Acetylsalicylic acid.]
[N01AB08, sevoflurane, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Sevoflurane.]
[N05AD08, droperidol, The risk or severity of hypertension can be increased when Droperidol is combined with Acetylsalicylic acid.]
[A08AA10, sibutramine, Sibutramine may increase the antiplatelet activities of Acetylsalicylic acid.]
[C10AA01, simvastatin, The metabolism of Acetylsalicylic acid can be decreased when combined with Simvastatin.]
[V03AG05, sodium phosphate, The risk or severity of renal failure can be increased when Sodium phosphate, monobasic is combined with Acetylsalicylic acid.]
[A12CA02, sodium sulfate, Acetylsalicylic acid may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[C09AA11, spirapril, The therapeutic efficacy of Spirapril can be decreased when used in combination with Acetylsalicylic acid.]
[R03DA01, dyphylline, Acetylsalicylic acid may decrease the excretion rate of Dyphylline which could result in a higher serum level.]
[N02CC01, sumatriptan, The risk or severity of hypertension can be increased when Sumatriptan is combined with Acetylsalicylic acid.]
[V04CX07, edrophonium, Acetylsalicylic acid may decrease the excretion rate of Edrophonium which could result in a higher serum level.]
[C07AB13, talinolol, Acetylsalicylic acid may decrease the antihypertensive activities of Talinolol.]
[H01AA01, corticotropin, The risk or severity of gastrointestinal irritation can be increased when Corticotropin is combined with Acetylsalicylic acid.]
[J01CG02, tazobactam, The excretion of Tazobactam can be decreased when combined with Acetylsalicylic acid.]
[J01MA05, temafloxacin, Acetylsalicylic acid may increase the neuroexcitatory activities of Temafloxacin.]
[L01AX03, temozolomide, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Temozolomide.]
[M01AC02, tenoxicam, The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Tenoxicam.]
[G04CA03, terazosin, Acetylsalicylic acid may decrease the antihypertensive activities of Terazosin.]
[D01BA02, terbinafine, The metabolism of Acetylsalicylic acid can be decreased when combined with Terbinafine.]
[G04BD05, terodiline, The risk or severity of hyperkalemia can be increased when Acetylsalicylic acid is combined with Terodiline.]
[C07AA16, tertatolol, Acetylsalicylic acid may decrease the antihypertensive activities of Tertatolol.]
[S01GA02, tetrahydrozoline, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Tetryzoline.]
[N06AX14, tianeptine, The risk or severity of gastrointestinal bleeding can be increased when Tianeptine is combined with Acetylsalicylic acid.]
[C09AA02, enalapril, The therapeutic efficacy of Enalapril can be decreased when used in combination with Acetylsalicylic acid.]
[M01AG02, tolfenamic acid, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Tolfenamic acid.]
[N06AG03, toloxatone, The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Acetylsalicylic acid.]
[N06BA09, atomoxetine, The risk or severity of hypertension can be increased when Atomoxetine is combined with Acetylsalicylic acid.]
[N03AX11, topiramate, Acetylsalicylic acid may decrease the excretion rate of Topiramate which could result in a higher serum level.]
[C03CA04, torsemide, Acetylsalicylic acid may decrease the excretion rate of Torasemide which could result in a higher serum level.]
[R01AA09, tramazoline, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Tramazoline.]
[C09AA10, trandolapril, The therapeutic efficacy of Trandolapril can be decreased when used in combination with Acetylsalicylic acid.]
[N05CC01, chloral hydrate, Acetylsalicylic acid may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.]
[B01AC18, triflusal, Acetylsalicylic acid may increase the antiplatelet activities of Triflusal.]
[H02CA01, trilostane, The risk or severity of gastrointestinal irritation can be increased when Trilostane is combined with Acetylsalicylic acid.]
[C05CA04, troxerutin, Acetylsalicylic acid may increase the anticoagulant activities of Troxerutin.]
[R03CC11, tulobuterol, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Tulobuterol.]
[C02CA06, urapidil, Acetylsalicylic acid may decrease the antihypertensive activities of Urapidil.]
[J01MA04, enoxacin, Acetylsalicylic acid may increase the neuroexcitatory activities of Enoxacin.]
[L01CA04, vinorelbine, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Vinorelbine.]
[S01FB02, ephedrine, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Ephedrine.]
[N06AX16, venlafaxine, Venlafaxine may increase the antiplatelet activities of Acetylsalicylic acid.]
[C01CX07, xamoterol, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Xamoterol.]
[S01GA03, xylometazoline, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Xylometazoline.]
[C08CA12, mepirodipine, The risk or severity of hyperkalemia can be increased when Acetylsalicylic acid is combined with Barnidipine.]
[S01EA01, epinephrine, The metabolism of Acetylsalicylic acid can be decreased when combined with Epinephrine.]
[L01DB03, epirubicin, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Epirubicin.]
[C09AA15, zofenopril, The therapeutic efficacy of Zofenopril can be decreased when used in combination with Acetylsalicylic acid.]
[N05CF02, zolpidem, The metabolism of Acetylsalicylic acid can be decreased when combined with Zolpidem.]
[M01AB04, zomepirac, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Zomepirac.]
[N03AX15, zonisamide, Acetylsalicylic acid may decrease the excretion rate of Zonisamide which could result in a higher serum level.]
[A10AB06, insulin glulisine, human, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Insulin glulisine.]
[N05CF01, zopiclone, The metabolism of Zopiclone can be decreased when combined with Acetylsalicylic acid.]
[B01AD03, anistreplase, Acetylsalicylic acid may increase the anticoagulant activities of Anistreplase.]
[L01XA02, carboplatin, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Carboplatin.]
[C02AC02, guanfacine, Acetylsalicylic acid may decrease the antihypertensive activities of Guanfacine.]
[B01AC11, iloprost, Acetylsalicylic acid may increase the antiplatelet activities of Iloprost.]
[G02AB03, ergonovine, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Ergometrine.]
[C04AE01, ergoloid mesylates, USP, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Ergoloid mesylate.]
[N02CA02, ergotamine, The risk or severity of hypertension can be increased when Ergotamine is combined with Acetylsalicylic acid.]
[L03AX05, pidotimod, Acetylsalicylic acid may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[N05CD04, estazolam, Acetylsalicylic acid may decrease the excretion rate of Estazolam which could result in a higher serum level.]
[A02BC02, pantoprazole, Acetylsalicylic acid may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[G03CA03, estradiol, The excretion of Estradiol can be decreased when combined with Acetylsalicylic acid.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Acetylsalicylic acid.]
[J04AK02, ethambutol, Acetylsalicylic acid may decrease the excretion rate of Ethambutol which could result in a higher serum level.]
[R03BA09, fluticasone furoate, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Acetylsalicylic acid.]
[R03BA05, fluticasone, The risk or severity of adverse effects can be increased when Fluticasone is combined with Acetylsalicylic acid.]
[C10AA04, fluvastatin, The metabolism of Acetylsalicylic acid can be decreased when combined with Fluvastatin.]
[V08CA03, gadodiamide, Acetylsalicylic acid may decrease the excretion rate of Gadodiamide which could result in a higher serum level.]
[C01CA15, gepefrine, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Gepefrine.]
[L02AA03, ethinyl estradiol, The metabolism of Ethinylestradiol can be decreased when combined with Acetylsalicylic acid.]
[C01BD05, ibutilide, Acetylsalicylic acid may decrease the excretion rate of Ibutilide which could result in a higher serum level.]
[N03AD01, ethosuximide, The risk or severity of hyperkalemia can be increased when Ethosuximide is combined with Acetylsalicylic acid.]
[M01AC06, meloxicam, The risk or severity of gastrointestinal bleeding can be increased when Meloxicam is combined with Acetylsalicylic acid.]
[C01CA01, etilefrine, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Etilefrine.]
[N01AX07, etomidate, The risk or severity of hypertension can be increased when Etomidate is combined with Acetylsalicylic acid.]
[L01CB01, etoposide, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Etoposide.]
[L04AD02, tacrolimus, The risk or severity of renal failure can be increased when Acetylsalicylic acid is combined with Tacrolimus.]
[J01MA08, fleroxacin, Acetylsalicylic acid may increase the neuroexcitatory activities of Fleroxacin.]
[P01AX07, trimetrexate, Acetylsalicylic acid may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, Acetylsalicylic acid may decrease the excretion rate of Bupropion which could result in a higher serum level.]
[N06AB08, fluvoxamine, The risk or severity of gastrointestinal bleeding can be increased when Fluvoxamine is combined with Acetylsalicylic acid.]
[L02AE02, leuprolide, Acetylsalicylic acid may decrease the excretion rate of Leuprolide which could result in a higher serum level.]
[C10AA03, pravastatin, The excretion of Pravastatin can be decreased when combined with Acetylsalicylic acid.]
[M01CB01, gold sodium thiomalate, Acetylsalicylic acid may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[A05AA01, chenodeoxycholic acid, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Chenodeoxycholic acid.]
[D11AX24, deoxycholic acid, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Deoxycholic acid.]
[B05AA05, dextran, Acetylsalicylic acid may increase the anticoagulant activities of Dextran.]
[M05BA01, etidronic acid, The risk or severity of gastrointestinal bleeding can be increased when Acetylsalicylic acid is combined with Etidronic acid.]
[V03AF02, dexrazoxane, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Dexrazoxane.]
[A02BA03, famotidine, The excretion of Famotidine can be decreased when combined with Acetylsalicylic acid.]
[A16AA01, levocarnitine, The excretion of Levocarnitine can be decreased when combined with Acetylsalicylic acid.]
[C08CA02, felodipine, The metabolism of Acetylsalicylic acid can be decreased when combined with Felodipine.]
[C08EA01, fendiline, The risk or severity of hyperkalemia can be increased when Acetylsalicylic acid is combined with Fendiline.]
[M01AE04, fenoprofen, The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Fenoprofen.]
[R03CC04, fenoterol, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Fenoterol.]
[N02AB03, fentanyl, The risk or severity of hypertension can be increased when Fentanyl is combined with Acetylsalicylic acid.]
[R03CC02, albuterol, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Salbutamol.]
[S01EE01, latanoprost, The therapeutic efficacy of Latanoprost can be decreased when used in combination with Acetylsalicylic acid.]
[B01AD05, plasmin, Acetylsalicylic acid may increase the anticoagulant activities of Fibrinolysin.]
[L01BB06, clofarabine, The excretion of Clofarabine can be decreased when combined with Acetylsalicylic acid.]
[L04AA40, cladribine, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Cladribine.]
[N07AX03, cevimeline, Acetylsalicylic acid may decrease the excretion rate of Cevimeline which could result in a higher serum level.]
[G04BD02, flavoxate, Acetylsalicylic acid may decrease the excretion rate of Flavoxate which could result in a higher serum level.]
[C01BC04, flecainide, The metabolism of Acetylsalicylic acid can be decreased when combined with Flecainide.]
[N02BG04, floctafenine, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Floctafenine.]
[J02AC01, fluconazole, The metabolism of Acetylsalicylic acid can be decreased when combined with Fluconazole.]
[J02AX01, flucytosine, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Flucytosine.]
[H02AA02, fludrocortisone, The risk or severity of gastrointestinal irritation can be increased when Fludrocortisone is combined with Acetylsalicylic acid.]
[M01AG03, flufenamic acid, Flufenamic acid may decrease the antiplatelet activities of Acetylsalicylic acid.]
[V03AB25, flumazenil, Acetylsalicylic acid may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[D07XB01, flumethasone, The risk or severity of gastrointestinal irritation can be increased when Flumethasone is combined with Acetylsalicylic acid.]
[N07CA03, flunarizine, The risk or severity of hyperkalemia can be increased when Acetylsalicylic acid is combined with Flunarizine.]
[N05CD03, flunitrazepam, The metabolism of Flunitrazepam can be decreased when combined with Acetylsalicylic acid.]
[D07AC08, fluocinonide, The risk or severity of adverse effects can be increased when Fluocinonide is combined with Acetylsalicylic acid.]
[N06AA14, melitracen, The risk or severity of gastrointestinal bleeding can be increased when Melitracen is combined with Acetylsalicylic acid.]
[H02AB03, fluocortolone, The risk or severity of adverse effects can be increased when Fluocortolone is combined with Acetylsalicylic acid.]
[V03AZ01, ethanol, The risk or severity of adverse effects can be increased when Ethanol is combined with Acetylsalicylic acid.]
[L01BC09, floxuridine, The metabolism of Acetylsalicylic acid can be decreased when combined with Floxuridine.]
[S01CB05, fluorometholone, The risk or severity of gastrointestinal irritation can be increased when Fluorometholone is combined with Acetylsalicylic acid.]
[L01BC02, fluorouracil, The metabolism of Acetylsalicylic acid can be decreased when combined with Fluorouracil.]
[N06AB03, fluoxetine, The risk or severity of gastrointestinal bleeding can be increased when Fluoxetine is combined with Acetylsalicylic acid.]
[N05AF01, flupenthixol, The risk or severity of hypertension can be increased when Flupentixol is combined with Acetylsalicylic acid.]
[N05CD01, flurazepam, Acetylsalicylic acid may decrease the excretion rate of Flurazepam which could result in a higher serum level.]
[S01BC04, flurbiprofen, The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Flurbiprofen.]
[N05AG01, fluspirilene, The risk or severity of hyperkalemia can be increased when Acetylsalicylic acid is combined with Fluspirilene.]
[L02BB01, flutamide, Acetylsalicylic acid may decrease the excretion rate of Flutamide which could result in a higher serum level.]
[V04CX02, folic acid, Acetylsalicylic acid may decrease the excretion rate of Folic acid which could result in a higher serum level.]
[S02AA17, fosfomycin, Acetylsalicylic acid may decrease the excretion rate of Fosfomycin which could result in a higher serum level.]
[S01AA07, framycetin, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Acetylsalicylic acid.]
[L01BC03, tegafur, Acetylsalicylic acid may decrease the excretion rate of Tegafur which could result in a higher serum level.]
[N06BX17, adrafinil, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Adrafinil.]
[G01AX06, furazolidone, The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Acetylsalicylic acid.]
[C03CA01, furosemide, The risk or severity of increased serum creatinine can be increased when Acetylsalicylic acid is combined with Furosemide.]
[M05BA04, alendronic acid, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Alendronic acid.]
[N05CF04, eszopiclone, Acetylsalicylic acid may decrease the excretion rate of Eszopiclone which could result in a higher serum level.]
[C08DA02, gallopamil, The risk or severity of hyperkalemia can be increased when Acetylsalicylic acid is combined with Gallopamil.]
[S01AD09, ganciclovir, Acetylsalicylic acid may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C10AB04, gemfibrozil, The metabolism of Acetylsalicylic acid can be decreased when combined with Gemfibrozil.]
[J01XA03, telavancin, Acetylsalicylic acid may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01EA02, dasatinib, Dasatinib may increase the anticoagulant activities of Acetylsalicylic acid.]
[N04BC06, cabergoline, The risk or severity of hypertension can be increased when Cabergoline is combined with Acetylsalicylic acid.]
[A10BJ02, liraglutide, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Liraglutide.]
[J05AG04, etravirine, The metabolism of Acetylsalicylic acid can be decreased when combined with Etravirine.]
[N03AD03, methsuximide, The risk or severity of hyperkalemia can be increased when Acetylsalicylic acid is combined with Methsuximide.]
[N01AH02, alfentanil, The risk or severity of hypertension can be increased when Alfentanil is combined with Acetylsalicylic acid.]
[A10BB01, glyburide, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Glyburide.]
[A10BB09, gliclazide, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Gliclazide.]
[A10BB07, glipizide, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Glipizide.]
[M01AX05, glucosamine, Glucosamine may increase the antiplatelet activities of Acetylsalicylic acid.]
[N05CM18, dexmedetomidine, The risk or severity of hypertension can be increased when Dexmedetomidine is combined with Acetylsalicylic acid.]
[C05AE01, nitroglycerin, The serum concentration of Nitroglycerin can be increased when it is combined with Acetylsalicylic acid.]
[C02CA04, doxazosin, Acetylsalicylic acid may decrease the antihypertensive activities of Doxazosin.]
[H01AB01, thyrotropin alfa, The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Acetylsalicylic acid.]
[L01EX02, sorafenib, The metabolism of Acetylsalicylic acid can be decreased when combined with Sorafenib.]
[C07AB09, esmolol, Acetylsalicylic acid may decrease the antihypertensive activities of Esmolol.]
[M01CB04, aurothioglucose, Acetylsalicylic acid may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Acetylsalicylic acid may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[B01AA12, fluindione, Acetylsalicylic acid may increase the anticoagulant activities of Fluindione.]
[C09AA09, fosinopril, The therapeutic efficacy of Fosinopril can be decreased when used in combination with Acetylsalicylic acid.]
[S01EX01, guanethidine, Acetylsalicylic acid may decrease the antihypertensive activities of Guanethidine.]
[L02AE03, goserelin, Acetylsalicylic acid may decrease the excretion rate of Goserelin which could result in a higher serum level.]
[N05AD01, haloperidol, The therapeutic efficacy of Haloperidol can be increased when used in combination with Acetylsalicylic acid.]
[N01AB01, halothane, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Halothane.]
[N05AH04, quetiapine, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Quetiapine.]
[N06BX13, idebenone, Acetylsalicylic acid may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[A10AD05, insulin aspart, human, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Insulin aspart.]
[L01CE02, irinotecan, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Irinotecan.]
[M04AA01, allopurinol, The therapeutic efficacy of Allopurinol can be decreased when used in combination with Acetylsalicylic acid.]
[C09CA01, losartan, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Losartan is combined with Acetylsalicylic acid.]
[S01XA14, heparin, Acetylsalicylic acid may increase the anticoagulant activities of Heparin.]
[G03DC01, allylestrenol, Acetylsalicylic acid may decrease the excretion rate of Allylestrenol which could result in a higher serum level.]
[A07EC02, mesalamine, The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Acetylsalicylic acid.]
[C01CE02, milrinone, Acetylsalicylic acid may decrease the excretion rate of Milrinone which could result in a higher serum level.]
[L01XX03, altretamine, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Altretamine.]
[N05CA16, hexobarbital, The metabolism of Hexobarbital can be decreased when combined with Acetylsalicylic acid.]
[R03CC05, hexoprenaline, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Hexoprenaline.]
[J05AG01, nevirapine, The metabolism of Acetylsalicylic acid can be decreased when combined with Nevirapine.]
[C08CA10, nilvadipine, Acetylsalicylic acid may decrease the antihypertensive activities of Nilvadipine.]
[M02AA26, nimesulide, Acetylsalicylic acid may increase the antiplatelet activities of Nimesulide.]
[C09AA04, perindopril, The therapeutic efficacy of Perindopril can be decreased when used in combination with Acetylsalicylic acid.]
[C02DB02, hydralazine, Acetylsalicylic acid may decrease the antihypertensive activities of Hydralazine.]
[C03AA03, hydrochlorothiazide, Acetylsalicylic acid may decrease the excretion rate of Hydrochlorothiazide which could result in a higher serum level.]
[S02BA01, hydrocortisone, The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Acetylsalicylic acid.]
[C03AA02, hydroflumethiazide, Acetylsalicylic acid may decrease the excretion rate of Hydroflumethiazide which could result in a higher serum level.]
[B05XA17, potassium acetate, Potassium acetate may increase the hyperkalemic activities of Acetylsalicylic acid.]
[S01XA07, aluminum potassium sulfate, Potassium alum may increase the hyperkalemic activities of Acetylsalicylic acid.]
[A12BA02, potassium citrate, Acetylsalicylic acid may decrease the excretion rate of Potassium citrate which could result in a higher serum level.]
[V03AB33, hydroxocobalamin, Acetylsalicylic acid may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.]
[G04BD06, propiverine, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Propiverine.]
[B05AA07, hetastarch, Acetylsalicylic acid may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[L01XX05, hydroxyurea, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Hydroxyurea.]
[C02AC06, rilmenidine, Acetylsalicylic acid may decrease the antihypertensive activities of Rilmenidine.]
[M05BA07, risedronic acid, The risk or severity of gastrointestinal bleeding can be increased when Acetylsalicylic acid is combined with Risedronic acid.]
[R02AX02, ibuprofen, Ibuprofen may decrease the antiplatelet activities of Acetylsalicylic acid.]
[B05XA08, sodium acetate, Acetylsalicylic acid may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[B05CB02, sodium citrate, Acetylsalicylic acid may increase the anticoagulant activities of Sodium citrate.]
[L01DB06, idarubicin, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Idarubicin.]
[L01AA06, ifosfamide, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Ifosfamide.]
[N01AH03, sufentanil, The risk or severity of hypertension can be increased when Sufentanil is combined with Acetylsalicylic acid.]
[N06AA02, imipramine, The risk or severity of gastrointestinal bleeding can be increased when Imipramine is combined with Acetylsalicylic acid.]
[L01CD01, paclitaxel, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Paclitaxel.]
[R01AD07, tixocortol, The risk or severity of gastrointestinal irritation can be increased when Tixocortol is combined with Acetylsalicylic acid.]
[L01CE01, topotecan, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Topotecan.]
[C03BA11, indapamide, Acetylsalicylic acid may decrease the excretion rate of Indapamide which could result in a higher serum level.]
[S01BC01, indomethacin, The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Indomethacin.]
[C02CA02, indoramin, Acetylsalicylic acid may decrease the antihypertensive activities of Indoramin.]
[A11HA07, inositol, Acetylsalicylic acid may decrease the excretion rate of Inositol which could result in a higher serum level.]
[L03AB04, interferon alfa-2a, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Interferon alfa-2a.]
[L03AB05, interferon alfa-2b, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Interferon alfa-2b.]
[N06AX17, milnacipran, Milnacipran may increase the antiplatelet activities of Acetylsalicylic acid.]
[S01XA28, varenicline, Acetylsalicylic acid may decrease the excretion rate of Varenicline which could result in a higher serum level.]
[A10BH01, sitagliptin, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Sitagliptin.]
[N05BA12, alprazolam, Acetylsalicylic acid may decrease the excretion rate of Alprazolam which could result in a higher serum level.]
[N05CH02, ramelteon, Acetylsalicylic acid may decrease the excretion rate of Ramelteon which could result in a higher serum level.]
[A10BH02, vildagliptin, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Vildagliptin.]
[C10AA06, cerivastatin, The metabolism of Acetylsalicylic acid can be decreased when combined with Cerivastatin.]
[L01XX35, anagrelide, The risk or severity of bleeding can be increased when Anagrelide is combined with Acetylsalicylic acid.]
[C07AA01, alprenolol, Acetylsalicylic acid may decrease the antihypertensive activities of Alprenolol.]
[C03BA02, quinethazone, Acetylsalicylic acid may decrease the excretion rate of Quinethazone which could result in a higher serum level.]
[L03AB09, interferon alfacon-1, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Interferon alfacon-1.]
[V03AB01, ipecac, Acetylsalicylic acid may decrease the excretion rate of Ipecac which could result in a higher serum level.]
[J05AF04, stavudine, The excretion of Stavudine can be decreased when combined with Acetylsalicylic acid.]
[N06AA13, iprindole, The risk or severity of gastrointestinal bleeding can be increased when Iprindole is combined with Acetylsalicylic acid.]
[G04BE01, alprostadil, The excretion of Alprostadil can be decreased when combined with Acetylsalicylic acid.]
[N06AF05, iproniazid, The metabolism of Acetylsalicylic acid can be decreased when combined with Iproniazid.]
[N06AF01, isocarboxazid, The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Acetylsalicylic acid.]
[S01EC03, dorzolamide, The risk or severity of metabolic acidosis can be increased when Dorzolamide is combined with Acetylsalicylic acid.]
[P01AX06, atovaquone, The metabolism of Acetylsalicylic acid can be decreased when combined with Atovaquone.]
[R03CC06, isoetharine, The risk or severity of hypertension can be increased when Isoetharine is combined with Acetylsalicylic acid.]
[C09AA16, imidapril, The therapeutic efficacy of Imidapril can be decreased when used in combination with Acetylsalicylic acid.]
[N01AB06, isoflurane, The risk or severity of hypertension can be increased when Isoflurane is combined with Acetylsalicylic acid.]
[J04AC01, isoniazid, The metabolism of Acetylsalicylic acid can be decreased when combined with Isoniazid.]
[J05AX05, inosine pranobex, Acetylsalicylic acid may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[R03CB01, isoproterenol, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Isoprenaline.]
[A10BJ01, exenatide, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Exenatide.]
[C01DA14, isosorbide mononitrate, Acetylsalicylic acid may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[D10BA01, isotretinoin, Acetylsalicylic acid may decrease the excretion rate of Isotretinoin which could result in a higher serum level.]
[C04AA01, isoxsuprine, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Isoxsuprine.]
[B01AE06, bivalirudin, Acetylsalicylic acid may increase the anticoagulant activities of Bivalirudin.]
[S01AA24, kanamycin, Acetylsalicylic acid may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[L04AC07, tocilizumab, The metabolism of Acetylsalicylic acid can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, Acetylsalicylic acid may decrease the excretion rate of Ketamine which could result in a higher serum level.]
[C02KD01, ketanserin, Acetylsalicylic acid may increase the antiplatelet activities of Ketanserin.]
[B01AC22, prasugrel, Acetylsalicylic acid may increase the antiplatelet activities of Prasugrel.]
[J02AB02, ketoconazole, The risk or severity of hyperkalemia can be increased when Acetylsalicylic acid is combined with Ketoconazole.]
[N05AH03, olanzapine, The metabolism of Acetylsalicylic acid can be decreased when combined with Olanzapine.]
[M02AA10, ketoprofen, The risk or severity of bleeding and gastrointestinal bleeding can be increased when Acetylsalicylic acid is combined with Ketoprofen.]
[V03AC03, deferasirox, The risk or severity of gastrointestinal bleeding and peptic ulcer can be increased when Acetylsalicylic acid is combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Acetylsalicylic acid can be increased when combined with Abatacept.]
[C01CA22, arbutamine, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Arbutamine.]
[N04BC09, rotigotine, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Rotigotine.]
[D10AX03, azelaic acid, Acetylsalicylic acid may decrease the excretion rate of Azelaic acid which could result in a higher serum level.]
[J01MB02, nalidixic acid, Acetylsalicylic acid may increase the neuroexcitatory activities of Nalidixic acid.]
[M01AE11, tiaprofenic acid, The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Tiaprofenic acid.]
[C07AG01, labetalol, Acetylsalicylic acid may decrease the antihypertensive activities of Labetalol.]
[N04BB01, amantadine, Acetylsalicylic acid may decrease the excretion rate of Amantadine which could result in a higher serum level.]
[C02AA05, deserpidine, Acetylsalicylic acid may decrease the antihypertensive activities of Deserpidine.]
[A06AX03, lubiprostone, Acetylsalicylic acid may decrease the excretion rate of Lubiprostone which could result in a higher serum level.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be decreased when combined with Acetylsalicylic acid.]
[C03CC01, ethacrynic acid, Acetylsalicylic acid may decrease the excretion rate of Etacrynic acid which could result in a higher serum level.]
[L01DC03, mitomycin, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Mitomycin.]
[C08EX01, lidoflazine, The risk or severity of hyperkalemia can be increased when Acetylsalicylic acid is combined with Lidoflazine.]
[S01AA21, amikacin, Acetylsalicylic acid may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[N06BA13, armodafinil, The metabolism of Acetylsalicylic acid can be decreased when combined with Armodafinil.]
[C03DB01, amiloride, Acetylsalicylic acid may decrease the excretion rate of Amiloride which could result in a higher serum level.]
[N02CA07, lisuride, The risk or severity of hypertension can be increased when Lisuride is combined with Acetylsalicylic acid.]
[N06AA07, lofepramine, The risk or severity of gastrointestinal bleeding can be increased when Lofepramine is combined with Acetylsalicylic acid.]
[L01AD02, lomustine, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Lomustine.]
[A07DA03, loperamide, The risk or severity of hyperkalemia can be increased when Loperamide is combined with Acetylsalicylic acid.]
[N05BA06, lorazepam, Acetylsalicylic acid may decrease the excretion rate of Lorazepam which could result in a higher serum level.]
[C10AA02, lovastatin, The metabolism of Acetylsalicylic acid can be decreased when combined with Lovastatin.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be decreased when combined with Acetylsalicylic acid.]
[L01EG01, temsirolimus, The risk or severity of angioedema can be increased when Acetylsalicylic acid is combined with Temsirolimus.]
[B05XA11, magnesium chloride, Acetylsalicylic acid may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[V04CC02, magnesium sulfate, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Acetylsalicylic acid.]
[L01BA05, pralatrexate, The serum concentration of Pralatrexate can be increased when it is combined with Acetylsalicylic acid.]
[L01EA03, nilotinib, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Nilotinib.]
[V04CX04, mannitol, Acetylsalicylic acid may decrease the excretion rate of Mannitol which could result in a higher serum level.]
[N06AA21, maprotiline, Acetylsalicylic acid may decrease the excretion rate of Maprotiline which could result in a higher serum level.]
[C02BB01, mecamylamine, Acetylsalicylic acid may decrease the antihypertensive activities of Mecamylamine.]
[L01AA05, mechlorethamine, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Mechlorethamine.]
[M02AA18, meclofenamic acid, The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Meclofenamic acid.]
[C01AA08, medigoxin, Acetylsalicylic acid may decrease the excretion rate of Metildigoxin which could result in a higher serum level.]
[C03BA05, mefruside, Acetylsalicylic acid may decrease the excretion rate of Mefruside which could result in a higher serum level.]
[B01AB06, nadroparin, Acetylsalicylic acid may increase the anticoagulant activities of Nadroparin.]
[B01AB05, enoxaparin, Acetylsalicylic acid may increase the anticoagulant activities of Enoxaparin.]
[B01AB04, dalteparin, Acetylsalicylic acid may increase the anticoagulant activities of Dalteparin.]
[L01AA03, melphalan, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Melphalan.]
[N06DX01, memantine, Acetylsalicylic acid may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02AB02, meperidine, Acetylsalicylic acid may decrease the excretion rate of Meperidine which could result in a higher serum level.]
[C01CA11, mephentermine, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Mephentermine.]
[N03AB04, mephenytoin, The metabolism of Acetylsalicylic acid can be decreased when combined with Mephenytoin.]
[N01BB03, mepivacaine, Acetylsalicylic acid may decrease the excretion rate of Mepivacaine which could result in a higher serum level.]
[G04BX16, tiopronin, Acetylsalicylic acid may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Acetylsalicylic acid may decrease the excretion rate of Mersalyl which could result in a higher serum level.]
[N05AX13, paliperidone, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Paliperidone.]
[C01CA09, metaraminol, The risk or severity of hypertension can be increased when Metaraminol is combined with Acetylsalicylic acid.]
[A10BA02, metformin, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Metformin.]
[N07BC02, methadone, Acetylsalicylic acid may decrease the excretion rate of Methadone which could result in a higher serum level.]
[N06BA03, methamphetamine, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Metamfetamine.]
[J05AF05, lamivudine, Acetylsalicylic acid may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[S01EC05, methazolamide, Acetylsalicylic acid may decrease the excretion rate of Methazolamide which could result in a higher serum level.]
[G02CB05, metergoline, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Metergoline.]
[H03BB02, methimazole, The metabolism of Acetylsalicylic acid can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, Acetylsalicylic acid may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[A11HA02, pyridoxine, Acetylsalicylic acid may decrease the excretion rate of Pyridoxine which could result in a higher serum level.]
[L04AX03, methotrexate, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Methotrexate.]
[N05AA02, methotrimeprazine, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Methotrimeprazine.]
[C01CA10, methoxamine, The risk or severity of hypertension can be increased when Methoxamine is combined with Acetylsalicylic acid.]
[D05BA02, methoxsalen, Acetylsalicylic acid may decrease the excretion rate of Methoxsalen which could result in a higher serum level.]
[N02BG09, methoxyflurane, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Methoxyflurane.]
[C03AA08, methyclothiazide, Acetylsalicylic acid may decrease the excretion rate of Methyclothiazide which could result in a higher serum level.]
[C02AB01, methyldopa, Acetylsalicylic acid may decrease the antihypertensive activities of Methyldopa.]
[V04CG05, methylene blue, The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Acetylsalicylic acid.]
[G02AB01, methylergonovine, The risk or severity of hypertension can be increased when Methylergometrine is combined with Acetylsalicylic acid.]
[N06BA04, methylphenidate, The risk or severity of hypertension can be increased when Methylphenidate is combined with Acetylsalicylic acid.]
[H02AB04, methylprednisolone, The risk or severity of gastrointestinal irritation can be increased when Methylprednisolone is combined with Acetylsalicylic acid.]
[D07AC14, methylprednisolone aceponate, The risk or severity of gastrointestinal irritation can be increased when Methylprednisolone aceponate is combined with Acetylsalicylic acid.]
[G03EK01, methyltestosterone, Acetylsalicylic acid may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.]
[N02CA04, methysergide, The risk or severity of hypertension can be increased when Methysergide is combined with Acetylsalicylic acid.]
[A03FA01, metoclopramide, Acetylsalicylic acid may decrease the excretion rate of Metoclopramide which could result in a higher serum level.]
[C03BA08, metolazone, Acetylsalicylic acid may decrease the excretion rate of Metolazone which could result in a higher serum level.]
[C07AB02, metoprolol, Acetylsalicylic acid may decrease the antihypertensive activities of Metoprolol.]
[P01AB01, metronidazole, The metabolism of Acetylsalicylic acid can be decreased when combined with Metronidazole.]
[V04CD01, metyrapone, Acetylsalicylic acid may decrease the excretion rate of Metyrapone which could result in a higher serum level.]
[N06AX03, mianserin, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Mianserin.]
[S02AA13, miconazole, The metabolism of Acetylsalicylic acid can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Aminophenazone.]
[B01AB07, parnaparin, Acetylsalicylic acid may increase the anticoagulant activities of Parnaparin.]
[N05CD08, midazolam, Acetylsalicylic acid may decrease the excretion rate of Midazolam which could result in a higher serum level.]
[C01CA17, midodrine, The risk or severity of hypertension can be increased when Midodrine is combined with Acetylsalicylic acid.]
[G03XB01, mifepristone, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Mifepristone.]
[B01AB10, tinzaparin, Acetylsalicylic acid may increase the anticoagulant activities of Tinzaparin.]
[J05AH01, zanamivir, Acetylsalicylic acid may decrease the excretion rate of Zanamivir which could result in a higher serum level.]
[C09CA03, valsartan, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Acetylsalicylic acid.]
[D11AX01, minoxidil, Acetylsalicylic acid may decrease the antihypertensive activities of Minoxidil.]
[L01DB07, mitoxantrone, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Mitoxantrone.]
[N06BA12, lisdexamfetamine, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Lisdexamfetamine.]
[L03AC01, aldesleukin, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Aldesleukin.]
[C01BD01, amiodarone, The metabolism of Acetylsalicylic acid can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The risk or severity of gastrointestinal bleeding can be increased when Amitriptyline is combined with Acetylsalicylic acid.]
[A04AA05, palonosetron, Acetylsalicylic acid may decrease the excretion rate of Palonosetron which could result in a higher serum level.]
[J01DD06, moxalactam, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Latamoxef.]
[L04AB05, certolizumab pegol, The metabolism of Acetylsalicylic acid can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Acetylsalicylic acid can be decreased when combined with Eltrombopag.]
[G04BA01, ammonium chloride, The serum concentration of Acetylsalicylic acid can be increased when it is combined with Ammonium chloride.]
[L04AA06, mycophenolic acid, Acetylsalicylic acid may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.]
[P01BA06, amodiaquine, The metabolism of Acetylsalicylic acid can be decreased when combined with Amodiaquine.]
[N06AA17, amoxapine, The risk or severity of gastrointestinal bleeding can be increased when Amoxapine is combined with Acetylsalicylic acid.]
[N03AB05, fosphenytoin, The protein binding of Fosphenytoin can be decreased when combined with Acetylsalicylic acid.]
[L03AB08, interferon beta-1b, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Interferon beta-1b.]
[C07AA12, nadolol, Acetylsalicylic acid may decrease the antihypertensive activities of Nadolol.]
[J01CA04, amoxicillin, Acetylsalicylic acid may decrease the excretion rate of Amoxicillin which could result in a higher serum level.]
[V03AB15, naloxone, Acetylsalicylic acid may decrease the excretion rate of Naloxone which could result in a higher serum level.]
[L04AC03, anakinra, The metabolism of Acetylsalicylic acid can be increased when combined with Anakinra.]
[S01GA01, naphazoline, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Naphazoline.]
[N06BA01, amphetamine, The risk or severity of hypertension can be increased when Amphetamine is combined with Acetylsalicylic acid.]
[M02AA12, naproxen, The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Naproxen.]
[A10BG01, troglitazone, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Troglitazone.]
[N06AX21, duloxetine, Duloxetine may increase the antiplatelet activities of Acetylsalicylic acid.]
[N04BX01, tolcapone, Acetylsalicylic acid may decrease the excretion rate of Tolcapone which could result in a higher serum level.]
[L01CD02, docetaxel, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Docetaxel.]
[S03AA01, neomycin, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Neomycin.]
[N01AH06, remifentanil, The risk or severity of hypertension can be increased when Remifentanil is combined with Acetylsalicylic acid.]
[A10BX02, repaglinide, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Repaglinide.]
[B01AC17, tirofiban, Acetylsalicylic acid may increase the antiplatelet activities of Tirofiban.]
[N05AX14, iloperidone, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Iloperidone.]
[J02AA01, amphotericin B, The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Acetylsalicylic acid.]
[S01AA19, ampicillin, Acetylsalicylic acid may decrease the excretion rate of Ampicillin which could result in a higher serum level.]
[L03AX16, plerixafor, Acetylsalicylic acid may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Acetylsalicylic acid may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, Desvenlafaxine may increase the antiplatelet activities of Acetylsalicylic acid.]
[C09CA07, telmisartan, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Telmisartan is combined with Acetylsalicylic acid.]
[J05AB11, valacyclovir, The excretion of Valaciclovir can be decreased when combined with Acetylsalicylic acid.]
[C01CE01, inamrinone, Acetylsalicylic acid may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[L01XX01, amsacrine, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Amsacrine.]
[N06AF02, nialamide, The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Acetylsalicylic acid.]
[C08CA04, nicardipine, The metabolism of Acetylsalicylic acid can be decreased when combined with Nicardipine.]
[C04AE02, nicergoline, The risk or severity of hypertension can be increased when Nicergoline is combined with Acetylsalicylic acid.]
[P02DA01, niclosamide, The metabolism of Niclosamide can be decreased when combined with Acetylsalicylic acid.]
[C08CA05, nifedipine, The risk or severity of hyperkalemia can be increased when Acetylsalicylic acid is combined with Nifedipine.]
[M02AA17, niflumic acid, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Niflumic acid.]
[C08CA06, nimodipine, Acetylsalicylic acid may decrease the antihypertensive activities of Nimodipine.]
[C08CA07, nisoldipine, Acetylsalicylic acid may decrease the antihypertensive activities of Nisoldipine.]
[C08CA08, nitrendipine, Acetylsalicylic acid may decrease the antihypertensive activities of Nitrendipine.]
[R07AX01, nitric oxide, Acetylsalicylic acid may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.]
[J01XE01, nitrofurantoin, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Acetylsalicylic acid.]
[N05CF03, zaleplon, Acetylsalicylic acid may decrease the excretion rate of Zaleplon which could result in a higher serum level.]
[N04BC05, pramipexole, Acetylsalicylic acid may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[C02DD01, nitroprusside, Acetylsalicylic acid may decrease the antihypertensive activities of Nitroprusside.]
[N01AX13, nitrous oxide, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Nitrous oxide.]
[C01CA03, norepinephrine, The risk or severity of hypertension can be increased when Norepinephrine is combined with Acetylsalicylic acid.]
[S01AE02, norfloxacin, Acetylsalicylic acid may increase the neuroexcitatory activities of Norfloxacin.]
[C02KX01, bosentan, The metabolism of Acetylsalicylic acid can be increased when combined with Bosentan.]
[N06AA10, nortriptyline, The risk or severity of gastrointestinal bleeding can be increased when Nortriptyline is combined with Acetylsalicylic acid.]
[R05DA07, noscapine, The metabolism of Acetylsalicylic acid can be decreased when combined with Noscapine.]
[B01AC16, eptifibatide, Acetylsalicylic acid may increase the antiplatelet activities of Eptifibatide.]
[G02CA02, nylidrin, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Nylidrin.]
[B01AB08, reviparin, Acetylsalicylic acid may increase the anticoagulant activities of Reviparin.]
[S02AA16, ofloxacin, Acetylsalicylic acid may increase the neuroexcitatory activities of Ofloxacin.]
[L04AC04, rilonacept, The metabolism of Acetylsalicylic acid can be increased when combined with Rilonacept.]
[N06AA05, opipramol, The risk or severity of gastrointestinal bleeding can be increased when Opipramol is combined with Acetylsalicylic acid.]
[N02AA02, opium, Acetylsalicylic acid may decrease the excretion rate of Opium which could result in a higher serum level.]
[R03CB03, metaproterenol, The risk or severity of hypertension can be increased when Orciprenaline is combined with Acetylsalicylic acid.]
[B01AD07, reteplase, Acetylsalicylic acid may increase the anticoagulant activities of Reteplase.]
[B01AD09, ancrod, Acetylsalicylic acid may increase the anticoagulant activities of Ancrod.]
[G04CA02, tamsulosin, Acetylsalicylic acid may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C01AC01, ouabain, The serum concentration of Ouabain can be decreased when it is combined with Acetylsalicylic acid.]
[M05BA08, zoledronic acid, The risk or severity of gastrointestinal bleeding can be increased when Acetylsalicylic acid is combined with Zoledronic acid.]
[J01CF04, oxacillin, Acetylsalicylic acid may decrease the excretion rate of Oxacillin which could result in a higher serum level.]
[A14AA08, oxandrolone, The metabolism of Acetylsalicylic acid can be decreased when combined with Oxandrolone.]
[N05BA04, oxazepam, Acetylsalicylic acid may decrease the excretion rate of Oxazepam which could result in a higher serum level.]
[J01MB05, oxolinic acid, Acetylsalicylic acid may increase the neuroexcitatory activities of Oxolinic acid.]
[C07AA02, oxprenolol, Acetylsalicylic acid may decrease the antihypertensive activities of Oxprenolol.]
[C01DX03, oxyfedrine, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Oxyfedrine.]
[S01GA04, oxymetazoline, The risk or severity of hypertension can be increased when Oxymetazoline is combined with Acetylsalicylic acid.]
[S01BC02, oxyphenbutazone, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Oxyphenbutazone.]
[S01AA04, oxytetracycline, The excretion of Oxytetracycline can be decreased when combined with Acetylsalicylic acid.]
[V04CH30, 4-aminohippuric acid, The excretion of Aminohippuric acid can be decreased when combined with Acetylsalicylic acid.]
[J04AA01, aminosalicylic acid, The therapeutic efficacy of Aminosalicylic acid can be decreased when used in combination with Acetylsalicylic acid.]
[N05AH05, asenapine, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Asenapine.]
[B01AB09, danaparoid, Acetylsalicylic acid may increase the anticoagulant activities of Danaparoid.]
[J04AB30, capreomycin, Acetylsalicylic acid may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[H02AB05, paramethasone, The risk or severity of adverse effects can be increased when Paramethasone is combined with Acetylsalicylic acid.]
[C02KC01, pargyline, The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Acetylsalicylic acid.]
[A07AA06, paromomycin, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Paromomycin.]
[J01MA03, pefloxacin, Acetylsalicylic acid may increase the neuroexcitatory activities of Pefloxacin.]
[G04BD11, fesoterodine, Acetylsalicylic acid may decrease the excretion rate of Fesoterodine which could result in a higher serum level.]
[C07AA23, penbutolol, Acetylsalicylic acid may decrease the antihypertensive activities of Penbutolol.]
[N05AG03, penfluridol, The risk or severity of hyperkalemia can be increased when Acetylsalicylic acid is combined with Penfluridol.]
[M01CC01, penicillamine, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Penicillamine.]
[S01AA14, penicillin G, The excretion of Benzylpenicillin can be decreased when combined with Acetylsalicylic acid.]
[J01CE09, penicillin G procaine, Acetylsalicylic acid may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[N05CA01, pentobarbital, Acetylsalicylic acid may decrease the excretion rate of Pentobarbital which could result in a higher serum level.]
[L01XX08, pentostatin, Acetylsalicylic acid may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, Acetylsalicylic acid may increase the antiplatelet activities of Pentoxifylline.]
[N04BC02, pergolide, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Pergolide.]
[C08EX02, perhexiline, The risk or severity of hyperkalemia can be increased when Acetylsalicylic acid is combined with Perhexiline.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Acetylsalicylic acid.]
[G04BX06, phenazopyridine, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Phenazopyridine.]
[N06AF03, phenelzine, The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Acetylsalicylic acid.]
[A10BA01, phenformin, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Phenformin.]
[B01AA02, phenindione, Acetylsalicylic acid may increase the anticoagulant activities of Phenindione.]
[C04AX02, phenoxybenzamine, Acetylsalicylic acid may decrease the antihypertensive activities of Phenoxybenzamine.]
[B01AA04, phenprocoumon, Acetylsalicylic acid may increase the anticoagulant activities of Phenprocoumon.]
[A08AA01, phentermine, The risk or severity of hypertension can be increased when Phentermine is combined with Acetylsalicylic acid.]
[V03AB36, phentolamine, Acetylsalicylic acid may decrease the antihypertensive activities of Phentolamine.]
[M02AA01, phenylbutazone, The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Phenylbutazone.]
[N03AB02, phenytoin, The serum concentration of Phenytoin can be increased when it is combined with Acetylsalicylic acid.]
[L04AB06, golimumab, The metabolism of Acetylsalicylic acid can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, Acetylsalicylic acid may increase the neuroexcitatory activities of Levofloxacin.]
[N07BB03, acamprosate, The excretion of Acamprosate can be decreased when combined with Acetylsalicylic acid.]
[B02BA01, vitamin K1, Acetylsalicylic acid may decrease the excretion rate of Phylloquinone which could result in a higher serum level.]
[J05AB12, cidofovir, The risk or severity of nephrotoxicity can be increased when Cidofovir is combined with Acetylsalicylic acid.]
[C08CX01, mibefradil, Acetylsalicylic acid may decrease the antihypertensive activities of Mibefradil.]
[C07AA03, pindolol, Acetylsalicylic acid may decrease the antihypertensive activities of Pindolol.]
[J01CA12, piperacillin, The excretion of Piperacillin can be decreased when combined with Acetylsalicylic acid.]
[N06BX03, piracetam, Acetylsalicylic acid may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[C09CA02, eprosartan, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Eprosartan is combined with Acetylsalicylic acid.]
[S01BC06, piroxicam, The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Piroxicam.]
[J01DD16, cefditoren, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Cefditoren.]
[J01MA11, grepafloxacin, Acetylsalicylic acid may increase the neuroexcitatory activities of Grepafloxacin.]
[N02CX01, pizotyline, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Pizotifen.]
[J05AG02, delavirdine, The metabolism of Acetylsalicylic acid can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Irbesartan is combined with Acetylsalicylic acid.]
[B01AC13, abciximab, Acetylsalicylic acid may increase the antiplatelet activities of Abciximab.]
[S01XA13, alteplase, Acetylsalicylic acid may increase the anticoagulant activities of Alteplase.]
[A10BG02, rosiglitazone, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Rosiglitazone.]
[A03AE01, alosetron, The metabolism of Alosetron can be decreased when combined with Acetylsalicylic acid.]
[L04AC08, canakinumab, The metabolism of Acetylsalicylic acid can be increased when combined with Canakinumab.]
[S03AA03, polymyxin B, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Polymyxin B.]
[C03AA05, polythiazide, Acetylsalicylic acid may decrease the excretion rate of Polythiazide which could result in a higher serum level.]
[J05AE03, ritonavir, The metabolism of Acetylsalicylic acid can be increased when combined with Ritonavir.]
[A10BH03, saxagliptin, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Saxagliptin.]
[B05XA01, potassium chloride, Potassium chloride may increase the hyperkalemic activities of Acetylsalicylic acid.]
[V03AB21, potassium iodide, Potassium Iodide may increase the hyperkalemic activities of Acetylsalicylic acid.]
[A10AD04, insulin lispro, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Insulin lispro.]
[C10AA08, pitavastatin, The metabolism of Pitavastatin can be decreased when combined with Acetylsalicylic acid.]
[C07AB01, practolol, Acetylsalicylic acid may decrease the antihypertensive activities of Practolol.]
[C02CA01, prazosin, Acetylsalicylic acid may decrease the antihypertensive activities of Prazosin.]
[S03BA02, prednisolone, The risk or severity of gastrointestinal irritation can be increased when Prednisolone is combined with Acetylsalicylic acid.]
[H02AB07, prednisone, The risk or severity of adverse effects can be increased when Prednisone is combined with Acetylsalicylic acid.]
[M02AA16, feprazone, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Feprazone.]
[C01DX02, prenylamine, The risk or severity of hyperkalemia can be increased when Acetylsalicylic acid is combined with Prenylamine.]
[N03AA03, primidone, The metabolism of Acetylsalicylic acid can be decreased when combined with Primidone.]
[M04AB01, probenecid, Probenecid may decrease the excretion rate of Acetylsalicylic acid which could result in a higher serum level.]
[C01BA02, procainamide, Acetylsalicylic acid may decrease the excretion rate of Procainamide which could result in a higher serum level.]
[S01HA05, procaine, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Acetylsalicylic acid.]
[L01XB01, procarbazine, The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Acetylsalicylic acid.]
[C10AB05, fenofibrate, The metabolism of Acetylsalicylic acid can be decreased when combined with Fenofibrate.]
[G03DA04, progesterone, The metabolism of Acetylsalicylic acid can be decreased when combined with Progesterone.]
[N05AA03, promazine, The risk or severity of hypertension can be increased when Promazine is combined with Acetylsalicylic acid.]
[R06AD02, promethazine, The metabolism of Acetylsalicylic acid can be decreased when combined with Promethazine.]
[C01BC03, propafenone, Acetylsalicylic acid may decrease the antihypertensive activities of Propafenone.]
[A03AB05, propantheline, Acetylsalicylic acid may decrease the excretion rate of Propantheline which could result in a higher serum level.]
[R06AX26, fexofenadine, The excretion of Fexofenadine can be decreased when combined with Acetylsalicylic acid.]
[N05AC01, periciazine, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Periciazine.]
[N05CM06, propiomazine, The risk or severity of hypertension can be increased when Propiomazine is combined with Acetylsalicylic acid.]
[N01AX10, propofol, The risk or severity of hypertension can be increased when Propofol is combined with Acetylsalicylic acid.]
[C07AA05, propranolol, The serum concentration of Propranolol can be decreased when it is combined with Acetylsalicylic acid.]
[H03BA02, propylthiouracil, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Propylthiouracil.]
[C01AB01, proscillaridin, The serum concentration of Proscillaridin can be decreased when it is combined with Acetylsalicylic acid.]
[N02CC04, rizatriptan, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Rizatriptan.]
[B01AC09, epoprostenol, Acetylsalicylic acid may increase the antiplatelet activities of Epoprostenol.]
[R03DC03, montelukast, The metabolism of Acetylsalicylic acid can be decreased when combined with Montelukast.]
[N06AA11, protriptyline, The risk or severity of gastrointestinal bleeding can be increased when Protriptyline is combined with Acetylsalicylic acid.]
[N05AX12, aripiprazole, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Aripiprazole.]
[N07XX07, dalfampridine, Acetylsalicylic acid may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[P02CC01, pyrantel, Acetylsalicylic acid may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[J04AK01, pyrazinamide, Acetylsalicylic acid may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.]
[A12BA05, potassium gluconate, Potassium gluconate may increase the hyperkalemic activities of Acetylsalicylic acid.]
[C01BA01, quinidine, Acetylsalicylic acid may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[P01BC01, quinine, The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Quinine.]
[A02BA02, ranitidine, The excretion of Ranitidine can be decreased when combined with Acetylsalicylic acid.]
[C02AA01, rescinnamine, The therapeutic efficacy of Rescinnamine can be decreased when used in combination with Acetylsalicylic acid.]
[C02AA02, reserpine, Acetylsalicylic acid may decrease the antihypertensive activities of Reserpine.]
[J05AP01, ribavirin, Acetylsalicylic acid may decrease the excretion rate of Ribavirin which could result in a higher serum level.]
[R03AC05, rimiterol, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Rimiterol.]
[G02CA01, ritodrine, The risk or severity of hypertension can be increased when Ritodrine is combined with Acetylsalicylic acid.]
[A07EC01, sulfasalazine, The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Sulfasalazine.]
[S01BC08, salicylic acid, The risk or severity of adverse effects can be increased when Salicylic acid is combined with Acetylsalicylic acid.]
[N05CA06, secobarbital, Acetylsalicylic acid may decrease the excretion rate of Secobarbital which could result in a higher serum level.]
[N04BD01, selegiline, The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Acetylsalicylic acid.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Obinutuzumab.]
[J01GB08, sisomicin, Acetylsalicylic acid may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Acetylsalicylic acid may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[V04CC01, sorbitol, Acetylsalicylic acid may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[C07AA07, sotalol, Acetylsalicylic acid may decrease the antihypertensive activities of Sotalol.]
[L01CD04, cabazitaxel, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Cabazitaxel.]
[C03DA01, spironolactone, Acetylsalicylic acid may decrease the excretion rate of Spironolactone which could result in a higher serum level.]
[N03AG01, valproic acid, The metabolism of Valproic acid can be decreased when combined with Acetylsalicylic acid.]
[D07AB02, hydrocortisone butyrate, The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Acetylsalicylic acid.]
[A05AA02, ursodiol, The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Ursodeoxycholic acid.]
[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Codeine.]
[M03AB01, succinylcholine, The risk or severity of bradycardia can be increased when Succinylcholine is combined with Codeine.]
[N05AL01, sulpiride, The risk or severity of adverse effects can be increased when Codeine is combined with Sulpiride.]
[N03AX03, sulthiame, The risk or severity of adverse effects can be increased when Codeine is combined with Sulthiame.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Codeine.]
[N05CD07, temazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Temazepam.]
[N07XX06, tetrabenazine, The metabolism of Tetrabenazine can be decreased when combined with Codeine.]
[S01HA03, tetracaine, The risk or severity of adverse effects can be increased when Codeine is combined with Tetracaine.]
[N05AE05, lurasidone, The risk or severity of adverse effects can be increased when Codeine is combined with Lurasidone.]
[A04AD10, dronabinol, Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[N04BC07, apomorphine, The risk or severity of adverse effects can be increased when Codeine is combined with Apomorphine.]
[L04AX02, thalidomide, Codeine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.]
[R03DA07, theobromine, The therapeutic efficacy of Theobromine can be decreased when used in combination with Codeine.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Codeine.]
[A11DA01, thiamine, The risk or severity of adverse effects can be increased when Codeine is combined with Thiamine.]
[R06AD03, thiethylperazine, The risk or severity of hypotension and CNS depression can be increased when Thiethylperazine is combined with Codeine.]
[N05CA19, thiopental, The risk or severity of adverse effects can be increased when Thiopental is combined with Codeine.]
[N05AB08, thioproperazine, The risk or severity of hypotension and CNS depression can be increased when Thioproperazine is combined with Codeine.]
[N05AC02, thioridazine, The metabolism of Codeine can be decreased when combined with Thioridazine.]
[N05AF04, thiothixene, The risk or severity of adverse effects can be increased when Codeine is combined with Thiothixene.]
[C01BB04, aprindine, The metabolism of Aprindine can be decreased when combined with Codeine.]
[N05AL03, tiapride, The risk or severity of adverse effects can be increased when Codeine is combined with Tiapride.]
[B01AC05, ticlopidine, The metabolism of Codeine can be decreased when combined with Ticlopidine.]
[N02AX01, tilidine, The risk or severity of adverse effects can be increased when Codeine is combined with Tilidine.]
[S01ED01, timolol, The metabolism of Timolol can be decreased when combined with Codeine.]
[M03BX04, tolperisone, The risk or severity of adverse effects can be increased when Codeine is combined with Tolperisone.]
[N02AX02, tramadol, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Tramadol.]
[N06AF04, tranylcypromine, The risk or severity of adverse effects can be increased when Codeine is combined with Tranylcypromine.]
[N06AX05, trazodone, The risk or severity of serotonin syndrome can be increased when Trazodone is combined with Codeine.]
[C03DB02, triamterene, The therapeutic efficacy of Triamterene can be decreased when used in combination with Codeine.]
[N05CD05, triazolam, The risk or severity of adverse effects can be increased when Codeine is combined with Triazolam.]
[C03AA06, trichlormethiazide, The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Codeine.]
[A03AB12, mepenzolate, The risk or severity of adverse effects can be increased when Mepenzolate is combined with Codeine.]
[N05AB06, trifluoperazine, The risk or severity of hypotension and CNS depression can be increased when Trifluoperazine is combined with Codeine.]
[S01AD02, trifluridine, The excretion of Trifluridine can be decreased when combined with Codeine.]
[N05AD02, trifluperidol, The risk or severity of adverse effects can be increased when Codeine is combined with Trifluperidol.]
[N05AA05, triflupromazine, The risk or severity of adverse effects can be increased when Triflupromazine is combined with Codeine.]
[N04AA01, trihexyphenidyl, The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Codeine.]
[A03AA05, trimebutine, The risk or severity of adverse effects can be increased when Trimebutine is combined with Codeine.]
[R06AD01, trimeprazine, The risk or severity of hypotension and CNS depression can be increased when Alimemazine is combined with Codeine.]
[N03AC02, trimethadione, The risk or severity of adverse effects can be increased when Codeine is combined with Trimethadione.]
[C02BA01, trimethaphan, The risk or severity of adverse effects can be increased when Trimethaphan is combined with Codeine.]
[N06AA06, trimipramine, The metabolism of Trimipramine can be decreased when combined with Codeine.]
[R06AC04, tripelennamine, The metabolism of Codeine can be decreased when combined with Tripelennamine.]
[A03BB01, butylscopolamine, The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Codeine.]
[J01FA08, troleandomycin, The metabolism of Codeine can be decreased when combined with Troleandomycin.]
[N06AX24, vilazodone, The metabolism of Codeine can be decreased when combined with Vilazodone.]
[N06AX02, tryptophan, The risk or severity of adverse effects can be increased when Tryptophan is combined with Codeine.]
[M03AA02, tubocurarine, The risk or severity of adverse effects can be increased when Tubocurarine is combined with Codeine.]
[L02BX03, abiraterone, The metabolism of Codeine can be decreased when combined with Abiraterone.]
[A10BH05, linagliptin, The metabolism of Codeine can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Codeine can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Codeine can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The metabolism of Codeine can be decreased when combined with Rilpivirine.]
[N03AX21, ezogabine, The risk or severity of adverse effects can be increased when Codeine is combined with Ezogabine.]
[B01AC24, ticagrelor, Codeine can cause a decrease in the absorption of Ticagrelor resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C08DA01, verapamil, The metabolism of Codeine can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Codeine can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Codeine can be decreased when combined with Vinblastine.]
[C03BA10, xipamide, The therapeutic efficacy of Xipamide can be decreased when used in combination with Codeine.]
[J05AF01, zidovudine, The excretion of Zidovudine can be decreased when combined with Codeine.]
[N05AF05, zuclopenthixol, The risk or severity of adverse effects can be increased when Codeine is combined with Zuclopenthixol.]
[J05AE02, indinavir, The metabolism of Codeine can be decreased when combined with Indinavir.]
[N03AX14, levetiracetam, The risk or severity of adverse effects can be increased when Codeine is combined with Levetiracetam.]
[L01EC01, vemurafenib, The metabolism of Codeine can be decreased when combined with Vemurafenib.]
[L01ED01, crizotinib, The metabolism of Codeine can be decreased when combined with Crizotinib.]
[N05AE04, ziprasidone, The risk or severity of adverse effects can be increased when Codeine is combined with Ziprasidone.]
[G03AC10, drospirenone, The therapeutic efficacy of Drospirenone can be decreased when used in combination with Codeine.]
[G04BD07, tolterodine, The risk or severity of adverse effects can be increased when Tolterodine is combined with Codeine.]
[C07AB03, atenolol, The metabolism of Atenolol can be decreased when combined with Codeine.]
[J02AC03, voriconazole, The metabolism of Codeine can be decreased when combined with Voriconazole.]
[M03AC04, atracurium, The risk or severity of adverse effects can be increased when Atracurium is combined with Codeine.]
[S01FA01, atropine, The risk or severity of adverse effects can be increased when Atropine is combined with Codeine.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Codeine.]
[M03BX01, baclofen, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[A08AA11, lorcaserin, The metabolism of Codeine can be decreased when combined with Lorcaserin.]
[G04BD12, mirabegron, The serum concentration of Codeine can be increased when it is combined with Mirabegron.]
[V03AX03, cobicistat, The metabolism of Codeine can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Codeine can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Codeine can be decreased when it is combined with Enzalutamide.]
[A06AX04, linaclotide, The therapeutic efficacy of Linaclotide can be decreased when used in combination with Codeine.]
[N05CA04, barbital, The risk or severity of adverse effects can be increased when Barbital is combined with Codeine.]
[J05AE04, nelfinavir, The metabolism of Codeine can be decreased when combined with Nelfinavir.]
[S01GA07, brimonidine, Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[N04BD02, rasagiline, The risk or severity of adverse effects can be increased when Codeine is combined with Rasagiline.]
[A03FA09, mosapride, The risk or severity of adverse effects can be increased when Codeine is combined with Mosapride.]
[N06DA02, donepezil, The risk or severity of adverse effects can be increased when Codeine is combined with Donepezil.]
[N03AX22, perampanel, Perampanel may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[N02CC03, zolmitriptan, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Codeine.]
[R06AC06, thonzylamine, The risk or severity of adverse effects can be increased when Thonzylamine is combined with Codeine.]
[G04BD10, darifenacin, The risk or severity of adverse effects can be increased when Darifenacin is combined with Codeine.]
[N01AA01, ethyl ether, The risk or severity of adverse effects can be increased when Codeine is combined with Diethyl ether.]
[G04BE03, sildenafil, The metabolism of Codeine can be decreased when combined with Sildenafil.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Codeine.]
[A10BH04, alogliptin, The metabolism of Alogliptin can be decreased when combined with Codeine.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Codeine can be decreased when combined with Glycerol phenylbutyrate.]
[C03AA01, bendroflumethiazide, The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Codeine.]
[L04AX06, pomalidomide, The risk or severity of adverse effects can be increased when Codeine is combined with Pomalidomide.]
[G03XC05, ospemifene, The metabolism of Codeine can be decreased when combined with Ospemifene.]
[N05AD07, benperidol, The risk or severity of adverse effects can be increased when Codeine is combined with Benperidol.]
[A10BK02, canagliflozin, The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Codeine.]
[A06AX06, tegaserod, The metabolism of Codeine can be decreased when combined with Tegaserod.]
[R02AD01, benzocaine, The risk or severity of adverse effects can be increased when Codeine is combined with Benzocaine.]
[M01AH01, celecoxib, The metabolism of Codeine can be decreased when combined with Celecoxib.]
[N02CC02, naratriptan, The risk or severity of adverse effects can be increased when Codeine is combined with Naratriptan.]
[L04AA18, everolimus, The metabolism of Codeine can be decreased when combined with Everolimus.]
[N04AC01, benztropine, The risk or severity of adverse effects can be increased when Benzatropine is combined with Codeine.]
[L01EC02, dabrafenib, The serum concentration of Codeine can be decreased when it is combined with Dabrafenib.]
[P03AX06, benzyl alcohol, The risk or severity of adverse effects can be increased when Codeine is combined with Benzyl alcohol.]
[N06AX28, levomilnacipran, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Levomilnacipran.]
[C08EA02, bepridil, The metabolism of Codeine can be decreased when combined with Bepridil.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Codeine.]
[N06AX26, vortioxetine, The risk or severity of adverse effects can be increased when Codeine is combined with Vortioxetine.]
[N03AF04, eslicarbazepine, The risk or severity of adverse effects can be increased when Codeine is combined with Eslicarbazepine.]
[J05AP05, simeprevir, The metabolism of Codeine can be decreased when combined with Simeprevir.]
[N03AG04, vigabatrin, The risk or severity of adverse effects can be increased when Codeine is combined with Vigabatrin.]
[A10BK01, dapagliflozin, The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Codeine.]
[C07AB04, acebutolol, The metabolism of Codeine can be decreased when combined with Acebutolol.]
[N05CH03, tasimelteon, The risk or severity of adverse effects can be increased when Codeine is combined with Tasimelteon.]
[A16AA07, metreleptin, The metabolism of Codeine can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Codeine can be increased when combined with Apremilast.]
[S01ED02, betaxolol, The metabolism of Codeine can be decreased when combined with Betaxolol.]
[L04AC11, siltuximab, The metabolism of Codeine can be increased when combined with Siltuximab.]
[A03BA03, hyoscyamine, The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Codeine.]
[N01AX05, alfaxalone, The risk or severity of adverse effects can be increased when Codeine is combined with Alfaxalone.]
[J05AF08, adefovir dipivoxil, The excretion of Adefovir dipivoxil can be decreased when combined with Codeine.]
[S01AA13, fusidic acid, The metabolism of Codeine can be decreased when combined with Fusidic acid.]
[D11AA01, glycopyrronium, The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Codeine.]
[N05CM19, suvorexant, Codeine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A16AX10, eliglustat, The metabolism of Codeine can be decreased when combined with Eliglustat.]
[J01XA05, oritavancin, The metabolism of Codeine can be decreased when combined with Oritavancin.]
[N05AA04, acepromazine, The risk or severity of hypotension and CNS depression can be increased when Acepromazine is combined with Codeine.]
[A06AB04, phenolphthalein, The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Codeine.]
[A06AH03, naloxegol, The risk or severity of adverse effects can be increased when Codeine is combined with Naloxegol.]
[N04AA02, biperiden, The risk or severity of adverse effects can be increased when Biperiden is combined with Codeine.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Codeine.]
[A06AG02, bisacodyl, The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Codeine.]
[J05AP09, dasabuvir, The metabolism of Dasabuvir can be decreased when combined with Codeine.]
[N06AX11, mirtazapine, Codeine may increase the serotonergic activities of Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Codeine can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The risk or severity of adverse effects can be increased when Palbociclib is combined with Codeine.]
[L01XH03, panobinostat, The metabolism of Codeine can be decreased when combined with Panobinostat.]
[A03AA09, difemerine, The risk or severity of adverse effects can be increased when Difemerine is combined with Codeine.]
[J05AP06, asunaprevir, The metabolism of Codeine can be decreased when combined with Asunaprevir.]
[A07DA06, eluxadoline, The risk or severity of constipation can be increased when Codeine is combined with Eluxadoline.]
[N05AX16, brexpiprazole, The risk or severity of adverse effects can be increased when Codeine is combined with Brexpiprazole.]
[A04AD14, rolapitant, The metabolism of Codeine can be decreased when combined with Rolapitant.]
[G02CX02, flibanserin, The risk or severity of adverse effects can be increased when Codeine is combined with Flibanserin.]
[A06AD03, magnesium peroxide, The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Codeine.]
[N05AX15, cariprazine, The risk or severity of adverse effects can be increased when Codeine is combined with Cariprazine.]
[S01EC01, acetazolamide, The risk or severity of adverse effects can be increased when Codeine is combined with Acetazolamide.]
[N05AB07, acetophenazine, The risk or severity of hypotension and CNS depression can be increased when Acetophenazine is combined with Codeine.]
[A02BC03, lansoprazole, The metabolism of Codeine can be decreased when combined with Lansoprazole.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Codeine.]
[J02AC05, isavuconazole, The metabolism of Codeine can be decreased when combined with Isavuconazole.]
[J05AF13, tenofovir alafenamide, The excretion of Tenofovir alafenamide can be decreased when combined with Codeine.]
[N05CA05, aprobarbital, The risk or severity of adverse effects can be increased when Aprobarbital is combined with Codeine.]
[N03AX23, brivaracetam, The risk or severity of adverse effects can be increased when Codeine is combined with Brivaracetam.]
[L01XX52, venetoclax, The metabolism of Codeine can be decreased when combined with Venetoclax.]
[N05BA08, bromazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Bromazepam.]
[N04BC01, bromocriptine, The risk or severity of adverse effects can be increased when Codeine is combined with Bromocriptine.]
[A03AX08, alverine, The risk or severity of adverse effects can be increased when Codeine is combined with Alverine.]
[N06AA19, amineptin, The risk or severity of adverse effects can be increased when Codeine is combined with Amineptine.]
[N06BX11, aniracetam, The risk or severity of adverse effects can be increased when Codeine is combined with Aniracetam.]
[C03CA02, bumetanide, The therapeutic efficacy of Bumetanide can be decreased when used in combination with Codeine.]
[N01BB01, bupivacaine, The risk or severity of adverse effects can be increased when Bupivacaine is combined with Codeine.]
[C07AA19, bupranolol, The metabolism of Bupranolol can be decreased when combined with Codeine.]
[N07BC01, buprenorphine, Codeine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.]
[N05BE01, buspirone, The risk or severity of adverse effects can be increased when Codeine is combined with Buspirone.]
[N02AF01, butorphanol, The therapeutic efficacy of Codeine can be decreased when used in combination with Butorphanol.]
[S01GX07, azelastine, Codeine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.]
[L01XK03, rucaparib, The metabolism of Codeine can be decreased when combined with Rucaparib.]
[A06AX07, plecanatide, The therapeutic efficacy of Plecanatide can be decreased when used in combination with Codeine.]
[L01EF02, ribociclib, The metabolism of Codeine can be decreased when combined with Ribociclib.]
[A06AH05, naldemedine, The therapeutic efficacy of Codeine can be decreased when used in combination with Naldemedine.]
[N07XX16, deutetrabenazine, The metabolism of Deutetrabenazine can be decreased when combined with Codeine.]
[N02BF02, pregabalin, The therapeutic efficacy of Codeine can be increased when used in combination with Pregabalin.]
[N03AX30, beclamide, The risk or severity of adverse effects can be increased when Codeine is combined with Beclamide.]
[S01HA02, benoxinate, The risk or severity of adverse effects can be increased when Codeine is combined with Oxybuprocaine.]
[J01XX08, linezolid, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Codeine.]
[J05AE09, tipranavir, The metabolism of Codeine can be decreased when combined with Tipranavir.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Codeine.]
[L04AB02, infliximab, The metabolism of Codeine can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Codeine can be decreased when combined with Midostaurin.]
[N04BD03, safinamide, The risk or severity of adverse effects can be increased when Codeine is combined with Safinamide.]
[S01EB09, acetylcholine, The risk or severity of adverse effects can be increased when Codeine is combined with Acetylcholine.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Codeine.]
[J05AG03, efavirenz, The metabolism of Codeine can be decreased when combined with Efavirenz.]
[C07AA17, bopindolol, The metabolism of Bopindolol can be decreased when combined with Codeine.]
[N04AA11, bornaprine, The risk or severity of adverse effects can be increased when Bornaprine is combined with Codeine.]
[N05AD06, bromperidol, The risk or severity of adverse effects can be increased when Codeine is combined with Bromperidol.]
[N05CD09, brotizolam, The risk or severity of adverse effects can be increased when Codeine is combined with Brotizolam.]
[C03DA03, canrenone, The therapeutic efficacy of Canrenone can be decreased when used in combination with Codeine.]
[N05CA03, butobarbital, The risk or severity of adverse effects can be increased when Butobarbital is combined with Codeine.]
[J05AX18, letermovir, The metabolism of Letermovir can be decreased when combined with Codeine.]
[N06AA15, butriptyline, The risk or severity of adverse effects can be increased when Codeine is combined with Butriptyline.]
[A10BK04, ertugliflozin, The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Codeine.]
[N05CA08, butylvinal, The risk or severity of adverse effects can be increased when Codeine is combined with Vinylbital.]
[C09AA01, captopril, The excretion of Captopril can be decreased when combined with Codeine.]
[L02BB05, apalutamide, The metabolism of Codeine can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Codeine can be increased when combined with Carbamazepine.]
[A06AC08, calcium polycarbophil, The therapeutic efficacy of Calcium polycarbophil can be decreased when used in combination with Codeine.]
[A03AA03, camylofine, The risk or severity of adverse effects can be increased when Camylofin is combined with Codeine.]
[R06AA08, carbinoxamine, The risk or severity of adverse effects can be increased when Codeine is combined with Carbinoxamine.]
[C07AG02, carvedilol, The metabolism of Carvedilol can be decreased when combined with Codeine.]
[N03AX24, cannabidiol, The risk or severity of adverse effects can be increased when Cannabidiol is combined with Codeine.]
[L01EC03, encorafenib, The metabolism of Encorafenib can be decreased when combined with Codeine.]
[J01DD14, ceftibuten, The excretion of Ceftibuten can be decreased when combined with Codeine.]
[C07AB08, celiprolol, The metabolism of Celiprolol can be decreased when combined with Codeine.]
[H01CC03, elagolix, The metabolism of Elagolix can be decreased when combined with Codeine.]
[L01XX62, ivosidenib, The metabolism of Codeine can be increased when combined with Ivosidenib.]
[P01BA07, tafenoquine, The metabolism of Tafenoquine can be decreased when combined with Codeine.]
[N03AX17, stiripentol, The metabolism of Codeine can be decreased when combined with Stiripentol.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Codeine.]
[S01GX12, cetirizine, The risk or severity of adverse effects can be increased when Codeine is combined with Cetirizine.]
[N05CM04, carbromal, The risk or severity of adverse effects can be increased when Codeine is combined with Carbromal.]
[N01BA04, chloroprocaine, The risk or severity of adverse effects can be increased when Codeine is combined with Chloroprocaine.]
[R06AA06, chlorphenoxamine, The risk or severity of adverse effects can be increased when Chlorphenoxamine is combined with Codeine.]
[R03BB08, revefenacin, The risk or severity of adverse effects can be increased when Revefenacin is combined with Codeine.]
[L04AA39, emapalumab, The metabolism of Codeine can be increased when combined with Emapalumab.]
[L01EX13, gilteritinib, The risk or severity of adverse effects can be increased when Gilteritinib is combined with Codeine.]
[A06AX05, prucalopride, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Codeine.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be decreased when combined with Codeine.]
[A03FA08, cinitapride, The risk or severity of adverse effects can be increased when Codeine is combined with Cinitapride.]
[P02BX04, triclabendazole, The metabolism of Codeine can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The risk or severity of adverse effects can be increased when Codeine is combined with Esketamine.]
[J01FA09, clarithromycin, The metabolism of Codeine can be decreased when combined with Clarithromycin.]
[N06BA14, solriamfetol, The risk or severity of adverse effects can be increased when Codeine is combined with Solriamfetol.]
[N06AX29, brexanolone, The risk or severity of adverse effects can be increased when Codeine is combined with Brexanolone.]
[N05BA09, clobazam, The metabolism of Codeine can be decreased when combined with Clobazam.]
[A06AB05, castor oil, The therapeutic efficacy of Castor oil can be decreased when used in combination with Codeine.]
[N05BA22, cloxazolam, The risk or severity of adverse effects can be increased when Codeine is combined with Cloxazolam.]
[L04AB01, etanercept, The metabolism of Codeine can be increased when combined with Etanercept.]
[J01DB04, cefazolin, The excretion of Cefazolin can be decreased when combined with Codeine.]
[N05AA06, cyamemazine, The risk or severity of hypotension and CNS depression can be increased when Cyamemazine is combined with Codeine.]
[J01DC07, cefotiam, The excretion of Cefotiam can be decreased when combined with Codeine.]
[C03BX03, cicletanine, The therapeutic efficacy of Cicletanine can be decreased when used in combination with Codeine.]
[J01DD07, ceftizoxime, The excretion of Ceftizoxime can be decreased when combined with Codeine.]
[M03BX08, cyclobenzaprine, The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Codeine.]
[L01EJ02, fedratinib, The metabolism of Codeine can be decreased when combined with Fedratinib.]
[N07XX11, pitolisant, The serum concentration of Codeine can be decreased when it is combined with Pitolisant.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Codeine.]
[C03AA09, cyclothiazide, The therapeutic efficacy of Cyclothiazide can be decreased when used in combination with Codeine.]
[G04BE04, yohimbine, The risk or severity of adverse effects can be increased when Codeine is combined with Yohimbine.]
[A06AB03, danthron, The therapeutic efficacy of Dantron can be decreased when used in combination with Codeine.]
[J01DB01, cephalexin, The excretion of Cephalexin can be decreased when combined with Codeine.]
[J01DB02, cephaloridine, The excretion of Cefaloridine can be decreased when combined with Codeine.]
[N02CC08, lasmiditan, The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Codeine.]
[N03AX25, cenobamate, The serum concentration of Codeine can be decreased when it is combined with Cenobamate.]
[A16AX16, givosiran, The serum concentration of Codeine can be increased when it is combined with Givosiran.]
[R06AB02, dexchlorpheniramine, The metabolism of Codeine can be decreased when combined with Dexchlorpheniramine.]
[N02AX03, dezocine, The risk or severity of adverse effects can be increased when Codeine is combined with Dezocine.]
[N05CM21, lemborexant, The risk or severity of adverse effects can be increased when Codeine is combined with Lemborexant.]
[N05AD10, lumateperone, The risk or severity of adverse effects can be increased when Codeine is combined with Lumateperone.]
[M01AX21, diacetylrhein, The metabolism of Codeine can be decreased when combined with Diacerein.]
[H02CA02, osilodrostat, The metabolism of Codeine can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Codeine can be decreased when combined with Amprenavir.]
[N02CC07, frovatriptan, The risk or severity of adverse effects can be increased when Codeine is combined with Frovatriptan.]
[N05CC04, dichloralphenazone, The risk or severity of adverse effects can be increased when Codeine is combined with Dichloralphenazone.]
[A07DA04, difenoxin, The risk or severity of adverse effects can be increased when Codeine is combined with Difenoxin.]
[N02AA08, dihydrocodeine, The risk or severity of adverse effects can be increased when Codeine is combined with Dihydrocodeine.]
[N02CC06, eletriptan, The risk or severity of adverse effects can be increased when Eletriptan is combined with Codeine.]
[C08CA16, clevidipine, The metabolism of Clevidipine can be decreased when combined with Codeine.]
[C01BD07, dronedarone, The metabolism of Codeine can be decreased when combined with Dronedarone.]
[N03AG02, dipropylacetamide, The risk or severity of adverse effects can be increased when Codeine is combined with Valpromide.]
[N05BA02, chlordiazepoxide, The risk or severity of adverse effects can be increased when Codeine is combined with Chlordiazepoxide.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Codeine.]
[A03AA08, dihexyverine, The risk or severity of adverse effects can be increased when Dihexyverine is combined with Codeine.]
[G04BD09, trospium, The risk or severity of adverse effects can be increased when Trospium is combined with Codeine.]
[N05CM02, chlormethiazole, The risk or severity of adverse effects can be increased when Codeine is combined with Clomethiazole.]
[M03BB02, chlormezanone, The risk or severity of adverse effects can be increased when Codeine is combined with Chlormezanone.]
[R02AD04, dyclonine, The risk or severity of adverse effects can be increased when Codeine is combined with Dyclonine.]
[P01BB01, proguanil, The metabolism of Codeine can be decreased when combined with Proguanil.]
[N05CD14, remimazolam, The risk or severity of adverse effects can be increased when Codeine is combined with Remimazolam.]
[N07XX04, sodium oxybate, Codeine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.]
[L04AC19, satralizumab, The serum concentration of Codeine can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Codeine is combined with Oliceridine.]
[P01BA01, chloroquine, The metabolism of Codeine can be decreased when combined with Chloroquine.]
[C03AA04, chlorothiazide, The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Codeine.]
[N05AA01, chlorpromazine, The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Codeine.]
[N05AF03, chlorprothixene, The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Codeine.]
[C03BA04, chlorthalidone, The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Codeine.]
[A11CC05, cholecalciferol, The metabolism of Codeine can be decreased when combined with Cholecalciferol.]
[N05BX03, etifoxine, The risk or severity of adverse effects can be increased when Codeine is combined with Etifoxine.]
[N02BA03, choline salicylate, The risk or severity of adverse effects can be increased when Codeine is combined with Choline salicylate.]
[N06BX18, vinpocetine, The risk or severity of adverse effects can be increased when Codeine is combined with Vinpocetine.]
[N05BA18, ethyl loflazepate, The risk or severity of adverse effects can be increased when Codeine is combined with Ethyl loflazepate.]
[B06AC06, berotralstat, The metabolism of Codeine can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The metabolism of Codeine can be decreased when combined with Lonafarnib.]
[P03AX07, abametapir, The serum concentration of Codeine can be increased when it is combined with Abametapir.]
[M03BA05, febarbamate, The risk or severity of adverse effects can be increased when Codeine is combined with Febarbamate.]
[N03AX10, felbamate, The risk or severity of adverse effects can be increased when Codeine is combined with Felbamate.]
[J01DD15, cefdinir, The excretion of Cefdinir can be decreased when combined with Codeine.]
[S01JA01, fluorescein, The excretion of Fluorescein can be decreased when combined with Codeine.]
[R03CC15, formoterol, The risk or severity of adverse effects can be increased when Codeine is combined with Formoterol.]
[N01AB05, trichloroethylene, The risk or severity of adverse effects can be increased when Codeine is combined with Trichloroethylene.]
[L03AB10, peginterferon alfa-2b, The metabolism of Codeine can be decreased when combined with Peginterferon alfa-2b.]
[A02BA01, cimetidine, The metabolism of Codeine can be decreased when combined with Cimetidine.]
[N02BF01, gabapentin, The risk or severity of adverse effects can be increased when Codeine is combined with Gabapentin.]
[N07CA02, cinnarizine, The metabolism of Cinnarizine can be decreased when combined with Codeine.]
[L01XX73, sotorasib, The serum concentration of Codeine can be decreased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, The metabolism of Codeine can be decreased when combined with Ciprofloxacin.]
[N06AB04, citalopram, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Citalopram.]
[C03DA05, finerenone, The therapeutic efficacy of Finerenone can be decreased when used in combination with Codeine.]
[P01CA03, fexinidazole, The metabolism of Fexinidazole can be decreased when combined with Codeine.]
[R06AA04, clemastine, The risk or severity of adverse effects can be increased when Clemastine is combined with Codeine.]
[M01AG01, mefenamic acid, The metabolism of Codeine can be decreased when combined with Mefenamic acid.]
[N06AX25, St. John's wort extract, The metabolism of Codeine can be increased when combined with St. John's Wort.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of neuropsychiatric effects can be increased when Ropeginterferon alfa-2b is combined with Codeine.]
[N01BB10, levobupivacaine, The risk or severity of adverse effects can be increased when Codeine is combined with Levobupivacaine.]
[L01EJ03, pacritinib, The serum concentration of Codeine can be increased when it is combined with Pacritinib.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Codeine.]
[N03AE01, clonazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Clonazepam.]
[S01EA04, clonidine, The risk or severity of sedation can be increased when Clonidine is combined with Codeine.]
[C01EB24, mavacamten, The serum concentration of Codeine can be decreased when it is combined with Mavacamten.]
[C03BA03, clopamide, The therapeutic efficacy of Clopamide can be decreased when used in combination with Codeine.]
[N05AH06, clothiapine, The risk or severity of adverse effects can be increased when Codeine is combined with Clothiapine.]
[N05BA21, clotiazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Clotiazepam.]
[A04AA01, ondansetron, The risk or severity of adverse effects can be increased when Codeine is combined with Ondansetron.]
[A04AA02, granisetron, The risk or severity of adverse effects can be increased when Codeine is combined with Granisetron.]
[N05AH02, clozapine, The risk or severity of adverse effects can be increased when Clozapine is combined with Codeine.]
[N05BA13, halazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Halazepam.]
[H01AC08, somatrogon, The metabolism of Codeine can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The risk or severity of adverse effects can be increased when Cocaine is combined with Codeine.]
[C02KB01, metyrosine, Codeine may increase the sedative activities of Metyrosine.]
[L04AC21, bimekizumab, The metabolism of Codeine can be increased when combined with Bimekizumab.]
[M03AC05, hexafluorenium, The risk or severity of adverse effects can be increased when Hexafluronium is combined with Codeine.]
[A03AB10, hexocyclium, The risk or severity of adverse effects can be increased when Hexocyclium is combined with Codeine.]
[A03BB06, homatropine methylbromide, The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Codeine.]
[N01AB07, desflurane, The risk or severity of adverse effects can be increased when Codeine is combined with Desflurane.]
[A04AA03, tropisetron, The risk or severity of adverse effects can be increased when Codeine is combined with Tropisetron.]
[C04AX28, ifenprodil, The risk or severity of adverse effects can be increased when Codeine is combined with Ifenprodil.]
[A10BX03, nateglinide, The metabolism of Nateglinide can be decreased when combined with Codeine.]
[J01FA15, telithromycin, The metabolism of Codeine can be decreased when combined with Telithromycin.]
[R03BA08, ciclesonide, The metabolism of Ciclesonide can be decreased when combined with Codeine.]
[R06AX27, desloratadine, The risk or severity of adverse effects can be increased when Desloratadine is combined with Codeine.]
[H01AX01, pegvisomant, The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Codeine.]
[N02CC05, almotriptan, The risk or severity of adverse effects can be increased when Codeine is combined with Almotriptan.]
[J02AC02, itraconazole, The metabolism of Codeine can be decreased when combined with Itraconazole.]
[S01AD03, acyclovir, The risk or severity of adverse effects can be increased when Codeine is combined with Acyclovir.]
[N05BA10, ketazolam, The risk or severity of adverse effects can be increased when Codeine is combined with Ketazolam.]
[L01EA01, imatinib, The serum concentration of Codeine can be increased when it is combined with Imatinib.]
[J02AC04, posaconazole, The metabolism of Codeine can be decreased when combined with Posaconazole.]
[A06AD12, lactitol, The therapeutic efficacy of Lactitol can be decreased when used in combination with Codeine.]
[N03AX09, lamotrigine, The risk or severity of adverse effects can be increased when Lamotrigine is combined with Codeine.]
[N07BC04, lofexidine, The therapeutic efficacy of Codeine can be increased when used in combination with Lofexidine.]
[N05CD06, lormetazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Lormetazepam.]
[A06AD01, magnesium carbonate, The therapeutic efficacy of Magnesium carbonate can be decreased when used in combination with Codeine.]
[C08CA11, manidipine, The metabolism of Codeine can be decreased when combined with Manidipine.]
[A03AA04, mebeverine, The risk or severity of adverse effects can be increased when Mebeverine is combined with Codeine.]
[N06AX13, medifoxamine, The risk or severity of adverse effects can be increased when Codeine is combined with Medifoxamine.]
[C07AA14, mepindolol, The metabolism of Mepindolol can be decreased when combined with Codeine.]
[R06AD07, mequitazine, The metabolism of Mequitazine can be decreased when combined with Codeine.]
[N04AA03, methixene, The risk or severity of adverse effects can be increased when Metixene is combined with Codeine.]
[R03CB02, methoxyphenamine, Methoxyphenamine may increase the analgesic activities of Codeine.]
[R06AE03, cyclizine, The risk or severity of adverse effects can be increased when Codeine is combined with Cyclizine.]
[N05CA10, cyclobarbital, The risk or severity of adverse effects can be increased when Codeine is combined with Cyclobarbital.]
[C03DA04, eplerenone, The therapeutic efficacy of Eplerenone can be decreased when used in combination with Codeine.]
[N05AD03, metylperon, The risk or severity of adverse effects can be increased when Codeine is combined with Melperone.]
[C03AA07, cyclopenthiazide, The therapeutic efficacy of Cyclopenthiazide can be decreased when used in combination with Codeine.]
[J05AF07, tenofovir disoproxil, The excretion of Tenofovir disoproxil can be decreased when combined with Codeine.]
[N06AX07, minaprine, The risk or severity of adverse effects can be increased when Codeine is combined with Minaprine.]
[S01XA18, cyclosporine, The metabolism of Codeine can be decreased when combined with Cyclosporine.]
[N06AG02, moclobemide, The risk or severity of adverse effects can be increased when Codeine is combined with Moclobemide.]
[R06AX02, cyproheptadine, The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Codeine.]
[C03XA02, conivaptan, The metabolism of Codeine can be decreased when combined with Conivaptan.]
[L01BC01, cytarabine, The risk or severity of adverse effects can be increased when Codeine is combined with Cytarabine.]
[M01AH05, etoricoxib, The metabolism of Codeine can be decreased when combined with Etoricoxib.]
[G03XA01, danazol, The metabolism of Codeine can be decreased when combined with Danazol.]
[M03CA01, dantrolene, The risk or severity of adverse effects can be increased when Codeine is combined with Dantrolene.]
[N06BX04, deanol, The risk or severity of adverse effects can be increased when Codeine is combined with Deanol.]
[C02CC04, debrisoquin, The metabolism of Debrisoquine can be decreased when combined with Codeine.]
[A04AD11, nabilone, Nabilone may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[N07BB05, nalmefene, The therapeutic efficacy of Codeine can be decreased when used in combination with Nalmefene.]
[B05XA15, potassium lactate, The therapeutic efficacy of Potassium lactate can be decreased when used in combination with Codeine.]
[N05BA16, nordazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Nordazepam.]
[C07AB12, nebivolol, The metabolism of Nebivolol can be decreased when combined with Codeine.]
[N06AX06, nefazodone, The metabolism of Codeine can be decreased when combined with Nefazodone.]
[N05CM16, niaprazine, The risk or severity of adverse effects can be increased when Codeine is combined with Niaprazine.]
[N03AG06, tiagabine, The risk or severity of adverse effects can be increased when Codeine is combined with Tiagabine.]
[M03AC11, cisatracurium, The risk or severity of adverse effects can be increased when Cisatracurium is combined with Codeine.]
[R05DA06, normethadone, The risk or severity of adverse effects can be increased when Codeine is combined with Normethadone.]
[N06AB10, escitalopram, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Escitalopram.]
[G04BD08, solifenacin, The risk or severity of adverse effects can be increased when Solifenacin is combined with Codeine.]
[N06AA01, desipramine, The risk or severity of adverse effects can be increased when Desipramine is combined with Codeine.]
[H01BA02, desmopressin, The risk or severity of hyponatremia can be increased when Codeine is combined with Desmopressin.]
[N03AF02, oxcarbazepine, The risk or severity of adverse effects can be increased when Codeine is combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Codeine can be increased when combined with Dexamethasone.]
[N06BX07, oxiracetam, The risk or severity of adverse effects can be increased when Codeine is combined with Oxiracetam.]
[N04AA08, dexetimide, The risk or severity of adverse effects can be increased when Dexetimide is combined with Codeine.]
[G04BD04, oxybutynin, The risk or severity of adverse effects can be increased when Oxybutynin is combined with Codeine.]
[A08AA04, dexfenfluramine, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Dexfenfluramine.]
[A03AA01, oxyphencyclimine, The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Codeine.]
[L04AB04, adalimumab, The metabolism of Codeine can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Codeine can be decreased when combined with Gefitinib.]
[N06BA02, dextroamphetamine, Amphetamine may increase the analgesic activities of Codeine.]
[R05DA09, dextromethorphan, The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Codeine.]
[N03AC01, paramethadione, The risk or severity of adverse effects can be increased when Codeine is combined with Paramethadione.]
[N02AC01, dextromoramide, The risk or severity of adverse effects can be increased when Codeine is combined with Dextromoramide.]
[N06AB05, paroxetine, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Paroxetine.]
[B01AC04, clopidogrel, Codeine can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N07BC06, heroin, The risk or severity of adverse effects can be increased when Codeine is combined with Diamorphine.]
[N05BA01, diazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Diazepam.]
[N03AX07, phenacemide, The risk or severity of adverse effects can be increased when Codeine is combined with Phenacemide.]
[N03AD02, phensuximide, The risk or severity of adverse effects can be increased when Codeine is combined with Phensuximide.]
[N06AA08, dibenzepin, The risk or severity of adverse effects can be increased when Codeine is combined with Dibenzepin.]
[S02DA04, dibucaine, The risk or severity of adverse effects can be increased when Codeine is combined with Cinchocaine.]
[S01EC02, dichlorphenamide, The therapeutic efficacy of Diclofenamide can be decreased when used in combination with Codeine.]
[A03AA07, dicyclomine, The risk or severity of adverse effects can be increased when Dicyclomine is combined with Codeine.]
[J05AF03, zalcitabine, The excretion of Zalcitabine can be decreased when combined with Codeine.]
[J05AF02, didanosine, The excretion of Didanosine can be decreased when combined with Codeine.]
[N05AD05, pipamperone, The risk or severity of adverse effects can be increased when Codeine is combined with Pipamperone.]
[A03AB14, pipenzolate, The risk or severity of adverse effects can be increased when Pipenzolate is combined with Codeine.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Codeine.]
[C03CA03, piretanide, The therapeutic efficacy of Piretanide can be decreased when used in combination with Codeine.]
[A08AA03, diethylpropion, Diethylpropion may increase the analgesic activities of Codeine.]
[C08CA03, isradipine, The metabolism of Codeine can be decreased when combined with Isradipine.]
[A03AB11, poldine, The risk or severity of adverse effects can be increased when Poldine is combined with Codeine.]
[N02CA01, dihydroergotamine, The risk or severity of adverse effects can be increased when Codeine is combined with Dihydroergotamine.]
[N02AA03, hydromorphone, The risk or severity of adverse effects can be increased when Codeine is combined with Hydromorphone.]
[J05AE08, atazanavir, The metabolism of Codeine can be decreased when combined with Atazanavir.]
[D04AB07, pramoxine, The risk or severity of adverse effects can be increased when Codeine is combined with Pramocaine.]
[C08DB01, diltiazem, The metabolism of Codeine can be decreased when combined with Diltiazem.]
[R06AA11, dimenhydrinate, The risk or severity of adverse effects can be increased when Codeine is combined with Dimenhydrinate.]
[M03BX03, pridinol, The risk or severity of adverse effects can be increased when Codeine is combined with Pridinol.]
[R06AB03, dimethindene, The risk or severity of adverse effects can be increased when Dimetindene is combined with Codeine.]
[M02AX03, dimethyl sulfoxide, The metabolism of Codeine can be decreased when combined with Dimethyl sulfoxide.]
[N03AG05, progabide, The risk or severity of adverse effects can be increased when Codeine is combined with Progabide.]
[G02AD02, dinoprostone, The risk or severity of adverse effects can be increased when Dinoprostone is combined with Codeine.]
[A07DA01, diphenoxylate, The risk or severity of adverse effects can be increased when Codeine is combined with Diphenoxylate.]
[N05CD10, quazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Quazepam.]
[N06BA11, dexmethylphenidate, The risk or severity of adverse effects can be increased when Codeine is combined with Dexmethylphenidate.]
[N06AA23, quinupramine, The risk or severity of adverse effects can be increased when Codeine is combined with Quinupramine.]
[A03FA02, cisapride, The metabolism of Codeine can be decreased when combined with Cisapride.]
[N05AL04, remoxipride, The risk or severity of adverse effects can be increased when Codeine is combined with Remoxipride.]
[C01BA03, disopyramide, The risk or severity of adverse effects can be increased when Disopyramide is combined with Codeine.]
[S02AA12, rifamycin SV, The metabolism of Codeine can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Codeine can be increased when combined with Rifapentine.]
[N07XX02, riluzole, The risk or severity of adverse effects can be increased when Codeine is combined with Riluzole.]
[N05AX08, risperidone, The risk or severity of adverse effects can be increased when Codeine is combined with Risperidone.]
[R06AE09, levocetirizine, The risk or severity of adverse effects can be increased when Codeine is combined with Levocetirizine.]
[N01BB09, ropivacaine, The risk or severity of adverse effects can be increased when Ropivacaine is combined with Codeine.]
[A04AD12, aprepitant, The metabolism of Codeine can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, The therapeutic efficacy of Tolvaptan can be decreased when used in combination with Codeine.]
[L01XG01, bortezomib, The metabolism of Codeine can be decreased when combined with Bortezomib.]
[C01EB18, ranolazine, The serum concentration of Codeine can be increased when it is combined with Ranolazine.]
[R03AC12, salmeterol, The risk or severity of adverse effects can be increased when Codeine is combined with Salmeterol.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Codeine.]
[C01CA04, dopamine, The risk or severity of adverse effects can be increased when Codeine is combined with Dopamine.]
[N06AA16, dothiepin, The risk or severity of adverse effects can be increased when Dosulepin is combined with Codeine.]
[N06AA12, doxepin, The risk or severity of adverse effects can be increased when Doxepin is combined with Codeine.]
[A06AB06, sennosides, USP, The therapeutic efficacy of Sennosides can be decreased when used in combination with Codeine.]
[L01DB01, doxorubicin, The metabolism of Codeine can be decreased when combined with Doxorubicin.]
[N06AB06, sertraline, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Sertraline.]
[N01AB08, sevoflurane, The risk or severity of adverse effects can be increased when Codeine is combined with Sevoflurane.]
[N05AD08, droperidol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[A08AA10, sibutramine, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Sibutramine.]
[C10AA01, simvastatin, The metabolism of Simvastatin can be decreased when combined with Codeine.]
[V03AG05, sodium phosphate, The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Codeine.]
[A12CA02, sodium sulfate, The therapeutic efficacy of Sodium sulfate can be decreased when used in combination with Codeine.]
[N05AL02, sultopride, The risk or severity of adverse effects can be increased when Codeine is combined with Sultopride.]
[N02CC01, sumatriptan, The risk or severity of adverse effects can be increased when Codeine is combined with Sumatriptan.]
[C07AB13, talinolol, The metabolism of Talinolol can be decreased when combined with Codeine.]
[J01CG02, tazobactam, The excretion of Tazobactam can be decreased when combined with Codeine.]
[D01BA02, terbinafine, The metabolism of Codeine can be decreased when combined with Terbinafine.]
[C07AA16, tertatolol, The metabolism of Tertatolol can be decreased when combined with Codeine.]
[M03BX07, tetrazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Tetrazepam.]
[N05AB05, thiopropazate, The risk or severity of adverse effects can be increased when Codeine is combined with Thiopropazate.]
[G04BD01, emepronium, The risk or severity of adverse effects can be increased when Emepronium is combined with Codeine.]
[N06AX14, tianeptine, The risk or severity of adverse effects can be increased when Codeine is combined with Tianeptine.]
[N05BA23, tofisopam, The risk or severity of adverse effects can be increased when Codeine is combined with Tofisopam.]
[N06AG03, toloxatone, The risk or severity of adverse effects can be increased when Codeine is combined with Toloxatone.]
[N06BA09, atomoxetine, The metabolism of Codeine can be decreased when combined with Atomoxetine.]
[N03AX11, topiramate, The risk or severity of adverse effects can be increased when Topiramate is combined with Codeine.]
[C03CA04, torsemide, The therapeutic efficacy of Torasemide can be decreased when used in combination with Codeine.]
[N05CD11, triazulenone, The risk or severity of adverse effects can be increased when Codeine is combined with Loprazolam.]
[N05CC01, chloral hydrate, The risk or severity of adverse effects can be increased when Codeine is combined with Chloral hydrate.]
[N05CM07, triclofos, The risk or severity of adverse effects can be increased when Codeine is combined with Triclofos.]
[A03AB08, tridihexethyl, The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Codeine.]
[R06AA10, trimethobenzamide, The risk or severity of adverse effects can be increased when Codeine is combined with Trimethobenzamide.]
[N04AA12, tropatepine, The risk or severity of adverse effects can be increased when Tropatepine is combined with Codeine.]
[N01AB04, enflurane, The risk or severity of adverse effects can be increased when Enflurane is combined with Codeine.]
[C02CA06, urapidil, The risk or severity of adverse effects can be increased when Codeine is combined with Urapidil.]
[N05AL06, veralipride, The risk or severity of adverse effects can be increased when Codeine is combined with Veralipride.]
[L01CA04, vinorelbine, The metabolism of Codeine can be decreased when combined with Vinorelbine.]
[S01GX10, epinastine, The risk or severity of adverse effects can be increased when Codeine is combined with Epinastine.]
[N06AX16, venlafaxine, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Venlafaxine.]
[C08CA12, mepirodipine, The metabolism of Codeine can be decreased when combined with Barnidipine.]
[S01EA01, epinephrine, The risk or severity of adverse effects can be increased when Codeine is combined with Epinephrine.]
[N05CF02, zolpidem, Codeine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.]
[N03AX15, zonisamide, The risk or severity of adverse effects can be increased when Codeine is combined with Zonisamide.]
[N05CF01, zopiclone, The risk or severity of adverse effects can be increased when Codeine is combined with Zopiclone.]
[N05AX11, zotepine, The risk or severity of adverse effects can be increased when Codeine is combined with Zotepine.]
[C02AC02, guanfacine, The risk or severity of adverse effects can be increased when Codeine is combined with Guanfacine.]
[C01BG01, moricizine, The risk or severity of hypotension and CNS depression can be increased when Moricizine is combined with Codeine.]
[G02AB03, ergonovine, The risk or severity of adverse effects can be increased when Codeine is combined with Ergometrine.]
[C04AE01, ergoloid mesylates, USP, The risk or severity of adverse effects can be increased when Codeine is combined with Ergoloid mesylate.]
[N02CA02, ergotamine, The metabolism of Codeine can be decreased when combined with Ergotamine.]
[S01AA17, erythromycin, The metabolism of Codeine can be decreased when combined with Erythromycin.]
[N05CD04, estazolam, The risk or severity of adverse effects can be increased when Codeine is combined with Estazolam.]
[H05BX01, cinacalcet, The metabolism of Codeine can be decreased when combined with Cinacalcet.]
[J04AK02, ethambutol, The metabolism of Codeine can be decreased when combined with Ethambutol.]
[C10AA04, fluvastatin, The metabolism of Fluvastatin can be decreased when combined with Codeine.]
[C01CA15, gepefrine, Gepefrine may increase the analgesic activities of Codeine.]
[N05CM08, ethchlorvynol, The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Codeine.]
[N04AA05, profenamine, The risk or severity of adverse effects can be increased when Profenamine is combined with Codeine.]
[N03AD01, ethosuximide, The risk or severity of adverse effects can be increased when Codeine is combined with Ethosuximide.]
[N03AB01, ethotoin, The risk or severity of adverse effects can be increased when Codeine is combined with Ethotoin.]
[N01AX07, etomidate, The risk or severity of adverse effects can be increased when Etomidate is combined with Codeine.]
[N05AE03, sertindole, The risk or severity of adverse effects can be increased when Codeine is combined with Sertindole.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Codeine.]
[R06AX12, terfenadine, The metabolism of Codeine can be decreased when combined with Terfenadine.]
[N06AX12, bupropion, The metabolism of Codeine can be decreased when combined with Bupropion.]
[N06AB08, fluvoxamine, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Fluvoxamine.]
[C01BC08, encainide, The metabolism of Encainide can be decreased when combined with Codeine.]
[A05AA01, chenodeoxycholic acid, The metabolism of Codeine can be decreased when combined with Chenodeoxycholic acid.]
[C08CA02, felodipine, The metabolism of Codeine can be decreased when combined with Felodipine.]
[N03AX26, fenfluramine, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Fenfluramine.]
[R03CC04, fenoterol, The risk or severity of adverse effects can be increased when Fenoterol is combined with Codeine.]
[N02AB03, fentanyl, The risk or severity of adverse effects can be increased when Codeine is combined with Fentanyl.]
[N07AX03, cevimeline, The metabolism of Codeine can be decreased when combined with Cevimeline.]
[G04BD02, flavoxate, The risk or severity of adverse effects can be increased when Flavoxate is combined with Codeine.]
[C01BC04, flecainide, The metabolism of Flecainide can be decreased when combined with Codeine.]
[J02AC01, fluconazole, The metabolism of Codeine can be decreased when combined with Fluconazole.]
[N07CA03, flunarizine, The risk or severity of adverse effects can be increased when Codeine is combined with Flunarizine.]
[N05CD03, flunitrazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Flunitrazepam.]
[N06AA14, melitracen, The risk or severity of adverse effects can be increased when Codeine is combined with Melitracen.]
[N06AB03, fluoxetine, The serum concentration of Codeine can be increased when it is combined with Fluoxetine.]
[N05AF01, flupenthixol, Codeine may increase the central nervous system depressant (CNS depressant) activities of Flupentixol.]
[N05AB02, fluphenazine, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Codeine.]
[N05CD01, flurazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Flurazepam.]
[N05AG01, fluspirilene, The risk or severity of adverse effects can be increased when Codeine is combined with Fluspirilene.]
[M03AA01, alcuronium, The risk or severity of adverse effects can be increased when Alcuronium is combined with Codeine.]
[G01AX06, furazolidone, The risk or severity of adverse effects can be increased when Codeine is combined with Furazolidone.]
[J05AE10, darunavir, The metabolism of Codeine can be decreased when combined with Darunavir.]
[C03CA01, furosemide, The therapeutic efficacy of Furosemide can be decreased when used in combination with Codeine.]
[N05CF04, eszopiclone, The risk or severity of CNS depression can be increased when Codeine is combined with Eszopiclone.]
[N05AL05, amisulpride, The risk or severity of adverse effects can be increased when Codeine is combined with Amisulpride.]
[N06DA04, galantamine, The metabolism of Galantamine can be decreased when combined with Codeine.]
[M03AC02, gallamine, The risk or severity of adverse effects can be increased when Gallamine is combined with Codeine.]
[S01AD09, ganciclovir, The risk or severity of adverse effects can be increased when Codeine is combined with Ganciclovir.]
[N03AA04, barbexaclone, The risk or severity of adverse effects can be increased when Codeine is combined with Barbexaclone.]
[N06AX08, bifemelane, The risk or severity of adverse effects can be increased when Codeine is combined with Bifemelane.]
[N04BC06, cabergoline, The risk or severity of adverse effects can be increased when Cabergoline is combined with Codeine.]
[N03AD03, methsuximide, The risk or severity of adverse effects can be increased when Codeine is combined with Methsuximide.]
[N01AH02, alfentanil, The risk or severity of adverse effects can be increased when Codeine is combined with Alfentanil.]
[A06AH02, alvimopan, The risk or severity of adverse effects can be increased when Codeine is combined with Alvimopan.]
[N05CM18, dexmedetomidine, The risk or severity of adverse effects can be increased when Codeine is combined with Dexmedetomidine.]
[N05CE01, glutethimide, The risk or severity of adverse effects can be increased when Codeine is combined with Glutethimide.]
[A06AX01, glycerin, The therapeutic efficacy of Glycerin can be decreased when used in combination with Codeine.]
[C02CA04, doxazosin, The risk or severity of adverse effects can be increased when Doxazosin is combined with Codeine.]
[C07AB09, esmolol, The metabolism of Codeine can be decreased when combined with Esmolol.]
[P01BX01, halofantrine, The metabolism of Codeine can be decreased when combined with Halofantrine.]
[N05AD01, haloperidol, The risk or severity of CNS depression can be increased when Haloperidol is combined with Codeine.]
[N01AB01, halothane, The risk or severity of adverse effects can be increased when Codeine is combined with Halothane.]
[N05AH04, quetiapine, The risk or severity of adverse effects can be increased when Quetiapine is combined with Codeine.]
[N02CX03, iprazochrome, The risk or severity of adverse effects can be increased when Codeine is combined with Iprazochrome.]
[N05CA21, allobarbital, The risk or severity of adverse effects can be increased when Codeine is combined with Allobarbital.]
[B05CB03, magnesium citrate, The therapeutic efficacy of Magnesium citrate can be decreased when used in combination with Codeine.]
[A12CD02, sodium monofluorophosphate, The therapeutic efficacy of Sodium fluorophosphate can be decreased when used in combination with Codeine.]
[N05CA16, hexobarbital, The risk or severity of adverse effects can be increased when Hexobarbital is combined with Codeine.]
[J05AG01, nevirapine, The risk or severity of adverse effects can be increased when Nevirapine is combined with Codeine.]
[C08CA10, nilvadipine, The metabolism of Codeine can be decreased when combined with Nilvadipine.]
[C03AA03, hydrochlorothiazide, The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Codeine.]
[R05DA03, hydrocodone, Codeine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.]
[C03AA02, hydroflumethiazide, The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Codeine.]
[A12BA02, potassium citrate, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Codeine.]
[G04BD06, propiverine, The risk or severity of adverse effects can be increased when Propiverine is combined with Codeine.]
[P01BA02, hydroxychloroquine, The metabolism of Codeine can be decreased when combined with Hydroxychloroquine.]
[N05AX07, prothipendyl, The risk or severity of adverse effects can be increased when Codeine is combined with Prothipendyl.]
[N05BB01, hydroxyzine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[L01DB06, idarubicin, The metabolism of Idarubicin can be decreased when combined with Codeine.]
[A06AD21, sodium tartrate, The therapeutic efficacy of Sodium tartrate can be decreased when used in combination with Codeine.]
[N01AH03, sufentanil, The risk or severity of adverse effects can be increased when Codeine is combined with Sufentanil.]
[N06AA02, imipramine, The risk or severity of adverse effects can be increased when Imipramine is combined with Codeine.]
[M03BX02, tizanidine, The risk or severity of adverse effects can be increased when Codeine is combined with Tizanidine.]
[C03BA11, indapamide, The therapeutic efficacy of Indapamide can be decreased when used in combination with Codeine.]
[S01BC01, indomethacin, The excretion of Indomethacin can be decreased when combined with Codeine.]
[N06AX17, milnacipran, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Milnacipran.]
[A03AA30, piperidolate, The risk or severity of adverse effects can be increased when Piperidolate is combined with Codeine.]
[N01BB08, articaine, The risk or severity of adverse effects can be increased when Codeine is combined with Articaine.]
[N05BA12, alprazolam, The risk or severity of adverse effects can be increased when Codeine is combined with Alprazolam.]
[N05CH02, ramelteon, The risk or severity of adverse effects can be increased when Codeine is combined with Ramelteon.]
[R06AE01, buclizine, The risk or severity of adverse effects can be increased when Buclizine is combined with Codeine.]
[C10AA06, cerivastatin, The metabolism of Codeine can be decreased when combined with Cerivastatin.]
[C07AA01, alprenolol, The risk or severity of adverse effects can be increased when Codeine is combined with Alprenolol.]
[C03BA02, quinethazone, The therapeutic efficacy of Quinethazone can be decreased when used in combination with Codeine.]
[V03AB01, ipecac, The metabolism of Ipecac can be decreased when combined with Codeine.]
[J05AF04, stavudine, The excretion of Stavudine can be decreased when combined with Codeine.]
[N06AA13, iprindole, The risk or severity of adverse effects can be increased when Codeine is combined with Iprindole.]
[G04BE01, alprostadil, The excretion of Alprostadil can be decreased when combined with Codeine.]
[N06AF05, iproniazid, The risk or severity of adverse effects can be increased when Codeine is combined with Iproniazid.]
[N05AA07, chlorproethazine, The risk or severity of hypotension and CNS depression can be increased when Chlorproethazine is combined with Codeine.]
[N06AF01, isocarboxazid, The risk or severity of adverse effects can be increased when Codeine is combined with Isocarboxazid.]
[N01AB06, isoflurane, The risk or severity of adverse effects can be increased when Isoflurane is combined with Codeine.]
[N04BX02, entacapone, The risk or severity of adverse effects can be increased when Codeine is combined with Entacapone.]
[J04AC01, isoniazid, The metabolism of Codeine can be decreased when combined with Isoniazid.]
[N06AX18, reboxetine, The risk or severity of adverse effects can be increased when Reboxetine is combined with Codeine.]
[L04AC07, tocilizumab, The metabolism of Codeine can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The risk or severity of adverse effects can be increased when Codeine is combined with Ketamine.]
[C02KD01, ketanserin, The risk or severity of adverse effects can be increased when Codeine is combined with Ketanserin.]
[J02AB02, ketoconazole, The metabolism of Codeine can be decreased when combined with Ketoconazole.]
[H02CA04, levoketoconazole, The metabolism of Codeine can be decreased when combined with Levoketoconazole.]
[N05AH03, olanzapine, The risk or severity of adverse effects can be increased when Olanzapine is combined with Codeine.]
[L04AA24, abatacept, The metabolism of Codeine can be increased when combined with Abatacept.]
[N04BC09, rotigotine, Codeine may increase the sedative activities of Rotigotine.]
[C07AG01, labetalol, The metabolism of Codeine can be decreased when combined with Labetalol.]
[N04BB01, amantadine, The risk or severity of adverse effects can be increased when Amantadine is combined with Codeine.]
[A06AD11, lactulose, The therapeutic efficacy of Lactulose can be decreased when used in combination with Codeine.]
[A06AX03, lubiprostone, The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Codeine.]
[N03AX18, lacosamide, The risk or severity of adverse effects can be increased when Codeine is combined with Lacosamide.]
[C03CC01, ethacrynic acid, The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Codeine.]
[N04BA01, levodopa, The risk or severity of adverse effects can be increased when Codeine is combined with Levodopa.]
[S02DA01, lidocaine, The risk or severity of adverse effects can be increased when Lidocaine is combined with Codeine.]
[C03DB01, amiloride, The therapeutic efficacy of Amiloride can be decreased when used in combination with Codeine.]
[N02CA07, lisuride, The risk or severity of adverse effects can be increased when Codeine is combined with Lisuride.]
[N06AA07, lofepramine, The risk or severity of adverse effects can be increased when Codeine is combined with Lofepramine.]
[N05BA06, lorazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Lorazepam.]
[C10AA02, lovastatin, The metabolism of Codeine can be decreased when combined with Lovastatin.]
[N05AH01, loxapine, The risk or severity of adverse effects can be increased when Codeine is combined with Loxapine.]
[L01EG01, temsirolimus, The metabolism of Codeine can be decreased when combined with Temsirolimus.]
[A12CC10, magnesium oxide, The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Codeine.]
[V04CC02, magnesium sulfate, The therapeutic efficacy of Codeine can be increased when used in combination with Magnesium sulfate.]
[L01EA03, nilotinib, The metabolism of Codeine can be decreased when combined with Nilotinib.]
[V04CX04, mannitol, The therapeutic efficacy of Mannitol can be decreased when used in combination with Codeine.]
[N06AA21, maprotiline, The risk or severity of adverse effects can be increased when Maprotiline is combined with Codeine.]
[A08AA05, mazindol, The risk or severity of adverse effects can be increased when Codeine is combined with Mazindol.]
[C02BB01, mecamylamine, The risk or severity of adverse effects can be increased when Mecamylamine is combined with Codeine.]
[R06AE05, meclizine, The risk or severity of adverse effects can be increased when Meclizine is combined with Codeine.]
[N05BA03, medazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Medazepam.]
[A06AB07, cascara sagrada, The therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Codeine.]
[C03BA05, mefruside, The therapeutic efficacy of Mefruside can be decreased when used in combination with Codeine.]
[N05CH01, melatonin, The risk or severity of adverse effects can be increased when Codeine is combined with Melatonin.]
[N02AB02, meperidine, The risk or severity of adverse effects can be increased when Codeine is combined with Meperidine.]
[C01CA11, mephentermine, Mephentermine may increase the analgesic activities of Codeine.]
[N03AB04, mephenytoin, The risk or severity of adverse effects can be increased when Codeine is combined with Mephenytoin.]
[N03AA01, mephobarbital, The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Codeine.]
[N01BB03, mepivacaine, The risk or severity of adverse effects can be increased when Codeine is combined with Mepivacaine.]
[N02AX05, meptazinol, The risk or severity of adverse effects can be increased when Codeine is combined with Meptazinol.]
[C03BC01, mersalyl, The therapeutic efficacy of Mersalyl can be decreased when used in combination with Codeine.]
[N05AC03, mesoridazine, The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Codeine.]
[N05AX13, paliperidone, The risk or severity of adverse effects can be increased when Codeine is combined with Paliperidone.]
[A04AA04, dolasetron, The risk or severity of adverse effects can be increased when Codeine is combined with Dolasetron.]
[N07BC02, methadone, The risk or severity of adverse effects can be increased when Methadone is combined with Codeine.]
[N06BA03, methamphetamine, Metamfetamine may increase the analgesic activities of Codeine.]
[A03AB07, methantheline, The risk or severity of adverse effects can be increased when Methantheline is combined with Codeine.]
[R06AC05, methapyrilene, The risk or severity of adverse effects can be increased when Codeine is combined with Methapyrilene.]
[N05CM01, methaqualone, The risk or severity of adverse effects can be increased when Codeine is combined with Methaqualone.]
[J05AF05, lamivudine, The risk or severity of adverse effects can be increased when Codeine is combined with Lamivudine.]
[N03AA30, metharbital, The risk or severity of adverse effects can be increased when Metharbital is combined with Codeine.]
[S01EC05, methazolamide, The therapeutic efficacy of Methazolamide can be decreased when used in combination with Codeine.]
[G02CB05, metergoline, The risk or severity of adverse effects can be increased when Codeine is combined with Metergoline.]
[H03BB02, methimazole, The metabolism of Codeine can be decreased when combined with Methimazole.]
[N05CA15, methohexital, The risk or severity of adverse effects can be increased when Codeine is combined with Methohexital.]
[N02BG08, ziconotide, The risk or severity of adverse effects can be increased when Codeine is combined with Ziconotide.]
[N05AA02, methotrimeprazine, Codeine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.]
[N02BG09, methoxyflurane, The risk or severity of adverse effects can be increased when Codeine is combined with Methoxyflurane.]
[C03AA08, methyclothiazide, The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Codeine.]
[A06AC06, methylcellulose, The therapeutic efficacy of Methylcellulose can be decreased when used in combination with Codeine.]
[V04CG05, methylene blue, Codeine may increase the serotonergic activities of Methylene blue.]
[N03AF03, rufinamide, The risk or severity of adverse effects can be increased when Rufinamide is combined with Codeine.]
[N05CE02, methyprylon, The risk or severity of adverse effects can be increased when Codeine is combined with Methyprylon.]
[N02CA04, methysergide, The risk or severity of adverse effects can be increased when Methysergide is combined with Codeine.]
[A03FA01, metoclopramide, The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Codeine.]
[C03BA08, metolazone, The therapeutic efficacy of Metolazone can be decreased when used in combination with Codeine.]
[C07AB02, metoprolol, The metabolism of Codeine can be decreased when combined with Metoprolol.]
[C01BB02, mexiletine, The metabolism of Mexiletine can be decreased when combined with Codeine.]
[N06AX03, mianserin, The risk or severity of adverse effects can be increased when Codeine is combined with Mianserin.]
[S02AA13, miconazole, The metabolism of Codeine can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be decreased when combined with Codeine.]
[N05CD08, midazolam, The risk or severity of adverse effects can be increased when Codeine is combined with Midazolam.]
[G03XB01, mifepristone, The metabolism of Codeine can be decreased when combined with Mifepristone.]
[A06AA01, mineral oil, The therapeutic efficacy of Mineral oil can be decreased when used in combination with Codeine.]
[J01AA08, minocycline, Minocycline may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[L01XX23, mitotane, The metabolism of Codeine can be increased when combined with Mitotane.]
[N06BA12, lisdexamfetamine, Lisdexamfetamine may increase the analgesic activities of Codeine.]
[N05AE02, molindone, The risk or severity of adverse effects can be increased when Codeine is combined with Molindone.]
[C01BD01, amiodarone, The metabolism of Codeine can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The risk or severity of adverse effects can be increased when Amitriptyline is combined with Codeine.]
[N02AA01, morphine, The risk or severity of adverse effects can be increased when Morphine is combined with Codeine.]
[A04AA05, palonosetron, The risk or severity of adverse effects can be increased when Codeine is combined with Palonosetron.]
[L04AB05, certolizumab pegol, The metabolism of Codeine can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Codeine can be decreased when combined with Eltrombopag.]
[L01EX03, pazopanib, The metabolism of Codeine can be decreased when combined with Pazopanib.]
[M03AC03, vecuronium, The risk or severity of adverse effects can be increased when Vecuronium is combined with Codeine.]
[N05CA02, amobarbital, The risk or severity of adverse effects can be increased when Amobarbital is combined with Codeine.]
[R03BB01, ipratropium bromide, The risk or severity of adverse effects can be increased when Ipratropium is combined with Codeine.]
[N06AA17, amoxapine, The risk or severity of adverse effects can be increased when Amoxapine is combined with Codeine.]
[N03AB05, fosphenytoin, The metabolism of Codeine can be increased when combined with Fosphenytoin.]
[C07AA12, nadolol, The metabolism of Nadolol can be decreased when combined with Codeine.]
[N04BC04, ropinirole, Codeine may increase the sedative activities of Ropinirole.]
[C04AX21, nafronyl, The risk or severity of adverse effects can be increased when Codeine is combined with Naftidrofuryl.]
[N02AF02, nalbuphine, The therapeutic efficacy of Codeine can be decreased when used in combination with Nalbuphine.]
[V03AB15, naloxone, The metabolism of Codeine can be decreased when combined with Naloxone.]
[N07BB04, naltrexone, The risk or severity of adverse effects can be increased when Codeine is combined with Naltrexone.]
[L04AC03, anakinra, The metabolism of Codeine can be increased when combined with Anakinra.]
[S01GA01, naphazoline, Naphazoline may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[N06BA01, amphetamine, Amphetamine may increase the analgesic activities of Codeine.]
[N06AX21, duloxetine, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Duloxetine.]
[N04BX01, tolcapone, The risk or severity of adverse effects can be increased when Codeine is combined with Tolcapone.]
[N01AH06, remifentanil, The risk or severity of adverse effects can be increased when Codeine is combined with Remifentanil.]
[N05AX14, iloperidone, The risk or severity of adverse effects can be increased when Codeine is combined with Iloperidone.]
[N06AX23, desvenlafaxine, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Desvenlafaxine.]
[C10AD02, niacin, The metabolism of Codeine can be decreased when combined with Niacin.]
[N06AF02, nialamide, The risk or severity of adverse effects can be increased when Codeine is combined with Nialamide.]
[C08CA04, nicardipine, The risk or severity of adverse effects can be increased when Nicardipine is combined with Codeine.]
[C04AE02, nicergoline, The metabolism of Nicergoline can be decreased when combined with Codeine.]
[N07BA01, nicotine, The risk or severity of adverse effects can be increased when Nicotine is combined with Codeine.]
[C08CA05, nifedipine, The metabolism of Nifedipine can be decreased when combined with Codeine.]
[N05CD02, nitrazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Nitrazepam.]
[N05CF03, zaleplon, The risk or severity of adverse effects can be increased when Codeine is combined with Zaleplon.]
[N04BC05, pramipexole, Codeine may increase the sedative activities of Pramipexole.]
[N01AX13, nitrous oxide, The risk or severity of adverse effects can be increased when Codeine is combined with Nitrous oxide.]
[N06AX04, nomifensine, The risk or severity of adverse effects can be increased when Codeine is combined with Nomifensine.]
[C01CA03, norepinephrine, The risk or severity of adverse effects can be increased when Codeine is combined with Norepinephrine.]
[N06AA10, nortriptyline, The risk or severity of adverse effects can be increased when Nortriptyline is combined with Codeine.]
[L04AC04, rilonacept, The metabolism of Codeine can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Codeine can be decreased when combined with Omeprazole.]
[N06AA05, opipramol, The risk or severity of adverse effects can be increased when Codeine is combined with Opipramol.]
[N02AA02, opium, The risk or severity of adverse effects can be increased when Codeine is combined with Opium.]
[G04CA02, tamsulosin, The metabolism of Tamsulosin can be decreased when combined with Codeine.]
[P02BA02, oxamniquine, The metabolism of Codeine can be decreased when combined with Oxamniquine.]
[N05BA04, oxazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Oxazepam.]
[C07AA02, oxprenolol, The risk or severity of adverse effects can be increased when Codeine is combined with Oxprenolol.]
[N02AA05, oxycodone, The risk or severity of adverse effects can be increased when Codeine is combined with Oxycodone.]
[N02AA11, oxymorphone, The risk or severity of adverse effects can be increased when Codeine is combined with Oxymorphone.]
[N05AE01, oxypertine, The risk or severity of adverse effects can be increased when Codeine is combined with Oxypertine.]
[A03AB03, oxyphenonium, The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Codeine.]
[V04CH30, 4-aminohippuric acid, The excretion of Aminohippuric acid can be decreased when combined with Codeine.]
[N05AH05, asenapine, The risk or severity of adverse effects can be increased when Codeine is combined with Asenapine.]
[N02AX06, tapentadol, Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[M03AC01, pancuronium, The risk or severity of adverse effects can be increased when Pancuronium is combined with Codeine.]
[N05CC05, paraldehyde, Codeine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.]
[C02KC01, pargyline, The risk or severity of adverse effects can be increased when Codeine is combined with Pargyline.]
[G04BD11, fesoterodine, The risk or severity of adverse effects can be increased when Fesoterodine is combined with Codeine.]
[C07AA23, penbutolol, The risk or severity of adverse effects can be increased when Codeine is combined with Penbutolol.]
[N05AG03, penfluridol, The risk or severity of adverse effects can be increased when Codeine is combined with Penfluridol.]
[N02AD01, pentazocine, The therapeutic efficacy of Codeine can be decreased when used in combination with Pentazocine.]
[N05CA01, pentobarbital, The risk or severity of adverse effects can be increased when Pentobarbital is combined with Codeine.]
[N05AB10, perazine, The risk or severity of hypotension and CNS depression can be increased when Perazine is combined with Codeine.]
[N04BC02, pergolide, The risk or severity of adverse effects can be increased when Codeine is combined with Pergolide.]
[C08EX02, perhexiline, The metabolism of Codeine can be decreased when combined with Perhexiline.]
[N05AB03, perphenazine, The risk or severity of hypotension and CNS depression can be increased when Perphenazine is combined with Codeine.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Codeine.]
[N02AD02, phenazocine, The risk or severity of adverse effects can be increased when Codeine is combined with Phenazocine.]
[N06AF03, phenelzine, The risk or severity of adverse effects can be increased when Codeine is combined with Phenelzine.]
[A10BA01, phenformin, The risk or severity of adverse effects can be increased when Codeine is combined with Phenformin.]
[A06AB01, oxyphenisatin, The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Codeine.]
[N01AH04, phenoperidine, The risk or severity of adverse effects can be increased when Codeine is combined with Phenoperidine.]
[C04AX02, phenoxybenzamine, The risk or severity of adverse effects can be increased when Phenoxybenzamine is combined with Codeine.]
[A08AA01, phentermine, Phentermine may increase the analgesic activities of Codeine.]
[N03AB02, phenytoin, The metabolism of Codeine can be increased when combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Codeine can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, The excretion of Levofloxacin can be decreased when combined with Codeine.]
[J05AB12, cidofovir, The excretion of Cidofovir can be decreased when combined with Codeine.]
[C08CX01, mibefradil, The metabolism of Codeine can be decreased when combined with Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Codeine.]
[C07AA03, pindolol, The risk or severity of adverse effects can be increased when Codeine is combined with Pindolol.]
[J05AE01, saquinavir, The metabolism of Codeine can be decreased when combined with Saquinavir.]
[P02CB01, piperazine, The metabolism of Piperazine can be decreased when combined with Codeine.]
[N05AC04, pipothiazine, The risk or severity of hypotension and CNS depression can be increased when Pipotiazine is combined with Codeine.]
[A02BX03, pirenzepine, The risk or severity of adverse effects can be increased when Pirenzepine is combined with Codeine.]
[N02AC03, pirinitramide, The risk or severity of adverse effects can be increased when Codeine is combined with Piritramide.]
[J01MA11, grepafloxacin, The excretion of Grepafloxacin can be decreased when combined with Codeine.]
[N02CX01, pizotyline, The risk or severity of adverse effects can be increased when Pizotifen is combined with Codeine.]
[J05AG02, delavirdine, The metabolism of Codeine can be decreased when combined with Delavirdine.]
[N05CA22, proxibarbal, The risk or severity of adverse effects can be increased when Codeine is combined with Proxibarbal.]
[A06AD15, polyethylene glycols, The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Codeine.]
[A03AE01, alosetron, The risk or severity of adverse effects can be increased when Codeine is combined with Alosetron.]
[L04AC08, canakinumab, The metabolism of Codeine can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, The therapeutic efficacy of Polythiazide can be decreased when used in combination with Codeine.]
[J05AE03, ritonavir, The serum concentration of Codeine can be increased when it is combined with Ritonavir.]
[C07AB01, practolol, The metabolism of Practolol can be decreased when combined with Codeine.]
[N05BA11, prazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Prazepam.]
[C02CA01, prazosin, The risk or severity of adverse effects can be increased when Codeine is combined with Prazosin.]
[N01BB04, prilocaine, The risk or severity of adverse effects can be increased when Codeine is combined with Prilocaine.]
[P01BA03, primaquine, The metabolism of Codeine can be decreased when combined with Primaquine.]
[N03AA03, primidone, The risk or severity of adverse effects can be increased when Primidone is combined with Codeine.]
[M04AB01, probenecid, The risk or severity of adverse effects can be increased when Probenecid is combined with Codeine.]
[C01BA02, procainamide, The metabolism of Procainamide can be decreased when combined with Codeine.]
[S01HA05, procaine, The risk or severity of adverse effects can be increased when Codeine is combined with Procaine.]
[L01XB01, procarbazine, The risk or severity of adverse effects can be increased when Codeine is combined with Procarbazine.]
[N05AB04, prochlorperazine, The risk or severity of hypotension and CNS depression can be increased when Prochlorperazine is combined with Codeine.]
[N04AA04, procyclidine, The risk or severity of adverse effects can be increased when Procyclidine is combined with Codeine.]
[G03DA04, progesterone, The risk or severity of adverse effects can be increased when Progesterone is combined with Codeine.]
[N05AA03, promazine, The risk or severity of adverse effects can be increased when Promazine is combined with Codeine.]
[C01BC03, propafenone, The metabolism of Codeine can be decreased when combined with Propafenone.]
[N01AX04, propanidid, The risk or severity of adverse effects can be increased when Codeine is combined with Propanidid.]
[A03AB05, propantheline, The risk or severity of adverse effects can be increased when Propantheline is combined with Codeine.]
[N05AC01, periciazine, The risk or severity of hypotension and CNS depression can be increased when Periciazine is combined with Codeine.]
[N05CM06, propiomazine, The risk or severity of adverse effects can be increased when Propiomazine is combined with Codeine.]
[N01AX10, propofol, Codeine may increase the sedative activities of Propofol.]
[N02AC04, propoxyphene, The risk or severity of adverse effects can be increased when Codeine is combined with Dextropropoxyphene.]
[C07AA05, propranolol, The metabolism of Codeine can be decreased when combined with Propranolol.]
[N02CC04, rizatriptan, The risk or severity of adverse effects can be increased when Codeine is combined with Rizatriptan.]
[N06AA11, protriptyline, The risk or severity of adverse effects can be increased when Codeine is combined with Protriptyline.]
[N05AX12, aripiprazole, The risk or severity of adverse effects can be increased when Aripiprazole is combined with Codeine.]
[A03AB15, diphemanil, The risk or severity of adverse effects can be increased when Diphemanil is combined with Codeine.]
[A03AB09, isopropamide, The risk or severity of adverse effects can be increased when Isopropamide is combined with Codeine.]
[S01FA03, methscopolamine, The risk or severity of adverse effects can be increased when Methscopolamine is combined with Codeine.]
[N05CA07, talbutal, The risk or severity of adverse effects can be increased when Talbutal is combined with Codeine.]
[N05CA09, vinbarbital, The risk or severity of adverse effects can be increased when Codeine is combined with Vinbarbital.]
[N05BB02, captodiamine, The risk or severity of adverse effects can be increased when Codeine is combined with Captodiame.]
[M03BA04, styramate, The risk or severity of adverse effects can be increased when Codeine is combined with Styramate.]
[P02CC01, pyrantel, The risk or severity of adverse effects can be increased when Codeine is combined with Pyrantel.]
[C01BA01, quinidine, The risk or severity of adverse effects can be increased when Quinidine is combined with Codeine.]
[P01BC01, quinine, The metabolism of Codeine can be decreased when combined with Quinine.]
[A02BA02, ranitidine, The metabolism of Codeine can be decreased when combined with Ranitidine.]
[C02AA02, reserpine, The risk or severity of adverse effects can be increased when Reserpine is combined with Codeine.]
[J04AB02, rifampin, The metabolism of Codeine can be increased when combined with Rifampicin.]
[N06AX01, 5-hydroxytryptophan, The risk or severity of adverse effects can be increased when Codeine is combined with Oxitriptan.]
[S01FA02, scopolamine, The risk or severity of adverse effects can be increased when Scopolamine is combined with Codeine.]
[N05CA06, secobarbital, The risk or severity of adverse effects can be increased when Secobarbital is combined with Codeine.]
[N04BD01, selegiline, The risk or severity of adverse effects can be increased when Codeine is combined with Selegiline.]
[V04CC01, sorbitol, The therapeutic efficacy of Sorbitol can be decreased when used in combination with Codeine.]
[C07AA07, sotalol, The metabolism of Sotalol can be decreased when combined with Codeine.]
[C03DA01, spironolactone, The therapeutic efficacy of Spironolactone can be decreased when used in combination with Codeine.]
[N03AG01, valproic acid, The risk or severity of adverse effects can be increased when Valproic acid is combined with Codeine.]
[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Codeine.]
[M03AB01, succinylcholine, The risk or severity of bradycardia can be increased when Succinylcholine is combined with Codeine.]
[N05AL01, sulpiride, The risk or severity of adverse effects can be increased when Codeine is combined with Sulpiride.]
[N03AX03, sulthiame, The risk or severity of adverse effects can be increased when Codeine is combined with Sulthiame.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Codeine.]
[N05CD07, temazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Temazepam.]
[N07XX06, tetrabenazine, The metabolism of Tetrabenazine can be decreased when combined with Codeine.]
[S01HA03, tetracaine, The risk or severity of adverse effects can be increased when Codeine is combined with Tetracaine.]
[N05AE05, lurasidone, The risk or severity of adverse effects can be increased when Codeine is combined with Lurasidone.]
[A04AD10, dronabinol, Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[N04BC07, apomorphine, The risk or severity of adverse effects can be increased when Codeine is combined with Apomorphine.]
[L04AX02, thalidomide, Codeine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.]
[R03DA07, theobromine, The therapeutic efficacy of Theobromine can be decreased when used in combination with Codeine.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Codeine.]
[A11DA01, thiamine, The risk or severity of adverse effects can be increased when Codeine is combined with Thiamine.]
[R06AD03, thiethylperazine, The risk or severity of hypotension and CNS depression can be increased when Thiethylperazine is combined with Codeine.]
[N05CA19, thiopental, The risk or severity of adverse effects can be increased when Thiopental is combined with Codeine.]
[N05AB08, thioproperazine, The risk or severity of hypotension and CNS depression can be increased when Thioproperazine is combined with Codeine.]
[N05AC02, thioridazine, The metabolism of Codeine can be decreased when combined with Thioridazine.]
[N05AF04, thiothixene, The risk or severity of adverse effects can be increased when Codeine is combined with Thiothixene.]
[C01BB04, aprindine, The metabolism of Aprindine can be decreased when combined with Codeine.]
[N05AL03, tiapride, The risk or severity of adverse effects can be increased when Codeine is combined with Tiapride.]
[B01AC05, ticlopidine, The metabolism of Codeine can be decreased when combined with Ticlopidine.]
[N02AX01, tilidine, The risk or severity of adverse effects can be increased when Codeine is combined with Tilidine.]
[S01ED01, timolol, The metabolism of Timolol can be decreased when combined with Codeine.]
[M03BX04, tolperisone, The risk or severity of adverse effects can be increased when Codeine is combined with Tolperisone.]
[N02AX02, tramadol, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Tramadol.]
[N06AF04, tranylcypromine, The risk or severity of adverse effects can be increased when Codeine is combined with Tranylcypromine.]
[N06AX05, trazodone, The risk or severity of serotonin syndrome can be increased when Trazodone is combined with Codeine.]
[C03DB02, triamterene, The therapeutic efficacy of Triamterene can be decreased when used in combination with Codeine.]
[N05CD05, triazolam, The risk or severity of adverse effects can be increased when Codeine is combined with Triazolam.]
[C03AA06, trichlormethiazide, The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Codeine.]
[A03AB12, mepenzolate, The risk or severity of adverse effects can be increased when Mepenzolate is combined with Codeine.]
[N05AB06, trifluoperazine, The risk or severity of hypotension and CNS depression can be increased when Trifluoperazine is combined with Codeine.]
[S01AD02, trifluridine, The excretion of Trifluridine can be decreased when combined with Codeine.]
[N05AD02, trifluperidol, The risk or severity of adverse effects can be increased when Codeine is combined with Trifluperidol.]
[N05AA05, triflupromazine, The risk or severity of adverse effects can be increased when Triflupromazine is combined with Codeine.]
[N04AA01, trihexyphenidyl, The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Codeine.]
[A03AA05, trimebutine, The risk or severity of adverse effects can be increased when Trimebutine is combined with Codeine.]
[R06AD01, trimeprazine, The risk or severity of hypotension and CNS depression can be increased when Alimemazine is combined with Codeine.]
[N03AC02, trimethadione, The risk or severity of adverse effects can be increased when Codeine is combined with Trimethadione.]
[C02BA01, trimethaphan, The risk or severity of adverse effects can be increased when Trimethaphan is combined with Codeine.]
[N06AA06, trimipramine, The metabolism of Trimipramine can be decreased when combined with Codeine.]
[R06AC04, tripelennamine, The metabolism of Codeine can be decreased when combined with Tripelennamine.]
[A03BB01, butylscopolamine, The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Codeine.]
[J01FA08, troleandomycin, The metabolism of Codeine can be decreased when combined with Troleandomycin.]
[N06AX24, vilazodone, The metabolism of Codeine can be decreased when combined with Vilazodone.]
[N06AX02, tryptophan, The risk or severity of adverse effects can be increased when Tryptophan is combined with Codeine.]
[M03AA02, tubocurarine, The risk or severity of adverse effects can be increased when Tubocurarine is combined with Codeine.]
[L02BX03, abiraterone, The metabolism of Codeine can be decreased when combined with Abiraterone.]
[A10BH05, linagliptin, The metabolism of Codeine can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Codeine can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Codeine can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The metabolism of Codeine can be decreased when combined with Rilpivirine.]
[N03AX21, ezogabine, The risk or severity of adverse effects can be increased when Codeine is combined with Ezogabine.]
[B01AC24, ticagrelor, Codeine can cause a decrease in the absorption of Ticagrelor resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C08DA01, verapamil, The metabolism of Codeine can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Codeine can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Codeine can be decreased when combined with Vinblastine.]
[C03BA10, xipamide, The therapeutic efficacy of Xipamide can be decreased when used in combination with Codeine.]
[J05AF01, zidovudine, The excretion of Zidovudine can be decreased when combined with Codeine.]
[N05AF05, zuclopenthixol, The risk or severity of adverse effects can be increased when Codeine is combined with Zuclopenthixol.]
[J05AE02, indinavir, The metabolism of Codeine can be decreased when combined with Indinavir.]
[N03AX14, levetiracetam, The risk or severity of adverse effects can be increased when Codeine is combined with Levetiracetam.]
[L01EC01, vemurafenib, The metabolism of Codeine can be decreased when combined with Vemurafenib.]
[L01ED01, crizotinib, The metabolism of Codeine can be decreased when combined with Crizotinib.]
[N05AE04, ziprasidone, The risk or severity of adverse effects can be increased when Codeine is combined with Ziprasidone.]
[G03AC10, drospirenone, The therapeutic efficacy of Drospirenone can be decreased when used in combination with Codeine.]
[G04BD07, tolterodine, The risk or severity of adverse effects can be increased when Tolterodine is combined with Codeine.]
[C07AB03, atenolol, The metabolism of Atenolol can be decreased when combined with Codeine.]
[J02AC03, voriconazole, The metabolism of Codeine can be decreased when combined with Voriconazole.]
[M03AC04, atracurium, The risk or severity of adverse effects can be increased when Atracurium is combined with Codeine.]
[S01FA01, atropine, The risk or severity of adverse effects can be increased when Atropine is combined with Codeine.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Codeine.]
[M03BX01, baclofen, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[A08AA11, lorcaserin, The metabolism of Codeine can be decreased when combined with Lorcaserin.]
[G04BD12, mirabegron, The serum concentration of Codeine can be increased when it is combined with Mirabegron.]
[V03AX03, cobicistat, The metabolism of Codeine can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Codeine can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Codeine can be decreased when it is combined with Enzalutamide.]
[A06AX04, linaclotide, The therapeutic efficacy of Linaclotide can be decreased when used in combination with Codeine.]
[N05CA04, barbital, The risk or severity of adverse effects can be increased when Barbital is combined with Codeine.]
[J05AE04, nelfinavir, The metabolism of Codeine can be decreased when combined with Nelfinavir.]
[S01GA07, brimonidine, Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[N04BD02, rasagiline, The risk or severity of adverse effects can be increased when Codeine is combined with Rasagiline.]
[A03FA09, mosapride, The risk or severity of adverse effects can be increased when Codeine is combined with Mosapride.]
[N06DA02, donepezil, The risk or severity of adverse effects can be increased when Codeine is combined with Donepezil.]
[N03AX22, perampanel, Perampanel may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[N02CC03, zolmitriptan, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Codeine.]
[R06AC06, thonzylamine, The risk or severity of adverse effects can be increased when Thonzylamine is combined with Codeine.]
[G04BD10, darifenacin, The risk or severity of adverse effects can be increased when Darifenacin is combined with Codeine.]
[N01AA01, ethyl ether, The risk or severity of adverse effects can be increased when Codeine is combined with Diethyl ether.]
[G04BE03, sildenafil, The metabolism of Codeine can be decreased when combined with Sildenafil.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Codeine.]
[A10BH04, alogliptin, The metabolism of Alogliptin can be decreased when combined with Codeine.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Codeine can be decreased when combined with Glycerol phenylbutyrate.]
[C03AA01, bendroflumethiazide, The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Codeine.]
[L04AX06, pomalidomide, The risk or severity of adverse effects can be increased when Codeine is combined with Pomalidomide.]
[G03XC05, ospemifene, The metabolism of Codeine can be decreased when combined with Ospemifene.]
[N05AD07, benperidol, The risk or severity of adverse effects can be increased when Codeine is combined with Benperidol.]
[A10BK02, canagliflozin, The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Codeine.]
[A06AX06, tegaserod, The metabolism of Codeine can be decreased when combined with Tegaserod.]
[R02AD01, benzocaine, The risk or severity of adverse effects can be increased when Codeine is combined with Benzocaine.]
[M01AH01, celecoxib, The metabolism of Codeine can be decreased when combined with Celecoxib.]
[N02CC02, naratriptan, The risk or severity of adverse effects can be increased when Codeine is combined with Naratriptan.]
[L04AA18, everolimus, The metabolism of Codeine can be decreased when combined with Everolimus.]
[N04AC01, benztropine, The risk or severity of adverse effects can be increased when Benzatropine is combined with Codeine.]
[L01EC02, dabrafenib, The serum concentration of Codeine can be decreased when it is combined with Dabrafenib.]
[P03AX06, benzyl alcohol, The risk or severity of adverse effects can be increased when Codeine is combined with Benzyl alcohol.]
[N06AX28, levomilnacipran, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Levomilnacipran.]
[C08EA02, bepridil, The metabolism of Codeine can be decreased when combined with Bepridil.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Codeine.]
[N06AX26, vortioxetine, The risk or severity of adverse effects can be increased when Codeine is combined with Vortioxetine.]
[N03AF04, eslicarbazepine, The risk or severity of adverse effects can be increased when Codeine is combined with Eslicarbazepine.]
[J05AP05, simeprevir, The metabolism of Codeine can be decreased when combined with Simeprevir.]
[N03AG04, vigabatrin, The risk or severity of adverse effects can be increased when Codeine is combined with Vigabatrin.]
[A10BK01, dapagliflozin, The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Codeine.]
[C07AB04, acebutolol, The metabolism of Codeine can be decreased when combined with Acebutolol.]
[N05CH03, tasimelteon, The risk or severity of adverse effects can be increased when Codeine is combined with Tasimelteon.]
[A16AA07, metreleptin, The metabolism of Codeine can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Codeine can be increased when combined with Apremilast.]
[S01ED02, betaxolol, The metabolism of Codeine can be decreased when combined with Betaxolol.]
[L04AC11, siltuximab, The metabolism of Codeine can be increased when combined with Siltuximab.]
[A03BA03, hyoscyamine, The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Codeine.]
[N01AX05, alfaxalone, The risk or severity of adverse effects can be increased when Codeine is combined with Alfaxalone.]
[D11AA01, glycopyrronium, The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Codeine.]
[N05CM19, suvorexant, Codeine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A16AX10, eliglustat, The metabolism of Codeine can be decreased when combined with Eliglustat.]
[J01XA05, oritavancin, The metabolism of Codeine can be decreased when combined with Oritavancin.]
[N05AA04, acepromazine, The risk or severity of hypotension and CNS depression can be increased when Acepromazine is combined with Codeine.]
[A06AB04, phenolphthalein, The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Codeine.]
[A06AH03, naloxegol, The risk or severity of adverse effects can be increased when Codeine is combined with Naloxegol.]
[N04AA02, biperiden, The risk or severity of adverse effects can be increased when Biperiden is combined with Codeine.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Codeine.]
[A06AG02, bisacodyl, The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Codeine.]
[J05AP09, dasabuvir, The metabolism of Dasabuvir can be decreased when combined with Codeine.]
[N06AX11, mirtazapine, Codeine may increase the serotonergic activities of Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Codeine can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The risk or severity of adverse effects can be increased when Palbociclib is combined with Codeine.]
[L01XH03, panobinostat, The metabolism of Codeine can be decreased when combined with Panobinostat.]
[A03AA09, difemerine, The risk or severity of adverse effects can be increased when Difemerine is combined with Codeine.]
[J05AF08, adefovir dipivoxil, The excretion of Adefovir dipivoxil can be decreased when combined with Codeine.]
[J05AP06, asunaprevir, The metabolism of Codeine can be decreased when combined with Asunaprevir.]
[A07DA06, eluxadoline, The risk or severity of constipation can be increased when Codeine is combined with Eluxadoline.]
[N05AX16, brexpiprazole, The risk or severity of adverse effects can be increased when Codeine is combined with Brexpiprazole.]
[A04AD14, rolapitant, The metabolism of Codeine can be decreased when combined with Rolapitant.]
[G02CX02, flibanserin, The risk or severity of adverse effects can be increased when Codeine is combined with Flibanserin.]
[A06AD03, magnesium peroxide, The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Codeine.]
[N05AX15, cariprazine, The risk or severity of adverse effects can be increased when Codeine is combined with Cariprazine.]
[S01EC01, acetazolamide, The risk or severity of adverse effects can be increased when Codeine is combined with Acetazolamide.]
[N05AB07, acetophenazine, The risk or severity of hypotension and CNS depression can be increased when Acetophenazine is combined with Codeine.]
[A02BC03, lansoprazole, The metabolism of Codeine can be decreased when combined with Lansoprazole.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Codeine.]
[J02AC05, isavuconazole, The metabolism of Codeine can be decreased when combined with Isavuconazole.]
[J05AF13, tenofovir alafenamide, The excretion of Tenofovir alafenamide can be decreased when combined with Codeine.]
[N05CA05, aprobarbital, The risk or severity of adverse effects can be increased when Aprobarbital is combined with Codeine.]
[N03AX23, brivaracetam, The risk or severity of adverse effects can be increased when Codeine is combined with Brivaracetam.]
[L01XX52, venetoclax, The metabolism of Codeine can be decreased when combined with Venetoclax.]
[N05BA08, bromazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Bromazepam.]
[N04BC01, bromocriptine, The risk or severity of adverse effects can be increased when Codeine is combined with Bromocriptine.]
[A03AX08, alverine, The risk or severity of adverse effects can be increased when Codeine is combined with Alverine.]
[N06AA19, amineptin, The risk or severity of adverse effects can be increased when Codeine is combined with Amineptine.]
[N06BX11, aniracetam, The risk or severity of adverse effects can be increased when Codeine is combined with Aniracetam.]
[C03CA02, bumetanide, The therapeutic efficacy of Bumetanide can be decreased when used in combination with Codeine.]
[N01BB01, bupivacaine, The risk or severity of adverse effects can be increased when Bupivacaine is combined with Codeine.]
[C07AA19, bupranolol, The metabolism of Bupranolol can be decreased when combined with Codeine.]
[N07BC01, buprenorphine, Codeine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.]
[N05BE01, buspirone, The risk or severity of adverse effects can be increased when Codeine is combined with Buspirone.]
[N02AF01, butorphanol, The therapeutic efficacy of Codeine can be decreased when used in combination with Butorphanol.]
[S01GX07, azelastine, Codeine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.]
[L01XK03, rucaparib, The metabolism of Codeine can be decreased when combined with Rucaparib.]
[A06AX07, plecanatide, The therapeutic efficacy of Plecanatide can be decreased when used in combination with Codeine.]
[L01EF02, ribociclib, The metabolism of Codeine can be decreased when combined with Ribociclib.]
[A06AH05, naldemedine, The therapeutic efficacy of Codeine can be decreased when used in combination with Naldemedine.]
[N07XX16, deutetrabenazine, The metabolism of Deutetrabenazine can be decreased when combined with Codeine.]
[N02BF02, pregabalin, The therapeutic efficacy of Codeine can be increased when used in combination with Pregabalin.]
[N03AX30, beclamide, The risk or severity of adverse effects can be increased when Codeine is combined with Beclamide.]
[S01HA02, benoxinate, The risk or severity of adverse effects can be increased when Codeine is combined with Oxybuprocaine.]
[J01XX08, linezolid, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Codeine.]
[J05AE09, tipranavir, The metabolism of Codeine can be decreased when combined with Tipranavir.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Codeine.]
[L04AB02, infliximab, The metabolism of Codeine can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Codeine can be decreased when combined with Midostaurin.]
[N04BD03, safinamide, The risk or severity of adverse effects can be increased when Codeine is combined with Safinamide.]
[S01EB09, acetylcholine, The risk or severity of adverse effects can be increased when Codeine is combined with Acetylcholine.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Codeine.]
[J05AG03, efavirenz, The metabolism of Codeine can be decreased when combined with Efavirenz.]
[C07AA17, bopindolol, The metabolism of Bopindolol can be decreased when combined with Codeine.]
[N04AA11, bornaprine, The risk or severity of adverse effects can be increased when Bornaprine is combined with Codeine.]
[N05AD06, bromperidol, The risk or severity of adverse effects can be increased when Codeine is combined with Bromperidol.]
[N05CD09, brotizolam, The risk or severity of adverse effects can be increased when Codeine is combined with Brotizolam.]
[C03DA03, canrenone, The therapeutic efficacy of Canrenone can be decreased when used in combination with Codeine.]
[N05CA03, butobarbital, The risk or severity of adverse effects can be increased when Butobarbital is combined with Codeine.]
[J05AX18, letermovir, The metabolism of Letermovir can be decreased when combined with Codeine.]
[N06AA15, butriptyline, The risk or severity of adverse effects can be increased when Codeine is combined with Butriptyline.]
[A10BK04, ertugliflozin, The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Codeine.]
[N05CA08, butylvinal, The risk or severity of adverse effects can be increased when Codeine is combined with Vinylbital.]
[C09AA01, captopril, The excretion of Captopril can be decreased when combined with Codeine.]
[L02BB05, apalutamide, The metabolism of Codeine can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Codeine can be increased when combined with Carbamazepine.]
[A06AC08, calcium polycarbophil, The therapeutic efficacy of Calcium polycarbophil can be decreased when used in combination with Codeine.]
[A03AA03, camylofine, The risk or severity of adverse effects can be increased when Camylofin is combined with Codeine.]
[R06AA08, carbinoxamine, The risk or severity of adverse effects can be increased when Codeine is combined with Carbinoxamine.]
[C07AG02, carvedilol, The metabolism of Carvedilol can be decreased when combined with Codeine.]
[N03AX24, cannabidiol, The risk or severity of adverse effects can be increased when Cannabidiol is combined with Codeine.]
[L01EC03, encorafenib, The metabolism of Encorafenib can be decreased when combined with Codeine.]
[J01DD14, ceftibuten, The excretion of Ceftibuten can be decreased when combined with Codeine.]
[C07AB08, celiprolol, The metabolism of Celiprolol can be decreased when combined with Codeine.]
[H01CC03, elagolix, The metabolism of Elagolix can be decreased when combined with Codeine.]
[L01XX62, ivosidenib, The metabolism of Codeine can be increased when combined with Ivosidenib.]
[P01BA07, tafenoquine, The metabolism of Tafenoquine can be decreased when combined with Codeine.]
[N03AX17, stiripentol, The metabolism of Codeine can be decreased when combined with Stiripentol.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Codeine.]
[S01GX12, cetirizine, The risk or severity of adverse effects can be increased when Codeine is combined with Cetirizine.]
[N05CM04, carbromal, The risk or severity of adverse effects can be increased when Codeine is combined with Carbromal.]
[N01BA04, chloroprocaine, The risk or severity of adverse effects can be increased when Codeine is combined with Chloroprocaine.]
[R06AA06, chlorphenoxamine, The risk or severity of adverse effects can be increased when Chlorphenoxamine is combined with Codeine.]
[R03BB08, revefenacin, The risk or severity of adverse effects can be increased when Revefenacin is combined with Codeine.]
[L04AA39, emapalumab, The metabolism of Codeine can be increased when combined with Emapalumab.]
[L01EX13, gilteritinib, The risk or severity of adverse effects can be increased when Gilteritinib is combined with Codeine.]
[A06AX05, prucalopride, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Codeine.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be decreased when combined with Codeine.]
[A03FA08, cinitapride, The risk or severity of adverse effects can be increased when Codeine is combined with Cinitapride.]
[P02BX04, triclabendazole, The metabolism of Codeine can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The risk or severity of adverse effects can be increased when Codeine is combined with Esketamine.]
[J01FA09, clarithromycin, The metabolism of Codeine can be decreased when combined with Clarithromycin.]
[N06BA14, solriamfetol, The risk or severity of adverse effects can be increased when Codeine is combined with Solriamfetol.]
[N06AX29, brexanolone, The risk or severity of adverse effects can be increased when Codeine is combined with Brexanolone.]
[N05BA09, clobazam, The metabolism of Codeine can be decreased when combined with Clobazam.]
[A06AB05, castor oil, The therapeutic efficacy of Castor oil can be decreased when used in combination with Codeine.]
[N05BA22, cloxazolam, The risk or severity of adverse effects can be increased when Codeine is combined with Cloxazolam.]
[L04AB01, etanercept, The metabolism of Codeine can be increased when combined with Etanercept.]
[J01DB04, cefazolin, The excretion of Cefazolin can be decreased when combined with Codeine.]
[N05AA06, cyamemazine, The risk or severity of hypotension and CNS depression can be increased when Cyamemazine is combined with Codeine.]
[J01DC07, cefotiam, The excretion of Cefotiam can be decreased when combined with Codeine.]
[C03BX03, cicletanine, The therapeutic efficacy of Cicletanine can be decreased when used in combination with Codeine.]
[J01DD07, ceftizoxime, The excretion of Ceftizoxime can be decreased when combined with Codeine.]
[M03BX08, cyclobenzaprine, The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Codeine.]
[L01EJ02, fedratinib, The metabolism of Codeine can be decreased when combined with Fedratinib.]
[N07XX11, pitolisant, The serum concentration of Codeine can be decreased when it is combined with Pitolisant.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Codeine.]
[C03AA09, cyclothiazide, The therapeutic efficacy of Cyclothiazide can be decreased when used in combination with Codeine.]
[G04BE04, yohimbine, The risk or severity of adverse effects can be increased when Codeine is combined with Yohimbine.]
[A06AB03, danthron, The therapeutic efficacy of Dantron can be decreased when used in combination with Codeine.]
[J01DB01, cephalexin, The excretion of Cephalexin can be decreased when combined with Codeine.]
[J01DB02, cephaloridine, The excretion of Cefaloridine can be decreased when combined with Codeine.]
[N02CC08, lasmiditan, The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Codeine.]
[N03AX25, cenobamate, The serum concentration of Codeine can be decreased when it is combined with Cenobamate.]
[A16AX16, givosiran, The serum concentration of Codeine can be increased when it is combined with Givosiran.]
[R06AB02, dexchlorpheniramine, The metabolism of Codeine can be decreased when combined with Dexchlorpheniramine.]
[N02AX03, dezocine, The risk or severity of adverse effects can be increased when Codeine is combined with Dezocine.]
[N05CM21, lemborexant, The risk or severity of adverse effects can be increased when Codeine is combined with Lemborexant.]
[N05AD10, lumateperone, The risk or severity of adverse effects can be increased when Codeine is combined with Lumateperone.]
[M01AX21, diacetylrhein, The metabolism of Codeine can be decreased when combined with Diacerein.]
[H02CA02, osilodrostat, The metabolism of Codeine can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Codeine can be decreased when combined with Amprenavir.]
[N02CC07, frovatriptan, The risk or severity of adverse effects can be increased when Codeine is combined with Frovatriptan.]
[N05CC04, dichloralphenazone, The risk or severity of adverse effects can be increased when Codeine is combined with Dichloralphenazone.]
[A07DA04, difenoxin, The risk or severity of adverse effects can be increased when Codeine is combined with Difenoxin.]
[N02AA08, dihydrocodeine, The risk or severity of adverse effects can be increased when Codeine is combined with Dihydrocodeine.]
[N02CC06, eletriptan, The risk or severity of adverse effects can be increased when Eletriptan is combined with Codeine.]
[C08CA16, clevidipine, The metabolism of Clevidipine can be decreased when combined with Codeine.]
[C01BD07, dronedarone, The metabolism of Codeine can be decreased when combined with Dronedarone.]
[N03AG02, dipropylacetamide, The risk or severity of adverse effects can be increased when Codeine is combined with Valpromide.]
[N02BA03, choline salicylate, The risk or severity of adverse effects can be increased when Codeine is combined with Choline salicylate.]
[S01AA13, fusidic acid, The metabolism of Codeine can be decreased when combined with Fusidic acid.]
[N05BA02, chlordiazepoxide, The risk or severity of adverse effects can be increased when Codeine is combined with Chlordiazepoxide.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Codeine.]
[A03AA08, dihexyverine, The risk or severity of adverse effects can be increased when Dihexyverine is combined with Codeine.]
[G04BD09, trospium, The risk or severity of adverse effects can be increased when Trospium is combined with Codeine.]
[N05CM02, chlormethiazole, The risk or severity of adverse effects can be increased when Codeine is combined with Clomethiazole.]
[M03BB02, chlormezanone, The risk or severity of adverse effects can be increased when Codeine is combined with Chlormezanone.]
[R02AD04, dyclonine, The risk or severity of adverse effects can be increased when Codeine is combined with Dyclonine.]
[P01BB01, proguanil, The metabolism of Codeine can be decreased when combined with Proguanil.]
[N05CD14, remimazolam, The risk or severity of adverse effects can be increased when Codeine is combined with Remimazolam.]
[N07XX04, sodium oxybate, Codeine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.]
[L04AC19, satralizumab, The serum concentration of Codeine can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Codeine is combined with Oliceridine.]
[P01BA01, chloroquine, The metabolism of Codeine can be decreased when combined with Chloroquine.]
[C03AA04, chlorothiazide, The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Codeine.]
[N05AA01, chlorpromazine, The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Codeine.]
[N05AF03, chlorprothixene, The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Codeine.]
[C03BA04, chlorthalidone, The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Codeine.]
[A11CC05, cholecalciferol, The metabolism of Codeine can be decreased when combined with Cholecalciferol.]
[N05BX03, etifoxine, The risk or severity of adverse effects can be increased when Codeine is combined with Etifoxine.]
[N06BX18, vinpocetine, The risk or severity of adverse effects can be increased when Codeine is combined with Vinpocetine.]
[N05BA18, ethyl loflazepate, The risk or severity of adverse effects can be increased when Codeine is combined with Ethyl loflazepate.]
[B06AC06, berotralstat, The metabolism of Codeine can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The metabolism of Codeine can be decreased when combined with Lonafarnib.]
[P03AX07, abametapir, The serum concentration of Codeine can be increased when it is combined with Abametapir.]
[M03BA05, febarbamate, The risk or severity of adverse effects can be increased when Codeine is combined with Febarbamate.]
[N03AX10, felbamate, The risk or severity of adverse effects can be increased when Codeine is combined with Felbamate.]
[J01DD15, cefdinir, The excretion of Cefdinir can be decreased when combined with Codeine.]
[S01JA01, fluorescein, The excretion of Fluorescein can be decreased when combined with Codeine.]
[R03CC15, formoterol, The risk or severity of adverse effects can be increased when Codeine is combined with Formoterol.]
[N01AB05, trichloroethylene, The risk or severity of adverse effects can be increased when Codeine is combined with Trichloroethylene.]
[L03AB10, peginterferon alfa-2b, The metabolism of Codeine can be decreased when combined with Peginterferon alfa-2b.]
[A02BA01, cimetidine, The metabolism of Codeine can be decreased when combined with Cimetidine.]
[N02BF01, gabapentin, The risk or severity of adverse effects can be increased when Codeine is combined with Gabapentin.]
[N07CA02, cinnarizine, The metabolism of Cinnarizine can be decreased when combined with Codeine.]
[L01XX73, sotorasib, The serum concentration of Codeine can be decreased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, The metabolism of Codeine can be decreased when combined with Ciprofloxacin.]
[N06AB04, citalopram, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Citalopram.]
[C03DA05, finerenone, The therapeutic efficacy of Finerenone can be decreased when used in combination with Codeine.]
[P01CA03, fexinidazole, The metabolism of Fexinidazole can be decreased when combined with Codeine.]
[R06AA04, clemastine, The risk or severity of adverse effects can be increased when Clemastine is combined with Codeine.]
[M01AG01, mefenamic acid, The metabolism of Codeine can be decreased when combined with Mefenamic acid.]
[N06AX25, St. John's wort extract, The metabolism of Codeine can be increased when combined with St. John's Wort.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of neuropsychiatric effects can be increased when Ropeginterferon alfa-2b is combined with Codeine.]
[N01BB10, levobupivacaine, The risk or severity of adverse effects can be increased when Codeine is combined with Levobupivacaine.]
[L01EJ03, pacritinib, The serum concentration of Codeine can be increased when it is combined with Pacritinib.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Codeine.]
[N03AE01, clonazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Clonazepam.]
[S01EA04, clonidine, The risk or severity of sedation can be increased when Clonidine is combined with Codeine.]
[C01EB24, mavacamten, The serum concentration of Codeine can be decreased when it is combined with Mavacamten.]
[C03BA03, clopamide, The therapeutic efficacy of Clopamide can be decreased when used in combination with Codeine.]
[N05AH06, clothiapine, The risk or severity of adverse effects can be increased when Codeine is combined with Clothiapine.]
[N05BA21, clotiazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Clotiazepam.]
[A04AA01, ondansetron, The risk or severity of adverse effects can be increased when Codeine is combined with Ondansetron.]
[A04AA02, granisetron, The risk or severity of adverse effects can be increased when Codeine is combined with Granisetron.]
[N05AH02, clozapine, The risk or severity of adverse effects can be increased when Clozapine is combined with Codeine.]
[N05BA13, halazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Halazepam.]
[H01AC08, somatrogon, The metabolism of Codeine can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The risk or severity of adverse effects can be increased when Cocaine is combined with Codeine.]
[C02KB01, metyrosine, Codeine may increase the sedative activities of Metyrosine.]
[L04AC21, bimekizumab, The metabolism of Codeine can be increased when combined with Bimekizumab.]
[M03AC05, hexafluorenium, The risk or severity of adverse effects can be increased when Hexafluronium is combined with Codeine.]
[A03AB10, hexocyclium, The risk or severity of adverse effects can be increased when Hexocyclium is combined with Codeine.]
[A03BB06, homatropine methylbromide, The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Codeine.]
[N01AB07, desflurane, The risk or severity of adverse effects can be increased when Codeine is combined with Desflurane.]
[A04AA03, tropisetron, The risk or severity of adverse effects can be increased when Codeine is combined with Tropisetron.]
[C04AX28, ifenprodil, The risk or severity of adverse effects can be increased when Codeine is combined with Ifenprodil.]
[A10BX03, nateglinide, The metabolism of Nateglinide can be decreased when combined with Codeine.]
[J01FA15, telithromycin, The metabolism of Codeine can be decreased when combined with Telithromycin.]
[R03BA08, ciclesonide, The metabolism of Ciclesonide can be decreased when combined with Codeine.]
[R06AX27, desloratadine, The risk or severity of adverse effects can be increased when Desloratadine is combined with Codeine.]
[H01AX01, pegvisomant, The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Codeine.]
[N02CC05, almotriptan, The risk or severity of adverse effects can be increased when Codeine is combined with Almotriptan.]
[J02AC02, itraconazole, The metabolism of Codeine can be decreased when combined with Itraconazole.]
[S01AD03, acyclovir, The risk or severity of adverse effects can be increased when Codeine is combined with Acyclovir.]
[N05BA10, ketazolam, The risk or severity of adverse effects can be increased when Codeine is combined with Ketazolam.]
[L01EA01, imatinib, The serum concentration of Codeine can be increased when it is combined with Imatinib.]
[J02AC04, posaconazole, The metabolism of Codeine can be decreased when combined with Posaconazole.]
[A06AD12, lactitol, The therapeutic efficacy of Lactitol can be decreased when used in combination with Codeine.]
[N03AX09, lamotrigine, The risk or severity of adverse effects can be increased when Lamotrigine is combined with Codeine.]
[N07BC04, lofexidine, The therapeutic efficacy of Codeine can be increased when used in combination with Lofexidine.]
[N05CD06, lormetazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Lormetazepam.]
[A06AD01, magnesium carbonate, The therapeutic efficacy of Magnesium carbonate can be decreased when used in combination with Codeine.]
[C08CA11, manidipine, The metabolism of Codeine can be decreased when combined with Manidipine.]
[A03AA04, mebeverine, The risk or severity of adverse effects can be increased when Mebeverine is combined with Codeine.]
[N06AX13, medifoxamine, The risk or severity of adverse effects can be increased when Codeine is combined with Medifoxamine.]
[C07AA14, mepindolol, The metabolism of Mepindolol can be decreased when combined with Codeine.]
[R06AD07, mequitazine, The metabolism of Mequitazine can be decreased when combined with Codeine.]
[N04AA03, methixene, The risk or severity of adverse effects can be increased when Metixene is combined with Codeine.]
[R03CB02, methoxyphenamine, Methoxyphenamine may increase the analgesic activities of Codeine.]
[R06AE03, cyclizine, The risk or severity of adverse effects can be increased when Codeine is combined with Cyclizine.]
[N05CA10, cyclobarbital, The risk or severity of adverse effects can be increased when Codeine is combined with Cyclobarbital.]
[C03DA04, eplerenone, The therapeutic efficacy of Eplerenone can be decreased when used in combination with Codeine.]
[N05AD03, metylperon, The risk or severity of adverse effects can be increased when Codeine is combined with Melperone.]
[C03AA07, cyclopenthiazide, The therapeutic efficacy of Cyclopenthiazide can be decreased when used in combination with Codeine.]
[J05AF07, tenofovir disoproxil, The excretion of Tenofovir disoproxil can be decreased when combined with Codeine.]
[N06AX07, minaprine, The risk or severity of adverse effects can be increased when Codeine is combined with Minaprine.]
[S01XA18, cyclosporine, The metabolism of Codeine can be decreased when combined with Cyclosporine.]
[N06AG02, moclobemide, The risk or severity of adverse effects can be increased when Codeine is combined with Moclobemide.]
[R06AX02, cyproheptadine, The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Codeine.]
[C03XA02, conivaptan, The metabolism of Codeine can be decreased when combined with Conivaptan.]
[L01BC01, cytarabine, The risk or severity of adverse effects can be increased when Codeine is combined with Cytarabine.]
[M01AH05, etoricoxib, The metabolism of Codeine can be decreased when combined with Etoricoxib.]
[G03XA01, danazol, The metabolism of Codeine can be decreased when combined with Danazol.]
[M03CA01, dantrolene, The risk or severity of adverse effects can be increased when Codeine is combined with Dantrolene.]
[N06BX04, deanol, The risk or severity of adverse effects can be increased when Codeine is combined with Deanol.]
[C02CC04, debrisoquin, The metabolism of Debrisoquine can be decreased when combined with Codeine.]
[A04AD11, nabilone, Nabilone may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[N07BB05, nalmefene, The therapeutic efficacy of Codeine can be decreased when used in combination with Nalmefene.]
[B05XA15, potassium lactate, The therapeutic efficacy of Potassium lactate can be decreased when used in combination with Codeine.]
[N05BA16, nordazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Nordazepam.]
[C07AB12, nebivolol, The metabolism of Nebivolol can be decreased when combined with Codeine.]
[N06AX06, nefazodone, The metabolism of Codeine can be decreased when combined with Nefazodone.]
[N05CM16, niaprazine, The risk or severity of adverse effects can be increased when Codeine is combined with Niaprazine.]
[N03AG06, tiagabine, The risk or severity of adverse effects can be increased when Codeine is combined with Tiagabine.]
[M03AC11, cisatracurium, The risk or severity of adverse effects can be increased when Cisatracurium is combined with Codeine.]
[R05DA06, normethadone, The risk or severity of adverse effects can be increased when Codeine is combined with Normethadone.]
[N06AB10, escitalopram, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Escitalopram.]
[G04BD08, solifenacin, The risk or severity of adverse effects can be increased when Solifenacin is combined with Codeine.]
[N06AA01, desipramine, The risk or severity of adverse effects can be increased when Desipramine is combined with Codeine.]
[H01BA02, desmopressin, The risk or severity of hyponatremia can be increased when Codeine is combined with Desmopressin.]
[N03AF02, oxcarbazepine, The risk or severity of adverse effects can be increased when Codeine is combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Codeine can be increased when combined with Dexamethasone.]
[N06BX07, oxiracetam, The risk or severity of adverse effects can be increased when Codeine is combined with Oxiracetam.]
[N04AA08, dexetimide, The risk or severity of adverse effects can be increased when Dexetimide is combined with Codeine.]
[G04BD04, oxybutynin, The risk or severity of adverse effects can be increased when Oxybutynin is combined with Codeine.]
[A08AA04, dexfenfluramine, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Dexfenfluramine.]
[A03AA01, oxyphencyclimine, The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Codeine.]
[L04AB04, adalimumab, The metabolism of Codeine can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Codeine can be decreased when combined with Gefitinib.]
[N06BA02, dextroamphetamine, Amphetamine may increase the analgesic activities of Codeine.]
[R05DA09, dextromethorphan, The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Codeine.]
[N03AC01, paramethadione, The risk or severity of adverse effects can be increased when Codeine is combined with Paramethadione.]
[N02AC01, dextromoramide, The risk or severity of adverse effects can be increased when Codeine is combined with Dextromoramide.]
[N06AB05, paroxetine, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Paroxetine.]
[B01AC04, clopidogrel, Codeine can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N07BC06, heroin, The risk or severity of adverse effects can be increased when Codeine is combined with Diamorphine.]
[N05BA01, diazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Diazepam.]
[N03AX07, phenacemide, The risk or severity of adverse effects can be increased when Codeine is combined with Phenacemide.]
[N03AD02, phensuximide, The risk or severity of adverse effects can be increased when Codeine is combined with Phensuximide.]
[N06AA08, dibenzepin, The risk or severity of adverse effects can be increased when Codeine is combined with Dibenzepin.]
[S02DA04, dibucaine, The risk or severity of adverse effects can be increased when Codeine is combined with Cinchocaine.]
[S01EC02, dichlorphenamide, The therapeutic efficacy of Diclofenamide can be decreased when used in combination with Codeine.]
[A03AA07, dicyclomine, The risk or severity of adverse effects can be increased when Dicyclomine is combined with Codeine.]
[J05AF03, zalcitabine, The excretion of Zalcitabine can be decreased when combined with Codeine.]
[J05AF02, didanosine, The excretion of Didanosine can be decreased when combined with Codeine.]
[N05AD05, pipamperone, The risk or severity of adverse effects can be increased when Codeine is combined with Pipamperone.]
[A03AB14, pipenzolate, The risk or severity of adverse effects can be increased when Pipenzolate is combined with Codeine.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Codeine.]
[C03CA03, piretanide, The therapeutic efficacy of Piretanide can be decreased when used in combination with Codeine.]
[A08AA03, diethylpropion, Diethylpropion may increase the analgesic activities of Codeine.]
[C08CA03, isradipine, The metabolism of Codeine can be decreased when combined with Isradipine.]
[A03AB11, poldine, The risk or severity of adverse effects can be increased when Poldine is combined with Codeine.]
[N02CA01, dihydroergotamine, The risk or severity of adverse effects can be increased when Codeine is combined with Dihydroergotamine.]
[N02AA03, hydromorphone, The risk or severity of adverse effects can be increased when Codeine is combined with Hydromorphone.]
[J05AE08, atazanavir, The metabolism of Codeine can be decreased when combined with Atazanavir.]
[D04AB07, pramoxine, The risk or severity of adverse effects can be increased when Codeine is combined with Pramocaine.]
[C08DB01, diltiazem, The metabolism of Codeine can be decreased when combined with Diltiazem.]
[R06AA11, dimenhydrinate, The risk or severity of adverse effects can be increased when Codeine is combined with Dimenhydrinate.]
[M03BX03, pridinol, The risk or severity of adverse effects can be increased when Codeine is combined with Pridinol.]
[R06AB03, dimethindene, The risk or severity of adverse effects can be increased when Dimetindene is combined with Codeine.]
[M02AX03, dimethyl sulfoxide, The metabolism of Codeine can be decreased when combined with Dimethyl sulfoxide.]
[N03AG05, progabide, The risk or severity of adverse effects can be increased when Codeine is combined with Progabide.]
[G02AD02, dinoprostone, The risk or severity of adverse effects can be increased when Dinoprostone is combined with Codeine.]
[A07DA01, diphenoxylate, The risk or severity of adverse effects can be increased when Codeine is combined with Diphenoxylate.]
[N05CD10, quazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Quazepam.]
[N06BA11, dexmethylphenidate, The risk or severity of adverse effects can be increased when Codeine is combined with Dexmethylphenidate.]
[N06AA23, quinupramine, The risk or severity of adverse effects can be increased when Codeine is combined with Quinupramine.]
[A03FA02, cisapride, The metabolism of Codeine can be decreased when combined with Cisapride.]
[N05AL04, remoxipride, The risk or severity of adverse effects can be increased when Codeine is combined with Remoxipride.]
[C01BA03, disopyramide, The risk or severity of adverse effects can be increased when Disopyramide is combined with Codeine.]
[S02AA12, rifamycin SV, The metabolism of Codeine can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Codeine can be increased when combined with Rifapentine.]
[N07XX02, riluzole, The risk or severity of adverse effects can be increased when Codeine is combined with Riluzole.]
[N05AX08, risperidone, The risk or severity of adverse effects can be increased when Codeine is combined with Risperidone.]
[R06AE09, levocetirizine, The risk or severity of adverse effects can be increased when Codeine is combined with Levocetirizine.]
[N01BB09, ropivacaine, The risk or severity of adverse effects can be increased when Ropivacaine is combined with Codeine.]
[A04AD12, aprepitant, The metabolism of Codeine can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, The therapeutic efficacy of Tolvaptan can be decreased when used in combination with Codeine.]
[L01XG01, bortezomib, The metabolism of Codeine can be decreased when combined with Bortezomib.]
[C01EB18, ranolazine, The serum concentration of Codeine can be increased when it is combined with Ranolazine.]
[R03AC12, salmeterol, The risk or severity of adverse effects can be increased when Codeine is combined with Salmeterol.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Codeine.]
[C01CA04, dopamine, The risk or severity of adverse effects can be increased when Codeine is combined with Dopamine.]
[N06AA16, dothiepin, The risk or severity of adverse effects can be increased when Dosulepin is combined with Codeine.]
[N06AA12, doxepin, The risk or severity of adverse effects can be increased when Doxepin is combined with Codeine.]
[A06AB06, sennosides, USP, The therapeutic efficacy of Sennosides can be decreased when used in combination with Codeine.]
[L01DB01, doxorubicin, The metabolism of Codeine can be decreased when combined with Doxorubicin.]
[N06AB06, sertraline, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Sertraline.]
[N01AB08, sevoflurane, The risk or severity of adverse effects can be increased when Codeine is combined with Sevoflurane.]
[N05AD08, droperidol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[A08AA10, sibutramine, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Sibutramine.]
[C10AA01, simvastatin, The metabolism of Simvastatin can be decreased when combined with Codeine.]
[V03AG05, sodium phosphate, The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Codeine.]
[A12CA02, sodium sulfate, The therapeutic efficacy of Sodium sulfate can be decreased when used in combination with Codeine.]
[N05AL02, sultopride, The risk or severity of adverse effects can be increased when Codeine is combined with Sultopride.]
[N02CC01, sumatriptan, The risk or severity of adverse effects can be increased when Codeine is combined with Sumatriptan.]
[C07AB13, talinolol, The metabolism of Talinolol can be decreased when combined with Codeine.]
[J01CG02, tazobactam, The excretion of Tazobactam can be decreased when combined with Codeine.]
[D01BA02, terbinafine, The metabolism of Codeine can be decreased when combined with Terbinafine.]
[C07AA16, tertatolol, The metabolism of Tertatolol can be decreased when combined with Codeine.]
[M03BX07, tetrazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Tetrazepam.]
[N05AB05, thiopropazate, The risk or severity of adverse effects can be increased when Codeine is combined with Thiopropazate.]
[G04BD01, emepronium, The risk or severity of adverse effects can be increased when Emepronium is combined with Codeine.]
[N06AX14, tianeptine, The risk or severity of adverse effects can be increased when Codeine is combined with Tianeptine.]
[N05BA23, tofisopam, The risk or severity of adverse effects can be increased when Codeine is combined with Tofisopam.]
[N06AG03, toloxatone, The risk or severity of adverse effects can be increased when Codeine is combined with Toloxatone.]
[N06BA09, atomoxetine, The metabolism of Codeine can be decreased when combined with Atomoxetine.]
[N03AX11, topiramate, The risk or severity of adverse effects can be increased when Topiramate is combined with Codeine.]
[C03CA04, torsemide, The therapeutic efficacy of Torasemide can be decreased when used in combination with Codeine.]
[N05CD11, triazulenone, The risk or severity of adverse effects can be increased when Codeine is combined with Loprazolam.]
[N05CM07, triclofos, The risk or severity of adverse effects can be increased when Codeine is combined with Triclofos.]
[A03AB08, tridihexethyl, The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Codeine.]
[R06AA10, trimethobenzamide, The risk or severity of adverse effects can be increased when Codeine is combined with Trimethobenzamide.]
[N04AA12, tropatepine, The risk or severity of adverse effects can be increased when Tropatepine is combined with Codeine.]
[N01AB04, enflurane, The risk or severity of adverse effects can be increased when Enflurane is combined with Codeine.]
[C02CA06, urapidil, The risk or severity of adverse effects can be increased when Codeine is combined with Urapidil.]
[N05AL06, veralipride, The risk or severity of adverse effects can be increased when Codeine is combined with Veralipride.]
[L01CA04, vinorelbine, The metabolism of Codeine can be decreased when combined with Vinorelbine.]
[S01GX10, epinastine, The risk or severity of adverse effects can be increased when Codeine is combined with Epinastine.]
[N06AX16, venlafaxine, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Venlafaxine.]
[C08CA12, mepirodipine, The metabolism of Codeine can be decreased when combined with Barnidipine.]
[S01EA01, epinephrine, The risk or severity of adverse effects can be increased when Codeine is combined with Epinephrine.]
[N05CF02, zolpidem, Codeine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.]
[N03AX15, zonisamide, The risk or severity of adverse effects can be increased when Codeine is combined with Zonisamide.]
[N05CF01, zopiclone, The risk or severity of adverse effects can be increased when Codeine is combined with Zopiclone.]
[N05AX11, zotepine, The risk or severity of adverse effects can be increased when Codeine is combined with Zotepine.]
[C02AC02, guanfacine, The risk or severity of adverse effects can be increased when Codeine is combined with Guanfacine.]
[C01BG01, moricizine, The risk or severity of hypotension and CNS depression can be increased when Moricizine is combined with Codeine.]
[G02AB03, ergonovine, The risk or severity of adverse effects can be increased when Codeine is combined with Ergometrine.]
[C04AE01, ergoloid mesylates, USP, The risk or severity of adverse effects can be increased when Codeine is combined with Ergoloid mesylate.]
[N02CA02, ergotamine, The metabolism of Codeine can be decreased when combined with Ergotamine.]
[S01AA17, erythromycin, The metabolism of Codeine can be decreased when combined with Erythromycin.]
[N05CD04, estazolam, The risk or severity of adverse effects can be increased when Codeine is combined with Estazolam.]
[H05BX01, cinacalcet, The metabolism of Codeine can be decreased when combined with Cinacalcet.]
[J04AK02, ethambutol, The metabolism of Codeine can be decreased when combined with Ethambutol.]
[C10AA04, fluvastatin, The metabolism of Fluvastatin can be decreased when combined with Codeine.]
[C01CA15, gepefrine, Gepefrine may increase the analgesic activities of Codeine.]
[N05CM08, ethchlorvynol, The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Codeine.]
[N04AA05, profenamine, The risk or severity of adverse effects can be increased when Profenamine is combined with Codeine.]
[N03AD01, ethosuximide, The risk or severity of adverse effects can be increased when Codeine is combined with Ethosuximide.]
[N03AB01, ethotoin, The risk or severity of adverse effects can be increased when Codeine is combined with Ethotoin.]
[N01AX07, etomidate, The risk or severity of adverse effects can be increased when Etomidate is combined with Codeine.]
[N05AE03, sertindole, The risk or severity of adverse effects can be increased when Codeine is combined with Sertindole.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Codeine.]
[R06AX12, terfenadine, The metabolism of Codeine can be decreased when combined with Terfenadine.]
[N06AX12, bupropion, The metabolism of Codeine can be decreased when combined with Bupropion.]
[N06AB08, fluvoxamine, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Fluvoxamine.]
[C01BC08, encainide, The metabolism of Encainide can be decreased when combined with Codeine.]
[C08CA02, felodipine, The metabolism of Codeine can be decreased when combined with Felodipine.]
[N03AX26, fenfluramine, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Fenfluramine.]
[R03CC04, fenoterol, The risk or severity of adverse effects can be increased when Fenoterol is combined with Codeine.]
[N02AB03, fentanyl, The risk or severity of adverse effects can be increased when Codeine is combined with Fentanyl.]
[N07AX03, cevimeline, The metabolism of Codeine can be decreased when combined with Cevimeline.]
[G04BD02, flavoxate, The risk or severity of adverse effects can be increased when Flavoxate is combined with Codeine.]
[C01BC04, flecainide, The metabolism of Flecainide can be decreased when combined with Codeine.]
[J02AC01, fluconazole, The metabolism of Codeine can be decreased when combined with Fluconazole.]
[N07CA03, flunarizine, The risk or severity of adverse effects can be increased when Codeine is combined with Flunarizine.]
[N05CD03, flunitrazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Flunitrazepam.]
[N06AA14, melitracen, The risk or severity of adverse effects can be increased when Codeine is combined with Melitracen.]
[N06AB03, fluoxetine, The serum concentration of Codeine can be increased when it is combined with Fluoxetine.]
[N05AF01, flupenthixol, Codeine may increase the central nervous system depressant (CNS depressant) activities of Flupentixol.]
[N05AB02, fluphenazine, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Codeine.]
[N05CD01, flurazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Flurazepam.]
[N05AG01, fluspirilene, The risk or severity of adverse effects can be increased when Codeine is combined with Fluspirilene.]
[M03AA01, alcuronium, The risk or severity of adverse effects can be increased when Alcuronium is combined with Codeine.]
[G01AX06, furazolidone, The risk or severity of adverse effects can be increased when Codeine is combined with Furazolidone.]
[J05AE10, darunavir, The metabolism of Codeine can be decreased when combined with Darunavir.]
[C03CA01, furosemide, The therapeutic efficacy of Furosemide can be decreased when used in combination with Codeine.]
[N05CF04, eszopiclone, The risk or severity of CNS depression can be increased when Codeine is combined with Eszopiclone.]
[N05AL05, amisulpride, The risk or severity of adverse effects can be increased when Codeine is combined with Amisulpride.]
[N06DA04, galantamine, The metabolism of Galantamine can be decreased when combined with Codeine.]
[M03AC02, gallamine, The risk or severity of adverse effects can be increased when Gallamine is combined with Codeine.]
[S01AD09, ganciclovir, The risk or severity of adverse effects can be increased when Codeine is combined with Ganciclovir.]
[N03AA04, barbexaclone, The risk or severity of adverse effects can be increased when Codeine is combined with Barbexaclone.]
[N06AX08, bifemelane, The risk or severity of adverse effects can be increased when Codeine is combined with Bifemelane.]
[N04BC06, cabergoline, The risk or severity of adverse effects can be increased when Cabergoline is combined with Codeine.]
[N03AD03, methsuximide, The risk or severity of adverse effects can be increased when Codeine is combined with Methsuximide.]
[N01AH02, alfentanil, The risk or severity of adverse effects can be increased when Codeine is combined with Alfentanil.]
[A06AH02, alvimopan, The risk or severity of adverse effects can be increased when Codeine is combined with Alvimopan.]
[N05CM18, dexmedetomidine, The risk or severity of adverse effects can be increased when Codeine is combined with Dexmedetomidine.]
[N05CE01, glutethimide, The risk or severity of adverse effects can be increased when Codeine is combined with Glutethimide.]
[A06AX01, glycerin, The therapeutic efficacy of Glycerin can be decreased when used in combination with Codeine.]
[C02CA04, doxazosin, The risk or severity of adverse effects can be increased when Doxazosin is combined with Codeine.]
[C07AB09, esmolol, The metabolism of Codeine can be decreased when combined with Esmolol.]
[P01BX01, halofantrine, The metabolism of Codeine can be decreased when combined with Halofantrine.]
[N05AD01, haloperidol, The risk or severity of CNS depression can be increased when Haloperidol is combined with Codeine.]
[N01AB01, halothane, The risk or severity of adverse effects can be increased when Codeine is combined with Halothane.]
[N05AH04, quetiapine, The risk or severity of adverse effects can be increased when Quetiapine is combined with Codeine.]
[N02CX03, iprazochrome, The risk or severity of adverse effects can be increased when Codeine is combined with Iprazochrome.]
[N05CA21, allobarbital, The risk or severity of adverse effects can be increased when Codeine is combined with Allobarbital.]
[B05CB03, magnesium citrate, The therapeutic efficacy of Magnesium citrate can be decreased when used in combination with Codeine.]
[A12CD02, sodium monofluorophosphate, The therapeutic efficacy of Sodium fluorophosphate can be decreased when used in combination with Codeine.]
[N05CA16, hexobarbital, The risk or severity of adverse effects can be increased when Hexobarbital is combined with Codeine.]
[J05AG01, nevirapine, The risk or severity of adverse effects can be increased when Nevirapine is combined with Codeine.]
[C08CA10, nilvadipine, The metabolism of Codeine can be decreased when combined with Nilvadipine.]
[C03AA03, hydrochlorothiazide, The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Codeine.]
[R05DA03, hydrocodone, Codeine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.]
[C03AA02, hydroflumethiazide, The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Codeine.]
[A12BA02, potassium citrate, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Codeine.]
[G04BD06, propiverine, The risk or severity of adverse effects can be increased when Propiverine is combined with Codeine.]
[P01BA02, hydroxychloroquine, The metabolism of Codeine can be decreased when combined with Hydroxychloroquine.]
[N05AX07, prothipendyl, The risk or severity of adverse effects can be increased when Codeine is combined with Prothipendyl.]
[N05BB01, hydroxyzine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[L01DB06, idarubicin, The metabolism of Idarubicin can be decreased when combined with Codeine.]
[A06AD21, sodium tartrate, The therapeutic efficacy of Sodium tartrate can be decreased when used in combination with Codeine.]
[N01AH03, sufentanil, The risk or severity of adverse effects can be increased when Codeine is combined with Sufentanil.]
[N06AA02, imipramine, The risk or severity of adverse effects can be increased when Imipramine is combined with Codeine.]
[M03BX02, tizanidine, The risk or severity of adverse effects can be increased when Codeine is combined with Tizanidine.]
[C03BA11, indapamide, The therapeutic efficacy of Indapamide can be decreased when used in combination with Codeine.]
[S01BC01, indomethacin, The excretion of Indomethacin can be decreased when combined with Codeine.]
[N06AX17, milnacipran, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Milnacipran.]
[A03AA30, piperidolate, The risk or severity of adverse effects can be increased when Piperidolate is combined with Codeine.]
[N01BB08, articaine, The risk or severity of adverse effects can be increased when Codeine is combined with Articaine.]
[N05BA12, alprazolam, The risk or severity of adverse effects can be increased when Codeine is combined with Alprazolam.]
[N05CH02, ramelteon, The risk or severity of adverse effects can be increased when Codeine is combined with Ramelteon.]
[R06AE01, buclizine, The risk or severity of adverse effects can be increased when Buclizine is combined with Codeine.]
[C10AA06, cerivastatin, The metabolism of Codeine can be decreased when combined with Cerivastatin.]
[C07AA01, alprenolol, The risk or severity of adverse effects can be increased when Codeine is combined with Alprenolol.]
[C03BA02, quinethazone, The therapeutic efficacy of Quinethazone can be decreased when used in combination with Codeine.]
[V03AB01, ipecac, The metabolism of Ipecac can be decreased when combined with Codeine.]
[J05AF04, stavudine, The excretion of Stavudine can be decreased when combined with Codeine.]
[N06AA13, iprindole, The risk or severity of adverse effects can be increased when Codeine is combined with Iprindole.]
[G04BE01, alprostadil, The excretion of Alprostadil can be decreased when combined with Codeine.]
[N06AF05, iproniazid, The risk or severity of adverse effects can be increased when Codeine is combined with Iproniazid.]
[N05AA07, chlorproethazine, The risk or severity of hypotension and CNS depression can be increased when Chlorproethazine is combined with Codeine.]
[N06AF01, isocarboxazid, The risk or severity of adverse effects can be increased when Codeine is combined with Isocarboxazid.]
[N01AB06, isoflurane, The risk or severity of adverse effects can be increased when Isoflurane is combined with Codeine.]
[N04BX02, entacapone, The risk or severity of adverse effects can be increased when Codeine is combined with Entacapone.]
[J04AC01, isoniazid, The metabolism of Codeine can be decreased when combined with Isoniazid.]
[N06AX18, reboxetine, The risk or severity of adverse effects can be increased when Reboxetine is combined with Codeine.]
[L04AC07, tocilizumab, The metabolism of Codeine can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The risk or severity of adverse effects can be increased when Codeine is combined with Ketamine.]
[C02KD01, ketanserin, The risk or severity of adverse effects can be increased when Codeine is combined with Ketanserin.]
[J02AB02, ketoconazole, The metabolism of Codeine can be decreased when combined with Ketoconazole.]
[H02CA04, levoketoconazole, The metabolism of Codeine can be decreased when combined with Levoketoconazole.]
[N05AH03, olanzapine, The risk or severity of adverse effects can be increased when Olanzapine is combined with Codeine.]
[L04AA24, abatacept, The metabolism of Codeine can be increased when combined with Abatacept.]
[N04BC09, rotigotine, Codeine may increase the sedative activities of Rotigotine.]
[C07AG01, labetalol, The metabolism of Codeine can be decreased when combined with Labetalol.]
[N04BB01, amantadine, The risk or severity of adverse effects can be increased when Amantadine is combined with Codeine.]
[A06AD11, lactulose, The therapeutic efficacy of Lactulose can be decreased when used in combination with Codeine.]
[A06AX03, lubiprostone, The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Codeine.]
[N03AX18, lacosamide, The risk or severity of adverse effects can be increased when Codeine is combined with Lacosamide.]
[C03CC01, ethacrynic acid, The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Codeine.]
[N04BA01, levodopa, The risk or severity of adverse effects can be increased when Codeine is combined with Levodopa.]
[S02DA01, lidocaine, The risk or severity of adverse effects can be increased when Lidocaine is combined with Codeine.]
[C03DB01, amiloride, The therapeutic efficacy of Amiloride can be decreased when used in combination with Codeine.]
[N02CA07, lisuride, The risk or severity of adverse effects can be increased when Codeine is combined with Lisuride.]
[N06AA07, lofepramine, The risk or severity of adverse effects can be increased when Codeine is combined with Lofepramine.]
[N05BA06, lorazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Lorazepam.]
[C10AA02, lovastatin, The metabolism of Codeine can be decreased when combined with Lovastatin.]
[N05AH01, loxapine, The risk or severity of adverse effects can be increased when Codeine is combined with Loxapine.]
[L01EG01, temsirolimus, The metabolism of Codeine can be decreased when combined with Temsirolimus.]
[A12CC10, magnesium oxide, The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Codeine.]
[V04CC02, magnesium sulfate, The therapeutic efficacy of Codeine can be increased when used in combination with Magnesium sulfate.]
[L01EA03, nilotinib, The metabolism of Codeine can be decreased when combined with Nilotinib.]
[V04CX04, mannitol, The therapeutic efficacy of Mannitol can be decreased when used in combination with Codeine.]
[N06AA21, maprotiline, The risk or severity of adverse effects can be increased when Maprotiline is combined with Codeine.]
[A08AA05, mazindol, The risk or severity of adverse effects can be increased when Codeine is combined with Mazindol.]
[C02BB01, mecamylamine, The risk or severity of adverse effects can be increased when Mecamylamine is combined with Codeine.]
[R06AE05, meclizine, The risk or severity of adverse effects can be increased when Meclizine is combined with Codeine.]
[N05BA03, medazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Medazepam.]
[A06AB07, cascara sagrada, The therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Codeine.]
[C03BA05, mefruside, The therapeutic efficacy of Mefruside can be decreased when used in combination with Codeine.]
[N05CH01, melatonin, The risk or severity of adverse effects can be increased when Codeine is combined with Melatonin.]
[N02AB02, meperidine, The risk or severity of adverse effects can be increased when Codeine is combined with Meperidine.]
[C01CA11, mephentermine, Mephentermine may increase the analgesic activities of Codeine.]
[N03AB04, mephenytoin, The risk or severity of adverse effects can be increased when Codeine is combined with Mephenytoin.]
[N03AA01, mephobarbital, The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Codeine.]
[N01BB03, mepivacaine, The risk or severity of adverse effects can be increased when Codeine is combined with Mepivacaine.]
[N02AX05, meptazinol, The risk or severity of adverse effects can be increased when Codeine is combined with Meptazinol.]
[C03BC01, mersalyl, The therapeutic efficacy of Mersalyl can be decreased when used in combination with Codeine.]
[N05AC03, mesoridazine, The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Codeine.]
[N05AX13, paliperidone, The risk or severity of adverse effects can be increased when Codeine is combined with Paliperidone.]
[A04AA04, dolasetron, The risk or severity of adverse effects can be increased when Codeine is combined with Dolasetron.]
[N07BC02, methadone, The risk or severity of adverse effects can be increased when Methadone is combined with Codeine.]
[N06BA03, methamphetamine, Metamfetamine may increase the analgesic activities of Codeine.]
[A03AB07, methantheline, The risk or severity of adverse effects can be increased when Methantheline is combined with Codeine.]
[R06AC05, methapyrilene, The risk or severity of adverse effects can be increased when Codeine is combined with Methapyrilene.]
[N05CM01, methaqualone, The risk or severity of adverse effects can be increased when Codeine is combined with Methaqualone.]
[J05AF05, lamivudine, The risk or severity of adverse effects can be increased when Codeine is combined with Lamivudine.]
[N03AA30, metharbital, The risk or severity of adverse effects can be increased when Metharbital is combined with Codeine.]
[S01EC05, methazolamide, The therapeutic efficacy of Methazolamide can be decreased when used in combination with Codeine.]
[G02CB05, metergoline, The risk or severity of adverse effects can be increased when Codeine is combined with Metergoline.]
[H03BB02, methimazole, The metabolism of Codeine can be decreased when combined with Methimazole.]
[N05CA15, methohexital, The risk or severity of adverse effects can be increased when Codeine is combined with Methohexital.]
[N02BG08, ziconotide, The risk or severity of adverse effects can be increased when Codeine is combined with Ziconotide.]
[N05AA02, methotrimeprazine, Codeine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.]
[N02BG09, methoxyflurane, The risk or severity of adverse effects can be increased when Codeine is combined with Methoxyflurane.]
[C03AA08, methyclothiazide, The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Codeine.]
[A06AC06, methylcellulose, The therapeutic efficacy of Methylcellulose can be decreased when used in combination with Codeine.]
[V04CG05, methylene blue, Codeine may increase the serotonergic activities of Methylene blue.]
[N03AF03, rufinamide, The risk or severity of adverse effects can be increased when Rufinamide is combined with Codeine.]
[N05CE02, methyprylon, The risk or severity of adverse effects can be increased when Codeine is combined with Methyprylon.]
[N02CA04, methysergide, The risk or severity of adverse effects can be increased when Methysergide is combined with Codeine.]
[A03FA01, metoclopramide, The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Codeine.]
[C03BA08, metolazone, The therapeutic efficacy of Metolazone can be decreased when used in combination with Codeine.]
[C07AB02, metoprolol, The metabolism of Codeine can be decreased when combined with Metoprolol.]
[C01BB02, mexiletine, The metabolism of Mexiletine can be decreased when combined with Codeine.]
[N06AX03, mianserin, The risk or severity of adverse effects can be increased when Codeine is combined with Mianserin.]
[S02AA13, miconazole, The metabolism of Codeine can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be decreased when combined with Codeine.]
[N05CD08, midazolam, The risk or severity of adverse effects can be increased when Codeine is combined with Midazolam.]
[G03XB01, mifepristone, The metabolism of Codeine can be decreased when combined with Mifepristone.]
[A06AA01, mineral oil, The therapeutic efficacy of Mineral oil can be decreased when used in combination with Codeine.]
[J01AA08, minocycline, Minocycline may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[L01XX23, mitotane, The metabolism of Codeine can be increased when combined with Mitotane.]
[N06BA12, lisdexamfetamine, Lisdexamfetamine may increase the analgesic activities of Codeine.]
[N05AE02, molindone, The risk or severity of adverse effects can be increased when Codeine is combined with Molindone.]
[C01BD01, amiodarone, The metabolism of Codeine can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The risk or severity of adverse effects can be increased when Amitriptyline is combined with Codeine.]
[N02AA01, morphine, The risk or severity of adverse effects can be increased when Morphine is combined with Codeine.]
[A04AA05, palonosetron, The risk or severity of adverse effects can be increased when Codeine is combined with Palonosetron.]
[L04AB05, certolizumab pegol, The metabolism of Codeine can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Codeine can be decreased when combined with Eltrombopag.]
[L01EX03, pazopanib, The metabolism of Codeine can be decreased when combined with Pazopanib.]
[M03AC03, vecuronium, The risk or severity of adverse effects can be increased when Vecuronium is combined with Codeine.]
[N05CA02, amobarbital, The risk or severity of adverse effects can be increased when Amobarbital is combined with Codeine.]
[N06AA17, amoxapine, The risk or severity of adverse effects can be increased when Amoxapine is combined with Codeine.]
[N03AB05, fosphenytoin, The metabolism of Codeine can be increased when combined with Fosphenytoin.]
[C07AA12, nadolol, The metabolism of Nadolol can be decreased when combined with Codeine.]
[N04BC04, ropinirole, Codeine may increase the sedative activities of Ropinirole.]
[C04AX21, nafronyl, The risk or severity of adverse effects can be increased when Codeine is combined with Naftidrofuryl.]
[N02AF02, nalbuphine, The therapeutic efficacy of Codeine can be decreased when used in combination with Nalbuphine.]
[V03AB15, naloxone, The metabolism of Codeine can be decreased when combined with Naloxone.]
[N07BB04, naltrexone, The risk or severity of adverse effects can be increased when Codeine is combined with Naltrexone.]
[L04AC03, anakinra, The metabolism of Codeine can be increased when combined with Anakinra.]
[S01GA01, naphazoline, Naphazoline may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[N06BA01, amphetamine, Amphetamine may increase the analgesic activities of Codeine.]
[N06AX21, duloxetine, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Duloxetine.]
[N04BX01, tolcapone, The risk or severity of adverse effects can be increased when Codeine is combined with Tolcapone.]
[N01AH06, remifentanil, The risk or severity of adverse effects can be increased when Codeine is combined with Remifentanil.]
[N05AX14, iloperidone, The risk or severity of adverse effects can be increased when Codeine is combined with Iloperidone.]
[N06AX23, desvenlafaxine, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Desvenlafaxine.]
[C10AD02, niacin, The metabolism of Codeine can be decreased when combined with Niacin.]
[N06AF02, nialamide, The risk or severity of adverse effects can be increased when Codeine is combined with Nialamide.]
[C08CA04, nicardipine, The risk or severity of adverse effects can be increased when Nicardipine is combined with Codeine.]
[C04AE02, nicergoline, The metabolism of Nicergoline can be decreased when combined with Codeine.]
[N07BA01, nicotine, The risk or severity of adverse effects can be increased when Nicotine is combined with Codeine.]
[C08CA05, nifedipine, The metabolism of Nifedipine can be decreased when combined with Codeine.]
[N05CD02, nitrazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Nitrazepam.]
[N05CF03, zaleplon, The risk or severity of adverse effects can be increased when Codeine is combined with Zaleplon.]
[N04BC05, pramipexole, Codeine may increase the sedative activities of Pramipexole.]
[N01AX13, nitrous oxide, The risk or severity of adverse effects can be increased when Codeine is combined with Nitrous oxide.]
[N06AX04, nomifensine, The risk or severity of adverse effects can be increased when Codeine is combined with Nomifensine.]
[C01CA03, norepinephrine, The risk or severity of adverse effects can be increased when Codeine is combined with Norepinephrine.]
[N06AA10, nortriptyline, The risk or severity of adverse effects can be increased when Nortriptyline is combined with Codeine.]
[L04AC04, rilonacept, The metabolism of Codeine can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Codeine can be decreased when combined with Omeprazole.]
[N06AA05, opipramol, The risk or severity of adverse effects can be increased when Codeine is combined with Opipramol.]
[N02AA02, opium, The risk or severity of adverse effects can be increased when Codeine is combined with Opium.]
[G04CA02, tamsulosin, The metabolism of Tamsulosin can be decreased when combined with Codeine.]
[P02BA02, oxamniquine, The metabolism of Codeine can be decreased when combined with Oxamniquine.]
[N05BA04, oxazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Oxazepam.]
[C07AA02, oxprenolol, The risk or severity of adverse effects can be increased when Codeine is combined with Oxprenolol.]
[N02AA05, oxycodone, The risk or severity of adverse effects can be increased when Codeine is combined with Oxycodone.]
[N02AA11, oxymorphone, The risk or severity of adverse effects can be increased when Codeine is combined with Oxymorphone.]
[N05AE01, oxypertine, The risk or severity of adverse effects can be increased when Codeine is combined with Oxypertine.]
[A03AB03, oxyphenonium, The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Codeine.]
[V04CH30, 4-aminohippuric acid, The excretion of Aminohippuric acid can be decreased when combined with Codeine.]
[N05AH05, asenapine, The risk or severity of adverse effects can be increased when Codeine is combined with Asenapine.]
[N02AX06, tapentadol, Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[M03AC01, pancuronium, The risk or severity of adverse effects can be increased when Pancuronium is combined with Codeine.]
[N05CC05, paraldehyde, Codeine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.]
[C02KC01, pargyline, The risk or severity of adverse effects can be increased when Codeine is combined with Pargyline.]
[G04BD11, fesoterodine, The risk or severity of adverse effects can be increased when Fesoterodine is combined with Codeine.]
[C07AA23, penbutolol, The risk or severity of adverse effects can be increased when Codeine is combined with Penbutolol.]
[N05AG03, penfluridol, The risk or severity of adverse effects can be increased when Codeine is combined with Penfluridol.]
[N02AD01, pentazocine, The therapeutic efficacy of Codeine can be decreased when used in combination with Pentazocine.]
[N05CA01, pentobarbital, The risk or severity of adverse effects can be increased when Pentobarbital is combined with Codeine.]
[N05AB10, perazine, The risk or severity of hypotension and CNS depression can be increased when Perazine is combined with Codeine.]
[N04BC02, pergolide, The risk or severity of adverse effects can be increased when Codeine is combined with Pergolide.]
[C08EX02, perhexiline, The metabolism of Codeine can be decreased when combined with Perhexiline.]
[N05AB03, perphenazine, The risk or severity of hypotension and CNS depression can be increased when Perphenazine is combined with Codeine.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Codeine.]
[N02AD02, phenazocine, The risk or severity of adverse effects can be increased when Codeine is combined with Phenazocine.]
[N06AF03, phenelzine, The risk or severity of adverse effects can be increased when Codeine is combined with Phenelzine.]
[A10BA01, phenformin, The risk or severity of adverse effects can be increased when Codeine is combined with Phenformin.]
[A06AB01, oxyphenisatin, The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Codeine.]
[N01AH04, phenoperidine, The risk or severity of adverse effects can be increased when Codeine is combined with Phenoperidine.]
[C04AX02, phenoxybenzamine, The risk or severity of adverse effects can be increased when Phenoxybenzamine is combined with Codeine.]
[A08AA01, phentermine, Phentermine may increase the analgesic activities of Codeine.]
[N03AB02, phenytoin, The metabolism of Codeine can be increased when combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Codeine can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, The excretion of Levofloxacin can be decreased when combined with Codeine.]
[J05AB12, cidofovir, The excretion of Cidofovir can be decreased when combined with Codeine.]
[C08CX01, mibefradil, The metabolism of Codeine can be decreased when combined with Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Codeine.]
[C07AA03, pindolol, The risk or severity of adverse effects can be increased when Codeine is combined with Pindolol.]
[J05AE01, saquinavir, The metabolism of Codeine can be decreased when combined with Saquinavir.]
[P02CB01, piperazine, The metabolism of Piperazine can be decreased when combined with Codeine.]
[N05AC04, pipothiazine, The risk or severity of hypotension and CNS depression can be increased when Pipotiazine is combined with Codeine.]
[A02BX03, pirenzepine, The risk or severity of adverse effects can be increased when Pirenzepine is combined with Codeine.]
[N02AC03, pirinitramide, The risk or severity of adverse effects can be increased when Codeine is combined with Piritramide.]
[J01MA11, grepafloxacin, The excretion of Grepafloxacin can be decreased when combined with Codeine.]
[N02CX01, pizotyline, The risk or severity of adverse effects can be increased when Pizotifen is combined with Codeine.]
[J05AG02, delavirdine, The metabolism of Codeine can be decreased when combined with Delavirdine.]
[N05CA22, proxibarbal, The risk or severity of adverse effects can be increased when Codeine is combined with Proxibarbal.]
[A06AD15, polyethylene glycols, The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Codeine.]
[A03AE01, alosetron, The risk or severity of adverse effects can be increased when Codeine is combined with Alosetron.]
[L04AC08, canakinumab, The metabolism of Codeine can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, The therapeutic efficacy of Polythiazide can be decreased when used in combination with Codeine.]
[J05AE03, ritonavir, The serum concentration of Codeine can be increased when it is combined with Ritonavir.]
[C07AB01, practolol, The metabolism of Practolol can be decreased when combined with Codeine.]
[N05BA11, prazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Prazepam.]
[C02CA01, prazosin, The risk or severity of adverse effects can be increased when Codeine is combined with Prazosin.]
[N01BB04, prilocaine, The risk or severity of adverse effects can be increased when Codeine is combined with Prilocaine.]
[P01BA03, primaquine, The metabolism of Codeine can be decreased when combined with Primaquine.]
[N03AA03, primidone, The risk or severity of adverse effects can be increased when Primidone is combined with Codeine.]
[M04AB01, probenecid, The risk or severity of adverse effects can be increased when Probenecid is combined with Codeine.]
[C01BA02, procainamide, The metabolism of Procainamide can be decreased when combined with Codeine.]
[S01HA05, procaine, The risk or severity of adverse effects can be increased when Codeine is combined with Procaine.]
[L01XB01, procarbazine, The risk or severity of adverse effects can be increased when Codeine is combined with Procarbazine.]
[N05AB04, prochlorperazine, The risk or severity of hypotension and CNS depression can be increased when Prochlorperazine is combined with Codeine.]
[N04AA04, procyclidine, The risk or severity of adverse effects can be increased when Procyclidine is combined with Codeine.]
[G03DA04, progesterone, The risk or severity of adverse effects can be increased when Progesterone is combined with Codeine.]
[N05AA03, promazine, The risk or severity of adverse effects can be increased when Promazine is combined with Codeine.]
[C01BC03, propafenone, The metabolism of Codeine can be decreased when combined with Propafenone.]
[N01AX04, propanidid, The risk or severity of adverse effects can be increased when Codeine is combined with Propanidid.]
[A03AB05, propantheline, The risk or severity of adverse effects can be increased when Propantheline is combined with Codeine.]
[N05AC01, periciazine, The risk or severity of hypotension and CNS depression can be increased when Periciazine is combined with Codeine.]
[N05CM06, propiomazine, The risk or severity of adverse effects can be increased when Propiomazine is combined with Codeine.]
[N01AX10, propofol, Codeine may increase the sedative activities of Propofol.]
[N02AC04, propoxyphene, The risk or severity of adverse effects can be increased when Codeine is combined with Dextropropoxyphene.]
[C07AA05, propranolol, The metabolism of Codeine can be decreased when combined with Propranolol.]
[N02CC04, rizatriptan, The risk or severity of adverse effects can be increased when Codeine is combined with Rizatriptan.]
[N06AA11, protriptyline, The risk or severity of adverse effects can be increased when Codeine is combined with Protriptyline.]
[N05AX12, aripiprazole, The risk or severity of adverse effects can be increased when Aripiprazole is combined with Codeine.]
[A03AB15, diphemanil, The risk or severity of adverse effects can be increased when Diphemanil is combined with Codeine.]
[A03AB09, isopropamide, The risk or severity of adverse effects can be increased when Isopropamide is combined with Codeine.]
[S01FA03, methscopolamine, The risk or severity of adverse effects can be increased when Methscopolamine is combined with Codeine.]
[N05CA07, talbutal, The risk or severity of adverse effects can be increased when Talbutal is combined with Codeine.]
[N05CA09, vinbarbital, The risk or severity of adverse effects can be increased when Codeine is combined with Vinbarbital.]
[N05BB02, captodiamine, The risk or severity of adverse effects can be increased when Codeine is combined with Captodiame.]
[M03BA04, styramate, The risk or severity of adverse effects can be increased when Codeine is combined with Styramate.]
[P02CC01, pyrantel, The risk or severity of adverse effects can be increased when Codeine is combined with Pyrantel.]
[C01BA01, quinidine, The risk or severity of adverse effects can be increased when Quinidine is combined with Codeine.]
[P01BC01, quinine, The metabolism of Codeine can be decreased when combined with Quinine.]
[A02BA02, ranitidine, The metabolism of Codeine can be decreased when combined with Ranitidine.]
[C02AA02, reserpine, The risk or severity of adverse effects can be increased when Reserpine is combined with Codeine.]
[J04AB02, rifampin, The metabolism of Codeine can be increased when combined with Rifampicin.]
[N06AX01, 5-hydroxytryptophan, The risk or severity of adverse effects can be increased when Codeine is combined with Oxitriptan.]
[S01FA02, scopolamine, The risk or severity of adverse effects can be increased when Scopolamine is combined with Codeine.]
[N05CA06, secobarbital, The risk or severity of adverse effects can be increased when Secobarbital is combined with Codeine.]
[N04BD01, selegiline, The risk or severity of adverse effects can be increased when Codeine is combined with Selegiline.]
[V04CC01, sorbitol, The therapeutic efficacy of Sorbitol can be decreased when used in combination with Codeine.]
[C07AA07, sotalol, The metabolism of Sotalol can be decreased when combined with Codeine.]
[C03DA01, spironolactone, The therapeutic efficacy of Spironolactone can be decreased when used in combination with Codeine.]
[N05CC01, chloral hydrate, The risk or severity of adverse effects can be increased when Codeine is combined with Chloral hydrate.]
[N03AG01, valproic acid, The risk or severity of adverse effects can be increased when Valproic acid is combined with Codeine.]
[A05AA01, chenodeoxycholic acid, The metabolism of Codeine can be decreased when combined with Chenodeoxycholic acid.]
[R03BB01, ipratropium bromide, The risk or severity of adverse effects can be increased when Ipratropium is combined with Codeine.]
[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Codeine.]
[M03AB01, succinylcholine, The risk or severity of bradycardia can be increased when Succinylcholine is combined with Codeine.]
[N05AL01, sulpiride, The risk or severity of adverse effects can be increased when Codeine is combined with Sulpiride.]
[N03AX03, sulthiame, The risk or severity of adverse effects can be increased when Codeine is combined with Sulthiame.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Codeine.]
[N05CD07, temazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Temazepam.]
[N07XX06, tetrabenazine, The metabolism of Tetrabenazine can be decreased when combined with Codeine.]
[S01HA03, tetracaine, The risk or severity of adverse effects can be increased when Codeine is combined with Tetracaine.]
[N05AE05, lurasidone, The risk or severity of adverse effects can be increased when Codeine is combined with Lurasidone.]
[A04AD10, dronabinol, Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[N04BC07, apomorphine, The risk or severity of adverse effects can be increased when Codeine is combined with Apomorphine.]
[L04AX02, thalidomide, Codeine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.]
[R03DA07, theobromine, The therapeutic efficacy of Theobromine can be decreased when used in combination with Codeine.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Codeine.]
[A11DA01, thiamine, The risk or severity of adverse effects can be increased when Codeine is combined with Thiamine.]
[R06AD03, thiethylperazine, The risk or severity of hypotension and CNS depression can be increased when Thiethylperazine is combined with Codeine.]
[N05CA19, thiopental, The risk or severity of adverse effects can be increased when Thiopental is combined with Codeine.]
[N05AB08, thioproperazine, The risk or severity of hypotension and CNS depression can be increased when Thioproperazine is combined with Codeine.]
[N05AC02, thioridazine, The metabolism of Codeine can be decreased when combined with Thioridazine.]
[N05AF04, thiothixene, The risk or severity of adverse effects can be increased when Codeine is combined with Thiothixene.]
[C01BB04, aprindine, The metabolism of Aprindine can be decreased when combined with Codeine.]
[N05AL03, tiapride, The risk or severity of adverse effects can be increased when Codeine is combined with Tiapride.]
[B01AC05, ticlopidine, The metabolism of Codeine can be decreased when combined with Ticlopidine.]
[N02AX01, tilidine, The risk or severity of adverse effects can be increased when Codeine is combined with Tilidine.]
[S01ED01, timolol, The metabolism of Timolol can be decreased when combined with Codeine.]
[M03BX04, tolperisone, The risk or severity of adverse effects can be increased when Codeine is combined with Tolperisone.]
[N02AX02, tramadol, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Tramadol.]
[N06AF04, tranylcypromine, The risk or severity of adverse effects can be increased when Codeine is combined with Tranylcypromine.]
[N06AX05, trazodone, The risk or severity of serotonin syndrome can be increased when Trazodone is combined with Codeine.]
[C03DB02, triamterene, The therapeutic efficacy of Triamterene can be decreased when used in combination with Codeine.]
[N05CD05, triazolam, The risk or severity of adverse effects can be increased when Codeine is combined with Triazolam.]
[C03AA06, trichlormethiazide, The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Codeine.]
[A03AB12, mepenzolate, The risk or severity of adverse effects can be increased when Mepenzolate is combined with Codeine.]
[N05AB06, trifluoperazine, The risk or severity of hypotension and CNS depression can be increased when Trifluoperazine is combined with Codeine.]
[S01AD02, trifluridine, The excretion of Trifluridine can be decreased when combined with Codeine.]
[N05AD02, trifluperidol, The risk or severity of adverse effects can be increased when Codeine is combined with Trifluperidol.]
[N05AA05, triflupromazine, The risk or severity of adverse effects can be increased when Triflupromazine is combined with Codeine.]
[N04AA01, trihexyphenidyl, The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Codeine.]
[A03AA05, trimebutine, The risk or severity of adverse effects can be increased when Trimebutine is combined with Codeine.]
[R06AD01, trimeprazine, The risk or severity of hypotension and CNS depression can be increased when Alimemazine is combined with Codeine.]
[N03AC02, trimethadione, The risk or severity of adverse effects can be increased when Codeine is combined with Trimethadione.]
[C02BA01, trimethaphan, The risk or severity of adverse effects can be increased when Trimethaphan is combined with Codeine.]
[N06AA06, trimipramine, The metabolism of Trimipramine can be decreased when combined with Codeine.]
[R06AC04, tripelennamine, The metabolism of Codeine can be decreased when combined with Tripelennamine.]
[A03BB01, butylscopolamine, The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Codeine.]
[J01FA08, troleandomycin, The metabolism of Codeine can be decreased when combined with Troleandomycin.]
[N06AX24, vilazodone, The metabolism of Codeine can be decreased when combined with Vilazodone.]
[N06AX02, tryptophan, The risk or severity of adverse effects can be increased when Tryptophan is combined with Codeine.]
[M03AA02, tubocurarine, The risk or severity of adverse effects can be increased when Tubocurarine is combined with Codeine.]
[L02BX03, abiraterone, The metabolism of Codeine can be decreased when combined with Abiraterone.]
[A10BH05, linagliptin, The metabolism of Codeine can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Codeine can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Codeine can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The metabolism of Codeine can be decreased when combined with Rilpivirine.]
[N03AX21, ezogabine, The risk or severity of adverse effects can be increased when Codeine is combined with Ezogabine.]
[B01AC24, ticagrelor, Codeine can cause a decrease in the absorption of Ticagrelor resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C08DA01, verapamil, The metabolism of Codeine can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Codeine can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Codeine can be decreased when combined with Vinblastine.]
[C03BA10, xipamide, The therapeutic efficacy of Xipamide can be decreased when used in combination with Codeine.]
[J05AF01, zidovudine, The excretion of Zidovudine can be decreased when combined with Codeine.]
[N05AF05, zuclopenthixol, The risk or severity of adverse effects can be increased when Codeine is combined with Zuclopenthixol.]
[J05AE02, indinavir, The metabolism of Codeine can be decreased when combined with Indinavir.]
[N03AX14, levetiracetam, The risk or severity of adverse effects can be increased when Codeine is combined with Levetiracetam.]
[L01EC01, vemurafenib, The metabolism of Codeine can be decreased when combined with Vemurafenib.]
[L01ED01, crizotinib, The metabolism of Codeine can be decreased when combined with Crizotinib.]
[N05AE04, ziprasidone, The risk or severity of adverse effects can be increased when Codeine is combined with Ziprasidone.]
[G03AC10, drospirenone, The therapeutic efficacy of Drospirenone can be decreased when used in combination with Codeine.]
[G04BD07, tolterodine, The risk or severity of adverse effects can be increased when Tolterodine is combined with Codeine.]
[C07AB03, atenolol, The metabolism of Atenolol can be decreased when combined with Codeine.]
[J02AC03, voriconazole, The metabolism of Codeine can be decreased when combined with Voriconazole.]
[M03AC04, atracurium, The risk or severity of adverse effects can be increased when Atracurium is combined with Codeine.]
[S01FA01, atropine, The risk or severity of adverse effects can be increased when Atropine is combined with Codeine.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Codeine.]
[M03BX01, baclofen, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[A08AA11, lorcaserin, The metabolism of Codeine can be decreased when combined with Lorcaserin.]
[G04BD12, mirabegron, The serum concentration of Codeine can be increased when it is combined with Mirabegron.]
[V03AX03, cobicistat, The metabolism of Codeine can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Codeine can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Codeine can be decreased when it is combined with Enzalutamide.]
[A06AX04, linaclotide, The therapeutic efficacy of Linaclotide can be decreased when used in combination with Codeine.]
[N05CA04, barbital, The risk or severity of adverse effects can be increased when Barbital is combined with Codeine.]
[J05AE04, nelfinavir, The metabolism of Codeine can be decreased when combined with Nelfinavir.]
[S01GA07, brimonidine, Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[N04BD02, rasagiline, The risk or severity of adverse effects can be increased when Codeine is combined with Rasagiline.]
[A03FA09, mosapride, The risk or severity of adverse effects can be increased when Codeine is combined with Mosapride.]
[N06DA02, donepezil, The risk or severity of adverse effects can be increased when Codeine is combined with Donepezil.]
[N03AX22, perampanel, Perampanel may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[N02CC03, zolmitriptan, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Codeine.]
[R06AC06, thonzylamine, The risk or severity of adverse effects can be increased when Thonzylamine is combined with Codeine.]
[G04BD10, darifenacin, The risk or severity of adverse effects can be increased when Darifenacin is combined with Codeine.]
[N01AA01, ethyl ether, The risk or severity of adverse effects can be increased when Codeine is combined with Diethyl ether.]
[G04BE03, sildenafil, The metabolism of Codeine can be decreased when combined with Sildenafil.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Codeine.]
[A10BH04, alogliptin, The metabolism of Alogliptin can be decreased when combined with Codeine.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Codeine can be decreased when combined with Glycerol phenylbutyrate.]
[C03AA01, bendroflumethiazide, The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Codeine.]
[L04AX06, pomalidomide, The risk or severity of adverse effects can be increased when Codeine is combined with Pomalidomide.]
[G03XC05, ospemifene, The metabolism of Codeine can be decreased when combined with Ospemifene.]
[N05AD07, benperidol, The risk or severity of adverse effects can be increased when Codeine is combined with Benperidol.]
[A10BK02, canagliflozin, The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Codeine.]
[A06AX06, tegaserod, The metabolism of Codeine can be decreased when combined with Tegaserod.]
[R02AD01, benzocaine, The risk or severity of adverse effects can be increased when Codeine is combined with Benzocaine.]
[M01AH01, celecoxib, The metabolism of Codeine can be decreased when combined with Celecoxib.]
[N02CC02, naratriptan, The risk or severity of adverse effects can be increased when Codeine is combined with Naratriptan.]
[L04AA18, everolimus, The metabolism of Codeine can be decreased when combined with Everolimus.]
[N04AC01, benztropine, The risk or severity of adverse effects can be increased when Benzatropine is combined with Codeine.]
[L01EC02, dabrafenib, The serum concentration of Codeine can be decreased when it is combined with Dabrafenib.]
[P03AX06, benzyl alcohol, The risk or severity of adverse effects can be increased when Codeine is combined with Benzyl alcohol.]
[N06AX28, levomilnacipran, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Levomilnacipran.]
[C08EA02, bepridil, The metabolism of Codeine can be decreased when combined with Bepridil.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Codeine.]
[N06AX26, vortioxetine, The risk or severity of adverse effects can be increased when Codeine is combined with Vortioxetine.]
[N03AF04, eslicarbazepine, The risk or severity of adverse effects can be increased when Codeine is combined with Eslicarbazepine.]
[J05AP05, simeprevir, The metabolism of Codeine can be decreased when combined with Simeprevir.]
[N03AG04, vigabatrin, The risk or severity of adverse effects can be increased when Codeine is combined with Vigabatrin.]
[A10BK01, dapagliflozin, The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Codeine.]
[C07AB04, acebutolol, The metabolism of Codeine can be decreased when combined with Acebutolol.]
[N05CH03, tasimelteon, The risk or severity of adverse effects can be increased when Codeine is combined with Tasimelteon.]
[A16AA07, metreleptin, The metabolism of Codeine can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Codeine can be increased when combined with Apremilast.]
[S01ED02, betaxolol, The metabolism of Codeine can be decreased when combined with Betaxolol.]
[L04AC11, siltuximab, The metabolism of Codeine can be increased when combined with Siltuximab.]
[A03BA03, hyoscyamine, The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Codeine.]
[N01AX05, alfaxalone, The risk or severity of adverse effects can be increased when Codeine is combined with Alfaxalone.]
[D11AA01, glycopyrronium, The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Codeine.]
[N05CM19, suvorexant, Codeine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A16AX10, eliglustat, The metabolism of Codeine can be decreased when combined with Eliglustat.]
[J01XA05, oritavancin, The metabolism of Codeine can be decreased when combined with Oritavancin.]
[N05AA04, acepromazine, The risk or severity of hypotension and CNS depression can be increased when Acepromazine is combined with Codeine.]
[A06AB04, phenolphthalein, The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Codeine.]
[A06AH03, naloxegol, The risk or severity of adverse effects can be increased when Codeine is combined with Naloxegol.]
[N04AA02, biperiden, The risk or severity of adverse effects can be increased when Biperiden is combined with Codeine.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Codeine.]
[A06AG02, bisacodyl, The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Codeine.]
[J05AP09, dasabuvir, The metabolism of Dasabuvir can be decreased when combined with Codeine.]
[N06AX11, mirtazapine, Codeine may increase the serotonergic activities of Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Codeine can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The risk or severity of adverse effects can be increased when Palbociclib is combined with Codeine.]
[L01XH03, panobinostat, The metabolism of Codeine can be decreased when combined with Panobinostat.]
[A03AA09, difemerine, The risk or severity of adverse effects can be increased when Difemerine is combined with Codeine.]
[J05AF08, adefovir dipivoxil, The excretion of Adefovir dipivoxil can be decreased when combined with Codeine.]
[J05AP06, asunaprevir, The metabolism of Codeine can be decreased when combined with Asunaprevir.]
[A07DA06, eluxadoline, The risk or severity of constipation can be increased when Codeine is combined with Eluxadoline.]
[N05AX16, brexpiprazole, The risk or severity of adverse effects can be increased when Codeine is combined with Brexpiprazole.]
[A04AD14, rolapitant, The metabolism of Codeine can be decreased when combined with Rolapitant.]
[G02CX02, flibanserin, The risk or severity of adverse effects can be increased when Codeine is combined with Flibanserin.]
[A06AD03, magnesium peroxide, The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Codeine.]
[N05AX15, cariprazine, The risk or severity of adverse effects can be increased when Codeine is combined with Cariprazine.]
[S01EC01, acetazolamide, The risk or severity of adverse effects can be increased when Codeine is combined with Acetazolamide.]
[N05AB07, acetophenazine, The risk or severity of hypotension and CNS depression can be increased when Acetophenazine is combined with Codeine.]
[A02BC03, lansoprazole, The metabolism of Codeine can be decreased when combined with Lansoprazole.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Codeine.]
[J02AC05, isavuconazole, The metabolism of Codeine can be decreased when combined with Isavuconazole.]
[J05AF13, tenofovir alafenamide, The excretion of Tenofovir alafenamide can be decreased when combined with Codeine.]
[N05CA05, aprobarbital, The risk or severity of adverse effects can be increased when Aprobarbital is combined with Codeine.]
[N03AX23, brivaracetam, The risk or severity of adverse effects can be increased when Codeine is combined with Brivaracetam.]
[L01XX52, venetoclax, The metabolism of Codeine can be decreased when combined with Venetoclax.]
[N05BA08, bromazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Bromazepam.]
[N04BC01, bromocriptine, The risk or severity of adverse effects can be increased when Codeine is combined with Bromocriptine.]
[A03AX08, alverine, The risk or severity of adverse effects can be increased when Codeine is combined with Alverine.]
[N06AA19, amineptin, The risk or severity of adverse effects can be increased when Codeine is combined with Amineptine.]
[N06BX11, aniracetam, The risk or severity of adverse effects can be increased when Codeine is combined with Aniracetam.]
[C03CA02, bumetanide, The therapeutic efficacy of Bumetanide can be decreased when used in combination with Codeine.]
[N01BB01, bupivacaine, The risk or severity of adverse effects can be increased when Bupivacaine is combined with Codeine.]
[C07AA19, bupranolol, The metabolism of Bupranolol can be decreased when combined with Codeine.]
[N07BC01, buprenorphine, Codeine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.]
[N05BE01, buspirone, The risk or severity of adverse effects can be increased when Codeine is combined with Buspirone.]
[N02AF01, butorphanol, The therapeutic efficacy of Codeine can be decreased when used in combination with Butorphanol.]
[S01GX07, azelastine, Codeine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.]
[L01XK03, rucaparib, The metabolism of Codeine can be decreased when combined with Rucaparib.]
[A06AX07, plecanatide, The therapeutic efficacy of Plecanatide can be decreased when used in combination with Codeine.]
[L01EF02, ribociclib, The metabolism of Codeine can be decreased when combined with Ribociclib.]
[A06AH05, naldemedine, The therapeutic efficacy of Codeine can be decreased when used in combination with Naldemedine.]
[N07XX16, deutetrabenazine, The metabolism of Deutetrabenazine can be decreased when combined with Codeine.]
[N02BF02, pregabalin, The therapeutic efficacy of Codeine can be increased when used in combination with Pregabalin.]
[N03AX30, beclamide, The risk or severity of adverse effects can be increased when Codeine is combined with Beclamide.]
[S01HA02, benoxinate, The risk or severity of adverse effects can be increased when Codeine is combined with Oxybuprocaine.]
[J01XX08, linezolid, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Codeine.]
[J05AE09, tipranavir, The metabolism of Codeine can be decreased when combined with Tipranavir.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Codeine.]
[L04AB02, infliximab, The metabolism of Codeine can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Codeine can be decreased when combined with Midostaurin.]
[N04BD03, safinamide, The risk or severity of adverse effects can be increased when Codeine is combined with Safinamide.]
[S01EB09, acetylcholine, The risk or severity of adverse effects can be increased when Codeine is combined with Acetylcholine.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Codeine.]
[J05AG03, efavirenz, The metabolism of Codeine can be decreased when combined with Efavirenz.]
[C07AA17, bopindolol, The metabolism of Bopindolol can be decreased when combined with Codeine.]
[N04AA11, bornaprine, The risk or severity of adverse effects can be increased when Bornaprine is combined with Codeine.]
[N05AD06, bromperidol, The risk or severity of adverse effects can be increased when Codeine is combined with Bromperidol.]
[N05CD09, brotizolam, The risk or severity of adverse effects can be increased when Codeine is combined with Brotizolam.]
[C03DA03, canrenone, The therapeutic efficacy of Canrenone can be decreased when used in combination with Codeine.]
[N05CA03, butobarbital, The risk or severity of adverse effects can be increased when Butobarbital is combined with Codeine.]
[J05AX18, letermovir, The metabolism of Letermovir can be decreased when combined with Codeine.]
[N06AA15, butriptyline, The risk or severity of adverse effects can be increased when Codeine is combined with Butriptyline.]
[A10BK04, ertugliflozin, The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Codeine.]
[N05CA08, butylvinal, The risk or severity of adverse effects can be increased when Codeine is combined with Vinylbital.]
[C09AA01, captopril, The excretion of Captopril can be decreased when combined with Codeine.]
[L02BB05, apalutamide, The metabolism of Codeine can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Codeine can be increased when combined with Carbamazepine.]
[A06AC08, calcium polycarbophil, The therapeutic efficacy of Calcium polycarbophil can be decreased when used in combination with Codeine.]
[A03AA03, camylofine, The risk or severity of adverse effects can be increased when Camylofin is combined with Codeine.]
[R06AA08, carbinoxamine, The risk or severity of adverse effects can be increased when Codeine is combined with Carbinoxamine.]
[C07AG02, carvedilol, The metabolism of Carvedilol can be decreased when combined with Codeine.]
[N03AX24, cannabidiol, The risk or severity of adverse effects can be increased when Cannabidiol is combined with Codeine.]
[L01EC03, encorafenib, The metabolism of Encorafenib can be decreased when combined with Codeine.]
[J01DD14, ceftibuten, The excretion of Ceftibuten can be decreased when combined with Codeine.]
[C07AB08, celiprolol, The metabolism of Celiprolol can be decreased when combined with Codeine.]
[H01CC03, elagolix, The metabolism of Elagolix can be decreased when combined with Codeine.]
[L01XX62, ivosidenib, The metabolism of Codeine can be increased when combined with Ivosidenib.]
[P01BA07, tafenoquine, The metabolism of Tafenoquine can be decreased when combined with Codeine.]
[N03AX17, stiripentol, The metabolism of Codeine can be decreased when combined with Stiripentol.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Codeine.]
[S01GX12, cetirizine, The risk or severity of adverse effects can be increased when Codeine is combined with Cetirizine.]
[N05CM04, carbromal, The risk or severity of adverse effects can be increased when Codeine is combined with Carbromal.]
[N01BA04, chloroprocaine, The risk or severity of adverse effects can be increased when Codeine is combined with Chloroprocaine.]
[R06AA06, chlorphenoxamine, The risk or severity of adverse effects can be increased when Chlorphenoxamine is combined with Codeine.]
[R03BB08, revefenacin, The risk or severity of adverse effects can be increased when Revefenacin is combined with Codeine.]
[L04AA39, emapalumab, The metabolism of Codeine can be increased when combined with Emapalumab.]
[L01EX13, gilteritinib, The risk or severity of adverse effects can be increased when Gilteritinib is combined with Codeine.]
[A06AX05, prucalopride, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Codeine.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be decreased when combined with Codeine.]
[A03FA08, cinitapride, The risk or severity of adverse effects can be increased when Codeine is combined with Cinitapride.]
[P02BX04, triclabendazole, The metabolism of Codeine can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The risk or severity of adverse effects can be increased when Codeine is combined with Esketamine.]
[J01FA09, clarithromycin, The metabolism of Codeine can be decreased when combined with Clarithromycin.]
[N06BA14, solriamfetol, The risk or severity of adverse effects can be increased when Codeine is combined with Solriamfetol.]
[N06AX29, brexanolone, The risk or severity of adverse effects can be increased when Codeine is combined with Brexanolone.]
[N05BA09, clobazam, The metabolism of Codeine can be decreased when combined with Clobazam.]
[A06AB05, castor oil, The therapeutic efficacy of Castor oil can be decreased when used in combination with Codeine.]
[N05BA22, cloxazolam, The risk or severity of adverse effects can be increased when Codeine is combined with Cloxazolam.]
[L04AB01, etanercept, The metabolism of Codeine can be increased when combined with Etanercept.]
[J01DB04, cefazolin, The excretion of Cefazolin can be decreased when combined with Codeine.]
[N05AA06, cyamemazine, The risk or severity of hypotension and CNS depression can be increased when Cyamemazine is combined with Codeine.]
[J01DC07, cefotiam, The excretion of Cefotiam can be decreased when combined with Codeine.]
[C03BX03, cicletanine, The therapeutic efficacy of Cicletanine can be decreased when used in combination with Codeine.]
[J01DD07, ceftizoxime, The excretion of Ceftizoxime can be decreased when combined with Codeine.]
[M03BX08, cyclobenzaprine, The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Codeine.]
[L01EJ02, fedratinib, The metabolism of Codeine can be decreased when combined with Fedratinib.]
[N07XX11, pitolisant, The serum concentration of Codeine can be decreased when it is combined with Pitolisant.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Codeine.]
[C03AA09, cyclothiazide, The therapeutic efficacy of Cyclothiazide can be decreased when used in combination with Codeine.]
[G04BE04, yohimbine, The risk or severity of adverse effects can be increased when Codeine is combined with Yohimbine.]
[A06AB03, danthron, The therapeutic efficacy of Dantron can be decreased when used in combination with Codeine.]
[J01DB01, cephalexin, The excretion of Cephalexin can be decreased when combined with Codeine.]
[J01DB02, cephaloridine, The excretion of Cefaloridine can be decreased when combined with Codeine.]
[N02CC08, lasmiditan, The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Codeine.]
[N03AX25, cenobamate, The serum concentration of Codeine can be decreased when it is combined with Cenobamate.]
[A16AX16, givosiran, The serum concentration of Codeine can be increased when it is combined with Givosiran.]
[R06AB02, dexchlorpheniramine, The metabolism of Codeine can be decreased when combined with Dexchlorpheniramine.]
[N02AX03, dezocine, The risk or severity of adverse effects can be increased when Codeine is combined with Dezocine.]
[N05CM21, lemborexant, The risk or severity of adverse effects can be increased when Codeine is combined with Lemborexant.]
[N05AD10, lumateperone, The risk or severity of adverse effects can be increased when Codeine is combined with Lumateperone.]
[M01AX21, diacetylrhein, The metabolism of Codeine can be decreased when combined with Diacerein.]
[H02CA02, osilodrostat, The metabolism of Codeine can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Codeine can be decreased when combined with Amprenavir.]
[N02CC07, frovatriptan, The risk or severity of adverse effects can be increased when Codeine is combined with Frovatriptan.]
[N05CC04, dichloralphenazone, The risk or severity of adverse effects can be increased when Codeine is combined with Dichloralphenazone.]
[A07DA04, difenoxin, The risk or severity of adverse effects can be increased when Codeine is combined with Difenoxin.]
[N02AA08, dihydrocodeine, The risk or severity of adverse effects can be increased when Codeine is combined with Dihydrocodeine.]
[N02CC06, eletriptan, The risk or severity of adverse effects can be increased when Eletriptan is combined with Codeine.]
[C08CA16, clevidipine, The metabolism of Clevidipine can be decreased when combined with Codeine.]
[C01BD07, dronedarone, The metabolism of Codeine can be decreased when combined with Dronedarone.]
[N03AG02, dipropylacetamide, The risk or severity of adverse effects can be increased when Codeine is combined with Valpromide.]
[N05BA02, chlordiazepoxide, The risk or severity of adverse effects can be increased when Codeine is combined with Chlordiazepoxide.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Codeine.]
[A03AA08, dihexyverine, The risk or severity of adverse effects can be increased when Dihexyverine is combined with Codeine.]
[G04BD09, trospium, The risk or severity of adverse effects can be increased when Trospium is combined with Codeine.]
[N05CM02, chlormethiazole, The risk or severity of adverse effects can be increased when Codeine is combined with Clomethiazole.]
[M03BB02, chlormezanone, The risk or severity of adverse effects can be increased when Codeine is combined with Chlormezanone.]
[R02AD04, dyclonine, The risk or severity of adverse effects can be increased when Codeine is combined with Dyclonine.]
[P01BB01, proguanil, The metabolism of Codeine can be decreased when combined with Proguanil.]
[N05CD14, remimazolam, The risk or severity of adverse effects can be increased when Codeine is combined with Remimazolam.]
[L04AC19, satralizumab, The serum concentration of Codeine can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Codeine is combined with Oliceridine.]
[P01BA01, chloroquine, The metabolism of Codeine can be decreased when combined with Chloroquine.]
[C03AA04, chlorothiazide, The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Codeine.]
[N05AA01, chlorpromazine, The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Codeine.]
[N05AF03, chlorprothixene, The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Codeine.]
[C03BA04, chlorthalidone, The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Codeine.]
[A11CC05, cholecalciferol, The metabolism of Codeine can be decreased when combined with Cholecalciferol.]
[N05BX03, etifoxine, The risk or severity of adverse effects can be increased when Codeine is combined with Etifoxine.]
[N02BA03, choline salicylate, The risk or severity of adverse effects can be increased when Codeine is combined with Choline salicylate.]
[N06BX18, vinpocetine, The risk or severity of adverse effects can be increased when Codeine is combined with Vinpocetine.]
[N05BA18, ethyl loflazepate, The risk or severity of adverse effects can be increased when Codeine is combined with Ethyl loflazepate.]
[B06AC06, berotralstat, The metabolism of Codeine can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The metabolism of Codeine can be decreased when combined with Lonafarnib.]
[P03AX07, abametapir, The serum concentration of Codeine can be increased when it is combined with Abametapir.]
[M03BA05, febarbamate, The risk or severity of adverse effects can be increased when Codeine is combined with Febarbamate.]
[N03AX10, felbamate, The risk or severity of adverse effects can be increased when Codeine is combined with Felbamate.]
[J01DD15, cefdinir, The excretion of Cefdinir can be decreased when combined with Codeine.]
[S01JA01, fluorescein, The excretion of Fluorescein can be decreased when combined with Codeine.]
[R03CC15, formoterol, The risk or severity of adverse effects can be increased when Codeine is combined with Formoterol.]
[N01AB05, trichloroethylene, The risk or severity of adverse effects can be increased when Codeine is combined with Trichloroethylene.]
[L03AB10, peginterferon alfa-2b, The metabolism of Codeine can be decreased when combined with Peginterferon alfa-2b.]
[A02BA01, cimetidine, The metabolism of Codeine can be decreased when combined with Cimetidine.]
[N02BF01, gabapentin, The risk or severity of adverse effects can be increased when Codeine is combined with Gabapentin.]
[N07CA02, cinnarizine, The metabolism of Cinnarizine can be decreased when combined with Codeine.]
[L01XX73, sotorasib, The serum concentration of Codeine can be decreased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, The metabolism of Codeine can be decreased when combined with Ciprofloxacin.]
[N06AB04, citalopram, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Citalopram.]
[C03DA05, finerenone, The therapeutic efficacy of Finerenone can be decreased when used in combination with Codeine.]
[P01CA03, fexinidazole, The metabolism of Fexinidazole can be decreased when combined with Codeine.]
[R06AA04, clemastine, The risk or severity of adverse effects can be increased when Clemastine is combined with Codeine.]
[N06AX25, St. John's wort extract, The metabolism of Codeine can be increased when combined with St. John's Wort.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of neuropsychiatric effects can be increased when Ropeginterferon alfa-2b is combined with Codeine.]
[N01BB10, levobupivacaine, The risk or severity of adverse effects can be increased when Codeine is combined with Levobupivacaine.]
[L01EJ03, pacritinib, The serum concentration of Codeine can be increased when it is combined with Pacritinib.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Codeine.]
[N03AE01, clonazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Clonazepam.]
[S01EA04, clonidine, The risk or severity of sedation can be increased when Clonidine is combined with Codeine.]
[C01EB24, mavacamten, The serum concentration of Codeine can be decreased when it is combined with Mavacamten.]
[C03BA03, clopamide, The therapeutic efficacy of Clopamide can be decreased when used in combination with Codeine.]
[N05AH06, clothiapine, The risk or severity of adverse effects can be increased when Codeine is combined with Clothiapine.]
[N05BA21, clotiazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Clotiazepam.]
[A04AA01, ondansetron, The risk or severity of adverse effects can be increased when Codeine is combined with Ondansetron.]
[A04AA02, granisetron, The risk or severity of adverse effects can be increased when Codeine is combined with Granisetron.]
[N05AH02, clozapine, The risk or severity of adverse effects can be increased when Clozapine is combined with Codeine.]
[N05BA13, halazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Halazepam.]
[H01AC08, somatrogon, The metabolism of Codeine can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The risk or severity of adverse effects can be increased when Cocaine is combined with Codeine.]
[C02KB01, metyrosine, Codeine may increase the sedative activities of Metyrosine.]
[L04AC21, bimekizumab, The metabolism of Codeine can be increased when combined with Bimekizumab.]
[S01AA13, fusidic acid, The metabolism of Codeine can be decreased when combined with Fusidic acid.]
[N07XX04, sodium oxybate, Codeine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.]
[M01AG01, mefenamic acid, The metabolism of Codeine can be decreased when combined with Mefenamic acid.]
[M03AC05, hexafluorenium, The risk or severity of adverse effects can be increased when Hexafluronium is combined with Codeine.]
[A03AB10, hexocyclium, The risk or severity of adverse effects can be increased when Hexocyclium is combined with Codeine.]
[A03BB06, homatropine methylbromide, The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Codeine.]
[N01AB07, desflurane, The risk or severity of adverse effects can be increased when Codeine is combined with Desflurane.]
[A04AA03, tropisetron, The risk or severity of adverse effects can be increased when Codeine is combined with Tropisetron.]
[C04AX28, ifenprodil, The risk or severity of adverse effects can be increased when Codeine is combined with Ifenprodil.]
[A10BX03, nateglinide, The metabolism of Nateglinide can be decreased when combined with Codeine.]
[J01FA15, telithromycin, The metabolism of Codeine can be decreased when combined with Telithromycin.]
[R03BA08, ciclesonide, The metabolism of Ciclesonide can be decreased when combined with Codeine.]
[R06AX27, desloratadine, The risk or severity of adverse effects can be increased when Desloratadine is combined with Codeine.]
[H01AX01, pegvisomant, The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Codeine.]
[N02CC05, almotriptan, The risk or severity of adverse effects can be increased when Codeine is combined with Almotriptan.]
[J02AC02, itraconazole, The metabolism of Codeine can be decreased when combined with Itraconazole.]
[S01AD03, acyclovir, The risk or severity of adverse effects can be increased when Codeine is combined with Acyclovir.]
[N05BA10, ketazolam, The risk or severity of adverse effects can be increased when Codeine is combined with Ketazolam.]
[L01EA01, imatinib, The serum concentration of Codeine can be increased when it is combined with Imatinib.]
[J02AC04, posaconazole, The metabolism of Codeine can be decreased when combined with Posaconazole.]
[A06AD12, lactitol, The therapeutic efficacy of Lactitol can be decreased when used in combination with Codeine.]
[N03AX09, lamotrigine, The risk or severity of adverse effects can be increased when Lamotrigine is combined with Codeine.]
[N07BC04, lofexidine, The therapeutic efficacy of Codeine can be increased when used in combination with Lofexidine.]
[N05CD06, lormetazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Lormetazepam.]
[A06AD01, magnesium carbonate, The therapeutic efficacy of Magnesium carbonate can be decreased when used in combination with Codeine.]
[C08CA11, manidipine, The metabolism of Codeine can be decreased when combined with Manidipine.]
[A03AA04, mebeverine, The risk or severity of adverse effects can be increased when Mebeverine is combined with Codeine.]
[N06AX13, medifoxamine, The risk or severity of adverse effects can be increased when Codeine is combined with Medifoxamine.]
[C07AA14, mepindolol, The metabolism of Mepindolol can be decreased when combined with Codeine.]
[R06AD07, mequitazine, The metabolism of Mequitazine can be decreased when combined with Codeine.]
[N04AA03, methixene, The risk or severity of adverse effects can be increased when Metixene is combined with Codeine.]
[R03CB02, methoxyphenamine, Methoxyphenamine may increase the analgesic activities of Codeine.]
[R06AE03, cyclizine, The risk or severity of adverse effects can be increased when Codeine is combined with Cyclizine.]
[N05CA10, cyclobarbital, The risk or severity of adverse effects can be increased when Codeine is combined with Cyclobarbital.]
[C03DA04, eplerenone, The therapeutic efficacy of Eplerenone can be decreased when used in combination with Codeine.]
[N05AD03, metylperon, The risk or severity of adverse effects can be increased when Codeine is combined with Melperone.]
[C03AA07, cyclopenthiazide, The therapeutic efficacy of Cyclopenthiazide can be decreased when used in combination with Codeine.]
[J05AF07, tenofovir disoproxil, The excretion of Tenofovir disoproxil can be decreased when combined with Codeine.]
[N06AX07, minaprine, The risk or severity of adverse effects can be increased when Codeine is combined with Minaprine.]
[S01XA18, cyclosporine, The metabolism of Codeine can be decreased when combined with Cyclosporine.]
[N06AG02, moclobemide, The risk or severity of adverse effects can be increased when Codeine is combined with Moclobemide.]
[R06AX02, cyproheptadine, The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Codeine.]
[C03XA02, conivaptan, The metabolism of Codeine can be decreased when combined with Conivaptan.]
[L01BC01, cytarabine, The risk or severity of adverse effects can be increased when Codeine is combined with Cytarabine.]
[M01AH05, etoricoxib, The metabolism of Codeine can be decreased when combined with Etoricoxib.]
[G03XA01, danazol, The metabolism of Codeine can be decreased when combined with Danazol.]
[M03CA01, dantrolene, The risk or severity of adverse effects can be increased when Codeine is combined with Dantrolene.]
[N06BX04, deanol, The risk or severity of adverse effects can be increased when Codeine is combined with Deanol.]
[C02CC04, debrisoquin, The metabolism of Debrisoquine can be decreased when combined with Codeine.]
[A04AD11, nabilone, Nabilone may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[N07BB05, nalmefene, The therapeutic efficacy of Codeine can be decreased when used in combination with Nalmefene.]
[B05XA15, potassium lactate, The therapeutic efficacy of Potassium lactate can be decreased when used in combination with Codeine.]
[N05BA16, nordazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Nordazepam.]
[C07AB12, nebivolol, The metabolism of Nebivolol can be decreased when combined with Codeine.]
[N06AX06, nefazodone, The metabolism of Codeine can be decreased when combined with Nefazodone.]
[N05CM16, niaprazine, The risk or severity of adverse effects can be increased when Codeine is combined with Niaprazine.]
[N03AG06, tiagabine, The risk or severity of adverse effects can be increased when Codeine is combined with Tiagabine.]
[M03AC11, cisatracurium, The risk or severity of adverse effects can be increased when Cisatracurium is combined with Codeine.]
[R05DA06, normethadone, The risk or severity of adverse effects can be increased when Codeine is combined with Normethadone.]
[N06AB10, escitalopram, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Escitalopram.]
[G04BD08, solifenacin, The risk or severity of adverse effects can be increased when Solifenacin is combined with Codeine.]
[N06AA01, desipramine, The risk or severity of adverse effects can be increased when Desipramine is combined with Codeine.]
[H01BA02, desmopressin, The risk or severity of hyponatremia can be increased when Codeine is combined with Desmopressin.]
[N03AF02, oxcarbazepine, The risk or severity of adverse effects can be increased when Codeine is combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Codeine can be increased when combined with Dexamethasone.]
[N06BX07, oxiracetam, The risk or severity of adverse effects can be increased when Codeine is combined with Oxiracetam.]
[N04AA08, dexetimide, The risk or severity of adverse effects can be increased when Dexetimide is combined with Codeine.]
[G04BD04, oxybutynin, The risk or severity of adverse effects can be increased when Oxybutynin is combined with Codeine.]
[A08AA04, dexfenfluramine, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Dexfenfluramine.]
[A03AA01, oxyphencyclimine, The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Codeine.]
[L04AB04, adalimumab, The metabolism of Codeine can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Codeine can be decreased when combined with Gefitinib.]
[N06BA02, dextroamphetamine, Amphetamine may increase the analgesic activities of Codeine.]
[R05DA09, dextromethorphan, The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Codeine.]
[N03AC01, paramethadione, The risk or severity of adverse effects can be increased when Codeine is combined with Paramethadione.]
[N02AC01, dextromoramide, The risk or severity of adverse effects can be increased when Codeine is combined with Dextromoramide.]
[N06AB05, paroxetine, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Paroxetine.]
[B01AC04, clopidogrel, Codeine can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N07BC06, heroin, The risk or severity of adverse effects can be increased when Codeine is combined with Diamorphine.]
[N05BA01, diazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Diazepam.]
[N03AX07, phenacemide, The risk or severity of adverse effects can be increased when Codeine is combined with Phenacemide.]
[N03AD02, phensuximide, The risk or severity of adverse effects can be increased when Codeine is combined with Phensuximide.]
[N06AA08, dibenzepin, The risk or severity of adverse effects can be increased when Codeine is combined with Dibenzepin.]
[S02DA04, dibucaine, The risk or severity of adverse effects can be increased when Codeine is combined with Cinchocaine.]
[S01EC02, dichlorphenamide, The therapeutic efficacy of Diclofenamide can be decreased when used in combination with Codeine.]
[A03AA07, dicyclomine, The risk or severity of adverse effects can be increased when Dicyclomine is combined with Codeine.]
[J05AF03, zalcitabine, The excretion of Zalcitabine can be decreased when combined with Codeine.]
[J05AF02, didanosine, The excretion of Didanosine can be decreased when combined with Codeine.]
[N05AD05, pipamperone, The risk or severity of adverse effects can be increased when Codeine is combined with Pipamperone.]
[A03AB14, pipenzolate, The risk or severity of adverse effects can be increased when Pipenzolate is combined with Codeine.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Codeine.]
[C03CA03, piretanide, The therapeutic efficacy of Piretanide can be decreased when used in combination with Codeine.]
[A08AA03, diethylpropion, Diethylpropion may increase the analgesic activities of Codeine.]
[C08CA03, isradipine, The metabolism of Codeine can be decreased when combined with Isradipine.]
[A03AB11, poldine, The risk or severity of adverse effects can be increased when Poldine is combined with Codeine.]
[N02CA01, dihydroergotamine, The risk or severity of adverse effects can be increased when Codeine is combined with Dihydroergotamine.]
[N02AA03, hydromorphone, The risk or severity of adverse effects can be increased when Codeine is combined with Hydromorphone.]
[J05AE08, atazanavir, The metabolism of Codeine can be decreased when combined with Atazanavir.]
[D04AB07, pramoxine, The risk or severity of adverse effects can be increased when Codeine is combined with Pramocaine.]
[C08DB01, diltiazem, The metabolism of Codeine can be decreased when combined with Diltiazem.]
[R06AA11, dimenhydrinate, The risk or severity of adverse effects can be increased when Codeine is combined with Dimenhydrinate.]
[M03BX03, pridinol, The risk or severity of adverse effects can be increased when Codeine is combined with Pridinol.]
[R06AB03, dimethindene, The risk or severity of adverse effects can be increased when Dimetindene is combined with Codeine.]
[M02AX03, dimethyl sulfoxide, The metabolism of Codeine can be decreased when combined with Dimethyl sulfoxide.]
[N03AG05, progabide, The risk or severity of adverse effects can be increased when Codeine is combined with Progabide.]
[G02AD02, dinoprostone, The risk or severity of adverse effects can be increased when Dinoprostone is combined with Codeine.]
[A07DA01, diphenoxylate, The risk or severity of adverse effects can be increased when Codeine is combined with Diphenoxylate.]
[N05CD10, quazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Quazepam.]
[N06BA11, dexmethylphenidate, The risk or severity of adverse effects can be increased when Codeine is combined with Dexmethylphenidate.]
[N06AA23, quinupramine, The risk or severity of adverse effects can be increased when Codeine is combined with Quinupramine.]
[A03FA02, cisapride, The metabolism of Codeine can be decreased when combined with Cisapride.]
[N05AL04, remoxipride, The risk or severity of adverse effects can be increased when Codeine is combined with Remoxipride.]
[C01BA03, disopyramide, The risk or severity of adverse effects can be increased when Disopyramide is combined with Codeine.]
[S02AA12, rifamycin SV, The metabolism of Codeine can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Codeine can be increased when combined with Rifapentine.]
[N07XX02, riluzole, The risk or severity of adverse effects can be increased when Codeine is combined with Riluzole.]
[N05AX08, risperidone, The risk or severity of adverse effects can be increased when Codeine is combined with Risperidone.]
[R06AE09, levocetirizine, The risk or severity of adverse effects can be increased when Codeine is combined with Levocetirizine.]
[N01BB09, ropivacaine, The risk or severity of adverse effects can be increased when Ropivacaine is combined with Codeine.]
[A04AD12, aprepitant, The metabolism of Codeine can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, The therapeutic efficacy of Tolvaptan can be decreased when used in combination with Codeine.]
[L01XG01, bortezomib, The metabolism of Codeine can be decreased when combined with Bortezomib.]
[C01EB18, ranolazine, The serum concentration of Codeine can be increased when it is combined with Ranolazine.]
[R03AC12, salmeterol, The risk or severity of adverse effects can be increased when Codeine is combined with Salmeterol.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Codeine.]
[C01CA04, dopamine, The risk or severity of adverse effects can be increased when Codeine is combined with Dopamine.]
[N06AA16, dothiepin, The risk or severity of adverse effects can be increased when Dosulepin is combined with Codeine.]
[N06AA12, doxepin, The risk or severity of adverse effects can be increased when Doxepin is combined with Codeine.]
[A06AB06, sennosides, USP, The therapeutic efficacy of Sennosides can be decreased when used in combination with Codeine.]
[L01DB01, doxorubicin, The metabolism of Codeine can be decreased when combined with Doxorubicin.]
[N06AB06, sertraline, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Sertraline.]
[N01AB08, sevoflurane, The risk or severity of adverse effects can be increased when Codeine is combined with Sevoflurane.]
[N05AD08, droperidol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[A08AA10, sibutramine, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Sibutramine.]
[C10AA01, simvastatin, The metabolism of Simvastatin can be decreased when combined with Codeine.]
[V03AG05, sodium phosphate, The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Codeine.]
[A12CA02, sodium sulfate, The therapeutic efficacy of Sodium sulfate can be decreased when used in combination with Codeine.]
[N05AL02, sultopride, The risk or severity of adverse effects can be increased when Codeine is combined with Sultopride.]
[N02CC01, sumatriptan, The risk or severity of adverse effects can be increased when Codeine is combined with Sumatriptan.]
[C07AB13, talinolol, The metabolism of Talinolol can be decreased when combined with Codeine.]
[J01CG02, tazobactam, The excretion of Tazobactam can be decreased when combined with Codeine.]
[D01BA02, terbinafine, The metabolism of Codeine can be decreased when combined with Terbinafine.]
[C07AA16, tertatolol, The metabolism of Tertatolol can be decreased when combined with Codeine.]
[M03BX07, tetrazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Tetrazepam.]
[N05AB05, thiopropazate, The risk or severity of adverse effects can be increased when Codeine is combined with Thiopropazate.]
[G04BD01, emepronium, The risk or severity of adverse effects can be increased when Emepronium is combined with Codeine.]
[N06AX14, tianeptine, The risk or severity of adverse effects can be increased when Codeine is combined with Tianeptine.]
[N05BA23, tofisopam, The risk or severity of adverse effects can be increased when Codeine is combined with Tofisopam.]
[N06AG03, toloxatone, The risk or severity of adverse effects can be increased when Codeine is combined with Toloxatone.]
[N06BA09, atomoxetine, The metabolism of Codeine can be decreased when combined with Atomoxetine.]
[N03AX11, topiramate, The risk or severity of adverse effects can be increased when Topiramate is combined with Codeine.]
[C03CA04, torsemide, The therapeutic efficacy of Torasemide can be decreased when used in combination with Codeine.]
[N05CD11, triazulenone, The risk or severity of adverse effects can be increased when Codeine is combined with Loprazolam.]
[N05CM07, triclofos, The risk or severity of adverse effects can be increased when Codeine is combined with Triclofos.]
[A03AB08, tridihexethyl, The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Codeine.]
[R06AA10, trimethobenzamide, The risk or severity of adverse effects can be increased when Codeine is combined with Trimethobenzamide.]
[N04AA12, tropatepine, The risk or severity of adverse effects can be increased when Tropatepine is combined with Codeine.]
[N01AB04, enflurane, The risk or severity of adverse effects can be increased when Enflurane is combined with Codeine.]
[C02CA06, urapidil, The risk or severity of adverse effects can be increased when Codeine is combined with Urapidil.]
[N05AL06, veralipride, The risk or severity of adverse effects can be increased when Codeine is combined with Veralipride.]
[L01CA04, vinorelbine, The metabolism of Codeine can be decreased when combined with Vinorelbine.]
[S01GX10, epinastine, The risk or severity of adverse effects can be increased when Codeine is combined with Epinastine.]
[N06AX16, venlafaxine, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Venlafaxine.]
[C08CA12, mepirodipine, The metabolism of Codeine can be decreased when combined with Barnidipine.]
[S01EA01, epinephrine, The risk or severity of adverse effects can be increased when Codeine is combined with Epinephrine.]
[N05CF02, zolpidem, Codeine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.]
[N03AX15, zonisamide, The risk or severity of adverse effects can be increased when Codeine is combined with Zonisamide.]
[N05CF01, zopiclone, The risk or severity of adverse effects can be increased when Codeine is combined with Zopiclone.]
[N05AX11, zotepine, The risk or severity of adverse effects can be increased when Codeine is combined with Zotepine.]
[C02AC02, guanfacine, The risk or severity of adverse effects can be increased when Codeine is combined with Guanfacine.]
[C01BG01, moricizine, The risk or severity of hypotension and CNS depression can be increased when Moricizine is combined with Codeine.]
[G02AB03, ergonovine, The risk or severity of adverse effects can be increased when Codeine is combined with Ergometrine.]
[C04AE01, ergoloid mesylates, USP, The risk or severity of adverse effects can be increased when Codeine is combined with Ergoloid mesylate.]
[N02CA02, ergotamine, The metabolism of Codeine can be decreased when combined with Ergotamine.]
[S01AA17, erythromycin, The metabolism of Codeine can be decreased when combined with Erythromycin.]
[N05CD04, estazolam, The risk or severity of adverse effects can be increased when Codeine is combined with Estazolam.]
[H05BX01, cinacalcet, The metabolism of Codeine can be decreased when combined with Cinacalcet.]
[J04AK02, ethambutol, The metabolism of Codeine can be decreased when combined with Ethambutol.]
[C10AA04, fluvastatin, The metabolism of Fluvastatin can be decreased when combined with Codeine.]
[C01CA15, gepefrine, Gepefrine may increase the analgesic activities of Codeine.]
[N05CM08, ethchlorvynol, The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Codeine.]
[N04AA05, profenamine, The risk or severity of adverse effects can be increased when Profenamine is combined with Codeine.]
[N03AD01, ethosuximide, The risk or severity of adverse effects can be increased when Codeine is combined with Ethosuximide.]
[N03AB01, ethotoin, The risk or severity of adverse effects can be increased when Codeine is combined with Ethotoin.]
[N01AX07, etomidate, The risk or severity of adverse effects can be increased when Etomidate is combined with Codeine.]
[N05AE03, sertindole, The risk or severity of adverse effects can be increased when Codeine is combined with Sertindole.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Codeine.]
[R06AX12, terfenadine, The metabolism of Codeine can be decreased when combined with Terfenadine.]
[N06AX12, bupropion, The metabolism of Codeine can be decreased when combined with Bupropion.]
[N06AB08, fluvoxamine, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Fluvoxamine.]
[C01BC08, encainide, The metabolism of Encainide can be decreased when combined with Codeine.]
[C08CA02, felodipine, The metabolism of Codeine can be decreased when combined with Felodipine.]
[N03AX26, fenfluramine, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Fenfluramine.]
[R03CC04, fenoterol, The risk or severity of adverse effects can be increased when Fenoterol is combined with Codeine.]
[N02AB03, fentanyl, The risk or severity of adverse effects can be increased when Codeine is combined with Fentanyl.]
[N07AX03, cevimeline, The metabolism of Codeine can be decreased when combined with Cevimeline.]
[G04BD02, flavoxate, The risk or severity of adverse effects can be increased when Flavoxate is combined with Codeine.]
[C01BC04, flecainide, The metabolism of Flecainide can be decreased when combined with Codeine.]
[J02AC01, fluconazole, The metabolism of Codeine can be decreased when combined with Fluconazole.]
[N07CA03, flunarizine, The risk or severity of adverse effects can be increased when Codeine is combined with Flunarizine.]
[N05CD03, flunitrazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Flunitrazepam.]
[N06AA14, melitracen, The risk or severity of adverse effects can be increased when Codeine is combined with Melitracen.]
[N06AB03, fluoxetine, The serum concentration of Codeine can be increased when it is combined with Fluoxetine.]
[N05AF01, flupenthixol, Codeine may increase the central nervous system depressant (CNS depressant) activities of Flupentixol.]
[N05AB02, fluphenazine, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Codeine.]
[N05CD01, flurazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Flurazepam.]
[N05AG01, fluspirilene, The risk or severity of adverse effects can be increased when Codeine is combined with Fluspirilene.]
[M03AA01, alcuronium, The risk or severity of adverse effects can be increased when Alcuronium is combined with Codeine.]
[G01AX06, furazolidone, The risk or severity of adverse effects can be increased when Codeine is combined with Furazolidone.]
[J05AE10, darunavir, The metabolism of Codeine can be decreased when combined with Darunavir.]
[C03CA01, furosemide, The therapeutic efficacy of Furosemide can be decreased when used in combination with Codeine.]
[N05CF04, eszopiclone, The risk or severity of CNS depression can be increased when Codeine is combined with Eszopiclone.]
[N05AL05, amisulpride, The risk or severity of adverse effects can be increased when Codeine is combined with Amisulpride.]
[N06DA04, galantamine, The metabolism of Galantamine can be decreased when combined with Codeine.]
[M03AC02, gallamine, The risk or severity of adverse effects can be increased when Gallamine is combined with Codeine.]
[S01AD09, ganciclovir, The risk or severity of adverse effects can be increased when Codeine is combined with Ganciclovir.]
[N03AA04, barbexaclone, The risk or severity of adverse effects can be increased when Codeine is combined with Barbexaclone.]
[N06AX08, bifemelane, The risk or severity of adverse effects can be increased when Codeine is combined with Bifemelane.]
[N04BC06, cabergoline, The risk or severity of adverse effects can be increased when Cabergoline is combined with Codeine.]
[N03AD03, methsuximide, The risk or severity of adverse effects can be increased when Codeine is combined with Methsuximide.]
[N01AH02, alfentanil, The risk or severity of adverse effects can be increased when Codeine is combined with Alfentanil.]
[A06AH02, alvimopan, The risk or severity of adverse effects can be increased when Codeine is combined with Alvimopan.]
[N05CM18, dexmedetomidine, The risk or severity of adverse effects can be increased when Codeine is combined with Dexmedetomidine.]
[N05CE01, glutethimide, The risk or severity of adverse effects can be increased when Codeine is combined with Glutethimide.]
[A06AX01, glycerin, The therapeutic efficacy of Glycerin can be decreased when used in combination with Codeine.]
[C02CA04, doxazosin, The risk or severity of adverse effects can be increased when Doxazosin is combined with Codeine.]
[C07AB09, esmolol, The metabolism of Codeine can be decreased when combined with Esmolol.]
[P01BX01, halofantrine, The metabolism of Codeine can be decreased when combined with Halofantrine.]
[N05AD01, haloperidol, The risk or severity of CNS depression can be increased when Haloperidol is combined with Codeine.]
[N01AB01, halothane, The risk or severity of adverse effects can be increased when Codeine is combined with Halothane.]
[N05AH04, quetiapine, The risk or severity of adverse effects can be increased when Quetiapine is combined with Codeine.]
[N02CX03, iprazochrome, The risk or severity of adverse effects can be increased when Codeine is combined with Iprazochrome.]
[N05CA21, allobarbital, The risk or severity of adverse effects can be increased when Codeine is combined with Allobarbital.]
[B05CB03, magnesium citrate, The therapeutic efficacy of Magnesium citrate can be decreased when used in combination with Codeine.]
[A12CD02, sodium monofluorophosphate, The therapeutic efficacy of Sodium fluorophosphate can be decreased when used in combination with Codeine.]
[N05CA16, hexobarbital, The risk or severity of adverse effects can be increased when Hexobarbital is combined with Codeine.]
[J05AG01, nevirapine, The risk or severity of adverse effects can be increased when Nevirapine is combined with Codeine.]
[C08CA10, nilvadipine, The metabolism of Codeine can be decreased when combined with Nilvadipine.]
[C03AA03, hydrochlorothiazide, The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Codeine.]
[R05DA03, hydrocodone, Codeine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.]
[C03AA02, hydroflumethiazide, The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Codeine.]
[A12BA02, potassium citrate, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Codeine.]
[G04BD06, propiverine, The risk or severity of adverse effects can be increased when Propiverine is combined with Codeine.]
[P01BA02, hydroxychloroquine, The metabolism of Codeine can be decreased when combined with Hydroxychloroquine.]
[N05AX07, prothipendyl, The risk or severity of adverse effects can be increased when Codeine is combined with Prothipendyl.]
[N05BB01, hydroxyzine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[L01DB06, idarubicin, The metabolism of Idarubicin can be decreased when combined with Codeine.]
[A06AD21, sodium tartrate, The therapeutic efficacy of Sodium tartrate can be decreased when used in combination with Codeine.]
[N01AH03, sufentanil, The risk or severity of adverse effects can be increased when Codeine is combined with Sufentanil.]
[N06AA02, imipramine, The risk or severity of adverse effects can be increased when Imipramine is combined with Codeine.]
[M03BX02, tizanidine, The risk or severity of adverse effects can be increased when Codeine is combined with Tizanidine.]
[C03BA11, indapamide, The therapeutic efficacy of Indapamide can be decreased when used in combination with Codeine.]
[S01BC01, indomethacin, The excretion of Indomethacin can be decreased when combined with Codeine.]
[N06AX17, milnacipran, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Milnacipran.]
[A03AA30, piperidolate, The risk or severity of adverse effects can be increased when Piperidolate is combined with Codeine.]
[N01BB08, articaine, The risk or severity of adverse effects can be increased when Codeine is combined with Articaine.]
[N05BA12, alprazolam, The risk or severity of adverse effects can be increased when Codeine is combined with Alprazolam.]
[N05CH02, ramelteon, The risk or severity of adverse effects can be increased when Codeine is combined with Ramelteon.]
[R06AE01, buclizine, The risk or severity of adverse effects can be increased when Buclizine is combined with Codeine.]
[C10AA06, cerivastatin, The metabolism of Codeine can be decreased when combined with Cerivastatin.]
[C07AA01, alprenolol, The risk or severity of adverse effects can be increased when Codeine is combined with Alprenolol.]
[C03BA02, quinethazone, The therapeutic efficacy of Quinethazone can be decreased when used in combination with Codeine.]
[V03AB01, ipecac, The metabolism of Ipecac can be decreased when combined with Codeine.]
[J05AF04, stavudine, The excretion of Stavudine can be decreased when combined with Codeine.]
[N06AA13, iprindole, The risk or severity of adverse effects can be increased when Codeine is combined with Iprindole.]
[G04BE01, alprostadil, The excretion of Alprostadil can be decreased when combined with Codeine.]
[N06AF05, iproniazid, The risk or severity of adverse effects can be increased when Codeine is combined with Iproniazid.]
[N05AA07, chlorproethazine, The risk or severity of hypotension and CNS depression can be increased when Chlorproethazine is combined with Codeine.]
[N06AF01, isocarboxazid, The risk or severity of adverse effects can be increased when Codeine is combined with Isocarboxazid.]
[N01AB06, isoflurane, The risk or severity of adverse effects can be increased when Isoflurane is combined with Codeine.]
[N04BX02, entacapone, The risk or severity of adverse effects can be increased when Codeine is combined with Entacapone.]
[J04AC01, isoniazid, The metabolism of Codeine can be decreased when combined with Isoniazid.]
[N06AX18, reboxetine, The risk or severity of adverse effects can be increased when Reboxetine is combined with Codeine.]
[L04AC07, tocilizumab, The metabolism of Codeine can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The risk or severity of adverse effects can be increased when Codeine is combined with Ketamine.]
[C02KD01, ketanserin, The risk or severity of adverse effects can be increased when Codeine is combined with Ketanserin.]
[J02AB02, ketoconazole, The metabolism of Codeine can be decreased when combined with Ketoconazole.]
[N05AH03, olanzapine, The risk or severity of adverse effects can be increased when Olanzapine is combined with Codeine.]
[L04AA24, abatacept, The metabolism of Codeine can be increased when combined with Abatacept.]
[N04BC09, rotigotine, Codeine may increase the sedative activities of Rotigotine.]
[C07AG01, labetalol, The metabolism of Codeine can be decreased when combined with Labetalol.]
[N04BB01, amantadine, The risk or severity of adverse effects can be increased when Amantadine is combined with Codeine.]
[A06AD11, lactulose, The therapeutic efficacy of Lactulose can be decreased when used in combination with Codeine.]
[A06AX03, lubiprostone, The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Codeine.]
[N03AX18, lacosamide, The risk or severity of adverse effects can be increased when Codeine is combined with Lacosamide.]
[C03CC01, ethacrynic acid, The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Codeine.]
[N04BA01, levodopa, The risk or severity of adverse effects can be increased when Codeine is combined with Levodopa.]
[S02DA01, lidocaine, The risk or severity of adverse effects can be increased when Lidocaine is combined with Codeine.]
[C03DB01, amiloride, The therapeutic efficacy of Amiloride can be decreased when used in combination with Codeine.]
[N02CA07, lisuride, The risk or severity of adverse effects can be increased when Codeine is combined with Lisuride.]
[N06AA07, lofepramine, The risk or severity of adverse effects can be increased when Codeine is combined with Lofepramine.]
[N05BA06, lorazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Lorazepam.]
[C10AA02, lovastatin, The metabolism of Codeine can be decreased when combined with Lovastatin.]
[N05AH01, loxapine, The risk or severity of adverse effects can be increased when Codeine is combined with Loxapine.]
[L01EG01, temsirolimus, The metabolism of Codeine can be decreased when combined with Temsirolimus.]
[A12CC10, magnesium oxide, The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Codeine.]
[V04CC02, magnesium sulfate, The therapeutic efficacy of Codeine can be increased when used in combination with Magnesium sulfate.]
[L01EA03, nilotinib, The metabolism of Codeine can be decreased when combined with Nilotinib.]
[V04CX04, mannitol, The therapeutic efficacy of Mannitol can be decreased when used in combination with Codeine.]
[N06AA21, maprotiline, The risk or severity of adverse effects can be increased when Maprotiline is combined with Codeine.]
[A08AA05, mazindol, The risk or severity of adverse effects can be increased when Codeine is combined with Mazindol.]
[C02BB01, mecamylamine, The risk or severity of adverse effects can be increased when Mecamylamine is combined with Codeine.]
[R06AE05, meclizine, The risk or severity of adverse effects can be increased when Meclizine is combined with Codeine.]
[N05BA03, medazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Medazepam.]
[A06AB07, cascara sagrada, The therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Codeine.]
[C03BA05, mefruside, The therapeutic efficacy of Mefruside can be decreased when used in combination with Codeine.]
[N05CH01, melatonin, The risk or severity of adverse effects can be increased when Codeine is combined with Melatonin.]
[N02AB02, meperidine, The risk or severity of adverse effects can be increased when Codeine is combined with Meperidine.]
[C01CA11, mephentermine, Mephentermine may increase the analgesic activities of Codeine.]
[N03AB04, mephenytoin, The risk or severity of adverse effects can be increased when Codeine is combined with Mephenytoin.]
[N03AA01, mephobarbital, The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Codeine.]
[N01BB03, mepivacaine, The risk or severity of adverse effects can be increased when Codeine is combined with Mepivacaine.]
[N02AX05, meptazinol, The risk or severity of adverse effects can be increased when Codeine is combined with Meptazinol.]
[C03BC01, mersalyl, The therapeutic efficacy of Mersalyl can be decreased when used in combination with Codeine.]
[N05AC03, mesoridazine, The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Codeine.]
[N05AX13, paliperidone, The risk or severity of adverse effects can be increased when Codeine is combined with Paliperidone.]
[A04AA04, dolasetron, The risk or severity of adverse effects can be increased when Codeine is combined with Dolasetron.]
[N07BC02, methadone, The risk or severity of adverse effects can be increased when Methadone is combined with Codeine.]
[N06BA03, methamphetamine, Metamfetamine may increase the analgesic activities of Codeine.]
[A03AB07, methantheline, The risk or severity of adverse effects can be increased when Methantheline is combined with Codeine.]
[R06AC05, methapyrilene, The risk or severity of adverse effects can be increased when Codeine is combined with Methapyrilene.]
[N05CM01, methaqualone, The risk or severity of adverse effects can be increased when Codeine is combined with Methaqualone.]
[J05AF05, lamivudine, The risk or severity of adverse effects can be increased when Codeine is combined with Lamivudine.]
[N03AA30, metharbital, The risk or severity of adverse effects can be increased when Metharbital is combined with Codeine.]
[S01EC05, methazolamide, The therapeutic efficacy of Methazolamide can be decreased when used in combination with Codeine.]
[G02CB05, metergoline, The risk or severity of adverse effects can be increased when Codeine is combined with Metergoline.]
[H03BB02, methimazole, The metabolism of Codeine can be decreased when combined with Methimazole.]
[N05CA15, methohexital, The risk or severity of adverse effects can be increased when Codeine is combined with Methohexital.]
[N02BG08, ziconotide, The risk or severity of adverse effects can be increased when Codeine is combined with Ziconotide.]
[N05AA02, methotrimeprazine, Codeine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.]
[N02BG09, methoxyflurane, The risk or severity of adverse effects can be increased when Codeine is combined with Methoxyflurane.]
[C03AA08, methyclothiazide, The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Codeine.]
[A06AC06, methylcellulose, The therapeutic efficacy of Methylcellulose can be decreased when used in combination with Codeine.]
[V04CG05, methylene blue, Codeine may increase the serotonergic activities of Methylene blue.]
[N03AF03, rufinamide, The risk or severity of adverse effects can be increased when Rufinamide is combined with Codeine.]
[N05CE02, methyprylon, The risk or severity of adverse effects can be increased when Codeine is combined with Methyprylon.]
[N02CA04, methysergide, The risk or severity of adverse effects can be increased when Methysergide is combined with Codeine.]
[A03FA01, metoclopramide, The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Codeine.]
[C03BA08, metolazone, The therapeutic efficacy of Metolazone can be decreased when used in combination with Codeine.]
[C07AB02, metoprolol, The metabolism of Codeine can be decreased when combined with Metoprolol.]
[C01BB02, mexiletine, The metabolism of Mexiletine can be decreased when combined with Codeine.]
[N06AX03, mianserin, The risk or severity of adverse effects can be increased when Codeine is combined with Mianserin.]
[S02AA13, miconazole, The metabolism of Codeine can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be decreased when combined with Codeine.]
[N05CD08, midazolam, The risk or severity of adverse effects can be increased when Codeine is combined with Midazolam.]
[G03XB01, mifepristone, The metabolism of Codeine can be decreased when combined with Mifepristone.]
[A06AA01, mineral oil, The therapeutic efficacy of Mineral oil can be decreased when used in combination with Codeine.]
[J01AA08, minocycline, Minocycline may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[L01XX23, mitotane, The metabolism of Codeine can be increased when combined with Mitotane.]
[N06BA12, lisdexamfetamine, Lisdexamfetamine may increase the analgesic activities of Codeine.]
[N05AE02, molindone, The risk or severity of adverse effects can be increased when Codeine is combined with Molindone.]
[C01BD01, amiodarone, The metabolism of Codeine can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The risk or severity of adverse effects can be increased when Amitriptyline is combined with Codeine.]
[N02AA01, morphine, The risk or severity of adverse effects can be increased when Morphine is combined with Codeine.]
[A04AA05, palonosetron, The risk or severity of adverse effects can be increased when Codeine is combined with Palonosetron.]
[L04AB05, certolizumab pegol, The metabolism of Codeine can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Codeine can be decreased when combined with Eltrombopag.]
[L01EX03, pazopanib, The metabolism of Codeine can be decreased when combined with Pazopanib.]
[M03AC03, vecuronium, The risk or severity of adverse effects can be increased when Vecuronium is combined with Codeine.]
[N05CA02, amobarbital, The risk or severity of adverse effects can be increased when Amobarbital is combined with Codeine.]
[N06AA17, amoxapine, The risk or severity of adverse effects can be increased when Amoxapine is combined with Codeine.]
[N03AB05, fosphenytoin, The metabolism of Codeine can be increased when combined with Fosphenytoin.]
[C07AA12, nadolol, The metabolism of Nadolol can be decreased when combined with Codeine.]
[N04BC04, ropinirole, Codeine may increase the sedative activities of Ropinirole.]
[C04AX21, nafronyl, The risk or severity of adverse effects can be increased when Codeine is combined with Naftidrofuryl.]
[N02AF02, nalbuphine, The therapeutic efficacy of Codeine can be decreased when used in combination with Nalbuphine.]
[V03AB15, naloxone, The metabolism of Codeine can be decreased when combined with Naloxone.]
[N07BB04, naltrexone, The risk or severity of adverse effects can be increased when Codeine is combined with Naltrexone.]
[L04AC03, anakinra, The metabolism of Codeine can be increased when combined with Anakinra.]
[S01GA01, naphazoline, Naphazoline may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[N06BA01, amphetamine, Amphetamine may increase the analgesic activities of Codeine.]
[N06AX21, duloxetine, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Duloxetine.]
[N04BX01, tolcapone, The risk or severity of adverse effects can be increased when Codeine is combined with Tolcapone.]
[N01AH06, remifentanil, The risk or severity of adverse effects can be increased when Codeine is combined with Remifentanil.]
[N05AX14, iloperidone, The risk or severity of adverse effects can be increased when Codeine is combined with Iloperidone.]
[N06AX23, desvenlafaxine, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Desvenlafaxine.]
[C10AD02, niacin, The metabolism of Codeine can be decreased when combined with Niacin.]
[N06AF02, nialamide, The risk or severity of adverse effects can be increased when Codeine is combined with Nialamide.]
[C08CA04, nicardipine, The risk or severity of adverse effects can be increased when Nicardipine is combined with Codeine.]
[C04AE02, nicergoline, The metabolism of Nicergoline can be decreased when combined with Codeine.]
[N07BA01, nicotine, The risk or severity of adverse effects can be increased when Nicotine is combined with Codeine.]
[C08CA05, nifedipine, The metabolism of Nifedipine can be decreased when combined with Codeine.]
[N05CD02, nitrazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Nitrazepam.]
[N05CF03, zaleplon, The risk or severity of adverse effects can be increased when Codeine is combined with Zaleplon.]
[N04BC05, pramipexole, Codeine may increase the sedative activities of Pramipexole.]
[N01AX13, nitrous oxide, The risk or severity of adverse effects can be increased when Codeine is combined with Nitrous oxide.]
[N06AX04, nomifensine, The risk or severity of adverse effects can be increased when Codeine is combined with Nomifensine.]
[C01CA03, norepinephrine, The risk or severity of adverse effects can be increased when Codeine is combined with Norepinephrine.]
[N06AA10, nortriptyline, The risk or severity of adverse effects can be increased when Nortriptyline is combined with Codeine.]
[L04AC04, rilonacept, The metabolism of Codeine can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Codeine can be decreased when combined with Omeprazole.]
[N06AA05, opipramol, The risk or severity of adverse effects can be increased when Codeine is combined with Opipramol.]
[N02AA02, opium, The risk or severity of adverse effects can be increased when Codeine is combined with Opium.]
[G04CA02, tamsulosin, The metabolism of Tamsulosin can be decreased when combined with Codeine.]
[P02BA02, oxamniquine, The metabolism of Codeine can be decreased when combined with Oxamniquine.]
[N05BA04, oxazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Oxazepam.]
[C07AA02, oxprenolol, The risk or severity of adverse effects can be increased when Codeine is combined with Oxprenolol.]
[N02AA05, oxycodone, The risk or severity of adverse effects can be increased when Codeine is combined with Oxycodone.]
[N02AA11, oxymorphone, The risk or severity of adverse effects can be increased when Codeine is combined with Oxymorphone.]
[N05AE01, oxypertine, The risk or severity of adverse effects can be increased when Codeine is combined with Oxypertine.]
[A03AB03, oxyphenonium, The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Codeine.]
[V04CH30, 4-aminohippuric acid, The excretion of Aminohippuric acid can be decreased when combined with Codeine.]
[N05AH05, asenapine, The risk or severity of adverse effects can be increased when Codeine is combined with Asenapine.]
[N02AX06, tapentadol, Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[M03AC01, pancuronium, The risk or severity of adverse effects can be increased when Pancuronium is combined with Codeine.]
[N05CC05, paraldehyde, Codeine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.]
[C02KC01, pargyline, The risk or severity of adverse effects can be increased when Codeine is combined with Pargyline.]
[G04BD11, fesoterodine, The risk or severity of adverse effects can be increased when Fesoterodine is combined with Codeine.]
[C07AA23, penbutolol, The risk or severity of adverse effects can be increased when Codeine is combined with Penbutolol.]
[N05AG03, penfluridol, The risk or severity of adverse effects can be increased when Codeine is combined with Penfluridol.]
[N02AD01, pentazocine, The therapeutic efficacy of Codeine can be decreased when used in combination with Pentazocine.]
[N05CA01, pentobarbital, The risk or severity of adverse effects can be increased when Pentobarbital is combined with Codeine.]
[N05AB10, perazine, The risk or severity of hypotension and CNS depression can be increased when Perazine is combined with Codeine.]
[N04BC02, pergolide, The risk or severity of adverse effects can be increased when Codeine is combined with Pergolide.]
[C08EX02, perhexiline, The metabolism of Codeine can be decreased when combined with Perhexiline.]
[N05AB03, perphenazine, The risk or severity of hypotension and CNS depression can be increased when Perphenazine is combined with Codeine.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Codeine.]
[N02AD02, phenazocine, The risk or severity of adverse effects can be increased when Codeine is combined with Phenazocine.]
[N06AF03, phenelzine, The risk or severity of adverse effects can be increased when Codeine is combined with Phenelzine.]
[A10BA01, phenformin, The risk or severity of adverse effects can be increased when Codeine is combined with Phenformin.]
[A06AB01, oxyphenisatin, The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Codeine.]
[N01AH04, phenoperidine, The risk or severity of adverse effects can be increased when Codeine is combined with Phenoperidine.]
[C04AX02, phenoxybenzamine, The risk or severity of adverse effects can be increased when Phenoxybenzamine is combined with Codeine.]
[A08AA01, phentermine, Phentermine may increase the analgesic activities of Codeine.]
[N03AB02, phenytoin, The metabolism of Codeine can be increased when combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Codeine can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, The excretion of Levofloxacin can be decreased when combined with Codeine.]
[J05AB12, cidofovir, The excretion of Cidofovir can be decreased when combined with Codeine.]
[C08CX01, mibefradil, The metabolism of Codeine can be decreased when combined with Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Codeine.]
[C07AA03, pindolol, The risk or severity of adverse effects can be increased when Codeine is combined with Pindolol.]
[J05AE01, saquinavir, The metabolism of Codeine can be decreased when combined with Saquinavir.]
[P02CB01, piperazine, The metabolism of Piperazine can be decreased when combined with Codeine.]
[N05AC04, pipothiazine, The risk or severity of hypotension and CNS depression can be increased when Pipotiazine is combined with Codeine.]
[A02BX03, pirenzepine, The risk or severity of adverse effects can be increased when Pirenzepine is combined with Codeine.]
[N02AC03, pirinitramide, The risk or severity of adverse effects can be increased when Codeine is combined with Piritramide.]
[J01MA11, grepafloxacin, The excretion of Grepafloxacin can be decreased when combined with Codeine.]
[N02CX01, pizotyline, The risk or severity of adverse effects can be increased when Pizotifen is combined with Codeine.]
[J05AG02, delavirdine, The metabolism of Codeine can be decreased when combined with Delavirdine.]
[N05CA22, proxibarbal, The risk or severity of adverse effects can be increased when Codeine is combined with Proxibarbal.]
[A06AD15, polyethylene glycols, The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Codeine.]
[A03AE01, alosetron, The risk or severity of adverse effects can be increased when Codeine is combined with Alosetron.]
[L04AC08, canakinumab, The metabolism of Codeine can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, The therapeutic efficacy of Polythiazide can be decreased when used in combination with Codeine.]
[J05AE03, ritonavir, The serum concentration of Codeine can be increased when it is combined with Ritonavir.]
[C07AB01, practolol, The metabolism of Practolol can be decreased when combined with Codeine.]
[N05BA11, prazepam, The risk or severity of adverse effects can be increased when Codeine is combined with Prazepam.]
[C02CA01, prazosin, The risk or severity of adverse effects can be increased when Codeine is combined with Prazosin.]
[N01BB04, prilocaine, The risk or severity of adverse effects can be increased when Codeine is combined with Prilocaine.]
[P01BA03, primaquine, The metabolism of Codeine can be decreased when combined with Primaquine.]
[N03AA03, primidone, The risk or severity of adverse effects can be increased when Primidone is combined with Codeine.]
[M04AB01, probenecid, The risk or severity of adverse effects can be increased when Probenecid is combined with Codeine.]
[C01BA02, procainamide, The metabolism of Procainamide can be decreased when combined with Codeine.]
[S01HA05, procaine, The risk or severity of adverse effects can be increased when Codeine is combined with Procaine.]
[L01XB01, procarbazine, The risk or severity of adverse effects can be increased when Codeine is combined with Procarbazine.]
[N05AB04, prochlorperazine, The risk or severity of hypotension and CNS depression can be increased when Prochlorperazine is combined with Codeine.]
[N04AA04, procyclidine, The risk or severity of adverse effects can be increased when Procyclidine is combined with Codeine.]
[G03DA04, progesterone, The risk or severity of adverse effects can be increased when Progesterone is combined with Codeine.]
[N05AA03, promazine, The risk or severity of adverse effects can be increased when Promazine is combined with Codeine.]
[C01BC03, propafenone, The metabolism of Codeine can be decreased when combined with Propafenone.]
[N01AX04, propanidid, The risk or severity of adverse effects can be increased when Codeine is combined with Propanidid.]
[A03AB05, propantheline, The risk or severity of adverse effects can be increased when Propantheline is combined with Codeine.]
[N05AC01, periciazine, The risk or severity of hypotension and CNS depression can be increased when Periciazine is combined with Codeine.]
[N05CM06, propiomazine, The risk or severity of adverse effects can be increased when Propiomazine is combined with Codeine.]
[N01AX10, propofol, Codeine may increase the sedative activities of Propofol.]
[N02AC04, propoxyphene, The risk or severity of adverse effects can be increased when Codeine is combined with Dextropropoxyphene.]
[C07AA05, propranolol, The metabolism of Codeine can be decreased when combined with Propranolol.]
[N02CC04, rizatriptan, The risk or severity of adverse effects can be increased when Codeine is combined with Rizatriptan.]
[N06AA11, protriptyline, The risk or severity of adverse effects can be increased when Codeine is combined with Protriptyline.]
[N05AX12, aripiprazole, The risk or severity of adverse effects can be increased when Aripiprazole is combined with Codeine.]
[A03AB15, diphemanil, The risk or severity of adverse effects can be increased when Diphemanil is combined with Codeine.]
[A03AB09, isopropamide, The risk or severity of adverse effects can be increased when Isopropamide is combined with Codeine.]
[S01FA03, methscopolamine, The risk or severity of adverse effects can be increased when Methscopolamine is combined with Codeine.]
[N05CA07, talbutal, The risk or severity of adverse effects can be increased when Talbutal is combined with Codeine.]
[N05CA09, vinbarbital, The risk or severity of adverse effects can be increased when Codeine is combined with Vinbarbital.]
[N05BB02, captodiamine, The risk or severity of adverse effects can be increased when Codeine is combined with Captodiame.]
[M03BA04, styramate, The risk or severity of adverse effects can be increased when Codeine is combined with Styramate.]
[P02CC01, pyrantel, The risk or severity of adverse effects can be increased when Codeine is combined with Pyrantel.]
[C01BA01, quinidine, The risk or severity of adverse effects can be increased when Quinidine is combined with Codeine.]
[P01BC01, quinine, The metabolism of Codeine can be decreased when combined with Quinine.]
[A02BA02, ranitidine, The metabolism of Codeine can be decreased when combined with Ranitidine.]
[C02AA02, reserpine, The risk or severity of adverse effects can be increased when Reserpine is combined with Codeine.]
[J04AB02, rifampin, The metabolism of Codeine can be increased when combined with Rifampicin.]
[N06AX01, 5-hydroxytryptophan, The risk or severity of adverse effects can be increased when Codeine is combined with Oxitriptan.]
[S01FA02, scopolamine, The risk or severity of adverse effects can be increased when Scopolamine is combined with Codeine.]
[N05CA06, secobarbital, The risk or severity of adverse effects can be increased when Secobarbital is combined with Codeine.]
[N04BD01, selegiline, The risk or severity of adverse effects can be increased when Codeine is combined with Selegiline.]
[V04CC01, sorbitol, The therapeutic efficacy of Sorbitol can be decreased when used in combination with Codeine.]
[C07AA07, sotalol, The metabolism of Sotalol can be decreased when combined with Codeine.]
[C03DA01, spironolactone, The therapeutic efficacy of Spironolactone can be decreased when used in combination with Codeine.]
[N05CC01, chloral hydrate, The risk or severity of adverse effects can be increased when Codeine is combined with Chloral hydrate.]
[N03AG01, valproic acid, The risk or severity of adverse effects can be increased when Valproic acid is combined with Codeine.]
[A05AA01, chenodeoxycholic acid, The metabolism of Codeine can be decreased when combined with Chenodeoxycholic acid.]
[H02CA04, levoketoconazole, The metabolism of Codeine can be decreased when combined with Levoketoconazole.]
[R03BB01, ipratropium bromide, The risk or severity of adverse effects can be increased when Ipratropium is combined with Codeine.]
